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Aptamer Biosensors 
Abstract 
Aptamers are single stranded nucleic acids, typically composed of between twenty to eighty nucleotides 
in length, capable of binding selectively to non-nucleic acid ligands. Aptamers are selected through a 
combinatorial chemistry process called Systematic Evolution of Ligands by Exponential enrichment 
(SELEX), which is composed of successive cycles of selection based on target affinity, followed by 
amplification. This results in the Darwinian evolution of the nucleic acid library resulting in increasing 
library homogeneity and target affinity over time. 
Aptamers have been extensively investigated for potential application as sensing molecules, with roles 
similar to those traditionally occupied by antibodies. Aptamers and monoclonal antibodies have similar 
sensitivity in the pico to micro molar range. However aptamers have a number of advantages over 
protein antibodies, such as greater thermal stability, ease of chemical amplification, and amenability to 
modification, especially at the 5’ and 3’ prime ends. 
The work performed in this Thesis is divided into three categories.  
The first section describes the development of voltammetric Kanamycin and Tetracycline biosensors 
based on electrode immobilized, redox label bioconjugated nucleotide molecular beacons. These 
sensors relies on the target-aptamer binding induced spatial displacement of the redox label towards or 
away from the electrode surface as a means of signal generation. Further study was conducted to test 
the feasibility of this sensor design under likely field operation environments such as in soil sample 
analysis for microbial product discovery and in agricultural effluence for regulatory purposes. The 
biosensor was also enhanced by gel encapsulation for defense against nuclease degradation. Negative 
control was performed against structurally similar antibiotics of the same family in order to prove the 
specificity of the biosensor. Lastly, the sensor was moved onto an automated platform in a multichannel 
format in order to improve the utility of the sensor. 
The second section describes the development of a voltammetric biosensor based on Enzyme-Linked 
Oligonucleotide Assay (ELONA) technology. Two sub-types of ELONA-like biosensors were originally 
envisioned, based respectively on direct and indirect ELONA. Both sub-types depend on the mass of 
redox label rich Gold Nanoparticles (GNP) at the electrode surface as a means of signal generation. 
Negative controls was performed against globular proteins Bovine Serum Albumin and Lysozyme, the 
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former since it is the most ubiquitous protein component of serum (the most likely biosensor 
operational environment), the latter as a worst case scenario for non-specific false positive results due 
to its positive charge.  
The last section describes an attempt to develop an automated SELEX device based on mesofluidic flow 
channels. It was hoped that by using flow channels of a millimeter scale it would be possible to retain 
both the advantages of the conventional auto sampler based SELEX protocols (large library and 
sequence variation), while also gaining the primary advantages of microfluidic SELEX (reduced 
contamination risk, low initial cost and maintenance). Essential components of the SELEX device, such as 
thermal cycler, liquid handling, electronics infrastructure, and software control were designed, tested 
and integrated. Lastly an attempt was made to perform automated SELEX against Lysozyme targets 
using the device, though no nucleic acid with high affinity to target had yet been successfully isolated by 
the end of this study.  
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Chapter 1: Introduction 
1.01 Overview of Biosensors 
A biosensor is an analytical device which converts a biological reaction into a measurable electronic 
signal [1]. While there is a large variety of biosensors, they all involve three basic components:  
A) A biorecognition element, which is the biological element with target binding capabilities.  
B) A transducer which transforms the change in the sensor molecule as a result of the sensor molecule-
target binding event into a signal measurable by the platform.  
C) The platform, typically the electronic components which amplifies and processes signals relayed by 
the transducer into a form that can be easily understood, and displays it.  
The combination of different molecular recognition and transduce components lead to a matrix of 
biosensor types as illustrated in figure 1.01. 
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Fig 1.01 Basic principle of biosensors. Bioreceptor molecules recognizes and binds target analyte, 
transducer converts this change into a signal compatible with the platform, which in turn converts the 
signal into a measurable format, and displays it.  
 
1.02 Operating Characteristics of Biosensors 
The success of any biosensor hinges on it having sufficient sensitivity and specificity. 
Specificity represents the range of targets which give rise to a signal from the biosensor. A good 
biosensor should not cross react with non-target molecules, yielding false positive signals. For practical 
purposes the biosensor should yield an unambiguous response, in order to reduce noise and false-
positive signals as a result of cross-reaction. Poor specificity is typically the result of the response of the 
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biosensor to the environmental matrix. Specificity will be discussed further in the experimental result 
sections.  
Sensitivity represents the lowest concentration of target the sensor is able to detect. This in turn 
strongly correlates to the ability of the biosensor to bind to the targeted analyte, and the ability of the 
sensor to convert this change into measurable signals. Low sensitivity results in the inability of the 
biosensor to detect the target molecule, resulting in a false negative signal. This is typically caused by 
low affinity of biosensory molecule to the target analyte or inability of transducer and platform to 
convert biosensory molecule-target interaction into measurable signal.  Sensitivity will be discussed 
further in the experimental result sections. 
While sensitivity and specificity form the two essential operating parameters which every biosensor 
must fulfil in order to be considered a functional device, the practical utility must also take into 
consideration secondary characteristics of a biosensor. This represents the practical desirability of a 
biosensor. These secondary characteristics include factors such as speed of response, dynamic range 
and robustness. 
 
1.03 Categorisation of Biosensors 
As shown in figure 1.01 there are many combinations of biorecognition molecules with transducer type 
and accordingly biosensors can be categorized in a number of ways. Perhaps the most common modes 
of classification is based on the nature of the bioreceptor molecule (a protein or aptamer biosensor, for 
example) or the nature of the transducing element (electrochemical or optical biosensors, for example).  
Biosensors can also be categorized by the mechanism of the signaling process (affinity or catalytic). 
Affinity or probing type sensors bind to the target analyte leading to the formation of a target-
bioreceptor complex, and the transducer revealing the concentration of the complex. Catalytic or 
reacting type biosensors convert the target analyte as substrate into a product, the concentration of 
which is measured by the transducer. Catalytic biosensors are more sensitive to environmental 
parameters that affect kinetic factors, such as pH and temperature, because of their dependence on 
rate rather than equilibrium processes. Affinity sensors depend on stoichiometry between bioreceptor 
molecules and targets for signal amplitude, whereas the magnitude of catalytic biosensor signal is 
dependent on the time and mass of the signaling substrate. A classic example of an affinity type 
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biosensor would be an affinity immunoassay [2][3] such as ELISA. The only major class of catalytic type 
biosensors are based on enzymatic mechanisms, a classic example being the electrochemical glucose 
oxidase sensor used for blood glucose monitoring [4]. 
Another mode of categorizing biosensors is by the presence or absence of a molecular label. A label is an 
exogenous molecule typically bioconjugated to the bioreceptor molecule, which is responsible for signal 
transduction to the platform. As such it could be viewed as a form of signal amplifier, and typically fills 
the role of transducer in a labeled biosensor system. Label free biosensors measure the change as a 
result of target-bioreceptor interaction itself, with the transducer detecting the intrinsic change at the 
molecular level involved in the binding event.  
Examples of label free biosensing techniques include SPR based sensing technology [5], nanomechanical 
cantilever sensors [6] derived from AFM technology or quartz crystal microbalances [7]. The most 
obvious advantage of label free biosensors is that no bioconjugated label is required, which reduces the 
cost of sensor surface synthesis due to the absence of labelling reagents and simplification of sensor 
surface fabrication by eliminating the bioconjugation steps. Some bioreceptor molecules (relatively 
complex proteins in particular) are not amenable to modification, which could lead to loss of sensitivity 
or specificity. Since the target-bioreceptor induced change in label free biosensors is being transduced 
directly into quantitative signal, this eliminates potential influence of the label in signal transduction 
which could potentially distort signal.  
The disadvantages of label free biosensing is that some bioreceptors do not generate sufficient change 
to be quantifiably measured without a label in the role of signal amplifier, thus reducing the range of 
potential bioreceptor molecules applicable. In addition the transducer and platform used in label free 
biosensing must typically be sensitive and relatively free from noise and interference. 
 
1.04 Components and Design Consideration of Biosensors 
There is a diverse range of organic molecules which could be used as biosensory molecules, including 
nucleic acids [8], antibodies [9] [10], enzymes [11] [12], binding proteins [13], and oligosaccharides [14]. 
The role of biosensory molecules is to interact with a target molecule and undergo change, which can 
occur in a variety of forms, including but not limited to heat generation [15], light generation [16], redox 
change, and mass change [7]. This change is then converted to a signal quantifiable to the platform by 
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the transducer, which converts these changes into measureable forms, such as calorimetric, optical, 
potentiometric or pietzoelectrical signals. In other words the transducer effectively bridges the organic 
biosensory molecule and the typically electromechanical platform. 
The role of the platform is to convert the signal produced by the transducer into a form measurable in 
human terms, typically by converting transducer signal into an electronic signal which is processed and 
displayed by a software. Thus the selection of the biosensor platform is largely dependent on the 
specific transducer used. For some applications, the results displayed can be qualitative in the form of 
an on/off output. However by attributing a numerical value to the magnitude of the target-sensor 
binding signal, it is also possible to create a quantitative biosensor. The mode of quantification of the 
transducer signal is dependent on the nature of the transducer itself, for example the magnitude of an 
optical transducer’s signal could be ascertained by using a platform measuring luminescensce, 
absorption, or light scattering. Signals generated by transducers that undergo electrochemical changes 
can be measured by methods such as measuring current change as a result of the application of 
potential (voltammetry and amperometry), potential difference between electrodes (potentiometry), 
and current consumption (coulometry). Other chemical changes which can be quantified include 
temperature, volumetric change and mass change. 
At present, biosensing is dominated by optical and electrochemical modes of signal transduction. The 
most common optical mode of biosensor activity is based on fluorescence. Here the transducer is most 
commonly a fluorophore, which are chemical compounds that exhibit light emission upon photo 
excitation. There is an abundance of well-studied, robust, fluorophores available for biosensor design, 
with high sensitivity to environment, allowing it to transduce changes in the sensing surface [17][18]. 
Optical biosensors in general are characterized by high sensitivity, robust signal reliability and relatively 
easy integration into the multichannel sensing format, a classic example of this being a DNA microarray.  
Electrochemical sensors have a number of inherent advantages [19] [20] over optical systems, including 
fast response, relatively low cost, and easy miniaturization (being highly compatible with 
microfabrication techniques and compatible with modern computer systems). Electrochemical 
biosensing will be further discussed in the electrochemistry section of this Chapter (see section 1.09). 
While a diverse range of recognition molecules have been investigated for biosensing applications, there 
has been a significant increase in research during the past decade regarding biosensors that use 
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synthetic single stranded nucleic acids, especially when combined with electrochemical transducers. 
These biorecognition nucleic acids are commonly referred to as aptamers. 
 
1.05 Overview of Aptamers 
Aptamers are single stranded nucleic acids, typically composed of several tens of nucleotides in length, 
capable of binding selectively to non-nucleic acid ligands. RNA aptamers were first discovered 
independently by Ellington and Szostak [21], and Tuerk and Gold [22] in 1990, with DNA aptamers being 
discovered shortly thereafter [23]. The term “aptamer” was coined by Ellington from the Greek word 
“aptus”, meaning to fit. Their functional roles are analogous to antibodies in a protein bioreceptor 
system.  
Aptamers have been observed to be able to bind to a diverse range of target molecule, including small 
organic molecules [24][25], proteins [26][27], viral particles [28][29] and whole cells [30]. This is not 
surprising, since nucleic acids must be able to interact with a number of non-nucleotide groups during 
process of gene regulation, both in the case of conventional DNA/regulatory complex interaction 
common to all cellular life [31][32][33] and in the role of riboswitch in the case of RNA[34].  
 
Fig 1.02 An illustration of (a) Thrombin aptamer in its resting, unbound secondary structure (b) the 
Thrombin aptamer complex binding of the same aptamer. Taken unmodified from [35] 
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1.06 Comparison of Aptamers and Antibodies 
Aptamers have been extensively investigated for potential application as sensing molecules, with roles 
similar to those traditionally occupied by antibodies [36]. Aptamers and monoclonal antibodies have 
similar level of affinity in target detection (both detect at the pico to micro molar range [37] [38]). 
However while aptamers, particularly unmodified RNA aptamers, are susceptible to hydrolysis by 
ubiquitous nuclease enzymes, they do have a number of advantages over antibody based sensing 
assays.  
This is primarily attributable to the polynucleotide structure of aptamers whereby they are much less 
dependent on a precise 3D structure for target binding unlike proteins, which have 3D structures 
assembled by a complex interaction of secondary, tertiary and quaternary structures, generally resulting 
in the burial of hydrophobic regions [39]. Therefore aptamer sensors are generally less susceptible to 
irreversible denaturation due to thermal damage than protein based sensors, allowing them to function 
in harsh environment. Denaturation of aptamers occurs readily in aptamers since the binding affinity is 
typically significantly below the primary phosphate bonds of the nucleic acid, and secondary structures 
spontaneously reform at low temperature, indeed the spatial arrangement of an aptamer population 
exist in a state of flux. Heating is therefore ideal for regenerating aptamer sensing surfaces. Heating 
antibodies generally results in irreversible damage [40] [41], as the protein structure reassemble in a 
manner different from that before heating. Antibodies with high temperature resistance are typically 
either specifically selected or engineered express this quality [42] [43]. This could be because a target-
compatible structure may not be the most energetically stable form as a result of post translational 
assembly, or barriers prevent the reformation of the sensing form (such as the tendency of large 
globular proteins in polar solvent such as water to reassemble into a form that exposes hydrophilic 
element and hide hydrophobic cores after heating [44] [45]). 
Another advantages of using aptamers is that they can be easily and cheaply prepared by chemical 
synthesis. This compares favourably to antibodies and enzymes which, being protein based, can require 
post translational modification, and therefore necessitate in vivo biological production [46] [47]. 
Additionally, because of their biological production, activity of antibody are subject to a relatively large 
degree of inter batch variation compared to aptamers. Typical aptamers are also much smaller than 
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most antibodies, and therefore less material needed for their synthesis (IgG has a MW of approximately 
150kDa, while a typical 40bp long aptamer would have a MW of approximately 12kDa). 
Broadly, aptamers are compatible with facilitated modification, typically of the 5’ and 3’ terminals of the 
sequence [48]. Antibodies cannot be easily redesigned without a causing damage to structure, due to 
the presence of complex 3D structures. 
Additionally, due to the empirical nature of the aptamer selection process, it is possible to select 
aptamers, at least in principle, against any targets in vitro. Antibodies are based on immunological 
molecules, and thus are conventionally physiologically selected in vivo, which does not facilitate 
selection of antibody against highly toxic or otherwise growth inhibitive targets, such as heavy metals 
for example. However methods do exist for performing in vitro selection of protein with defined 
specificity and affinity, using methods analogous to SELEX based aptamer selection (e.g. phage display).  
 
1.07 Aptamer Isolation and the SELEX Process 
Aptamers are selected by a combinatorial chemistry process composed of iterative cycles of affinity 
selection and amplification steps known as Systematic Evolution of Ligands by EXponential enrichment 
(SELEX) [21][22].  
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Fig 1.03 An overview of the SELEX process 
 
The SELEX process subjects a DNA library to repeating cycles of affinity selection and enrichment. 
Affinity selection selects sequences with high affinity to a desired target, after which these sequences 
are amplified to generate a new library pool for the subsequent SELEX cycle. This cycle is recursively 
repeated, with each round resulting in an increase in the average affinity of the DNA library while 
decreasing the variation in the library population. This process can be analogized to Darwinian selection, 
where the key survival trait is the ability to be retained in the process of partition. A review of the SELEX 
process and technologies developed in its optimization is provided below. 
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Fig 1.04 An overview of the common steps of the SELEX process. Labels in red represent essential steps 
of conventional SELEX, Labels in black describes the solution present in the represented step 
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1.07a Synthesis of DNA library 
The first step of any SELEX protocol, like any other combinatorial chemistry process, starts with the 
synthesis of a library pool. Due to the limited variation of nucleotide monomers and the low difference 
in coupling efficiency of the four nucleotide variations (A, T, C and G), the synthesis of an unbiased pool 
of DNA is relatively simple compared to other libraries (peptide for example), as bias is relatively small 
and well-studied and therefore can easily be compensated for [49]. 
The libraries used in conventional SELEX process contain constant regions flanking the random 
sequences, which are used for primer binding in the amplification phase of the SELEX process. The 
diversity of the SELEX library depends on the length of these random sequences. Thus theoretically a 
library with a 30 nucleotide long random region generates a library with 430 (1.153 x 1018) variations. In 
such cases it is highly unlikely that all the sequences will be present in a SELEX library, since 1.152x1018 is 
equivalent to a 1.915 x 10-6 mole mass of DNA. Thus if a SELEX operation uses a starting library of 1 
nanomole (this is a typical mass used), only approximately 1/2000 of possible sequences will be present 
in the starting pool. Thus the maximum variation of sequences present in the pool can be either a 
function of initial library mass or length of random sequence. 
It should also be mentioned that in practice additional variants of sequences not present in the initial 
library will be synthesized as a byproduct of the conventional SELEX process. This is largely due to the 
absence of 3’ to 5’ exonuclease proof reading feature in Taq polymerase [50]. This means that Taq 
polymerase has a low fidelity resulting in the formation of a relatively large number of non-perfect 
replication of DNA sequences in the process of amplification. Thus the number of sequences 
investigated may in practice be greater than that suggested by the size and random sequence length of 
the initial library. 
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Fig 1.05 Design of a typical SELEX library, containing a random sequence flanked by primer related 
sequences. An example of a random 30b library sequence is shown below (sequence is a commercial 
Trilink design, the same library design used for Automated SELEX operation in chapter 6) 
 
1.07b Selection 
Sequences with high affinity to the desired target are selected from the DNA library. This step defines 
the SELEX process, in that the conditions of affinity selection drives the evolution of the DNA library 
population. While a diverse range of methodology for affinity selection has been studied in order to fulfil 
the requirements of the specific investigation, all conventional SELEX affinity selection protocol share 
common functional steps.  
 
1.07c Affinity Selection 
 
 
Fig 1.06 A representation of the Affinity Selection step 
In conventional SELEX, the first step of affinity selection is the binding of target molecule to the 
oligonucleotide library. The end goal of affinity selection is to determine the sequence in the library with 
the greatest specific affinity to the target molecule, therefore this step typically involves the incubation 
of the library with a concentration of target molecules for an extended period of time. The empirical 
nature of the target-aptamer binding process mean that a thorough understanding of the target-
aptamer molecular interaction is not necessary for the process of aptamer selection, only that the target 
could be bound and retained. 
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1.07d Partition 
 
 
Fig 1.07 A representation of the Partition step 
After incubation, the target-bound nucleic acid sequences are partitioned from the unbound population. 
This is classically achieved by passing the target-aptamer solution through a filter with high adsorption 
efficiency against the target molecule or with a molecular weight cutoff below the size of the target 
molecule. This results in the retainment of target-aptamer complex, and the removal of unbound 
sequences. Membrane based retainment has an obvious disadvantage, in that they cannot be used for 
selecting non-protein targets. Another disadvantages is that in practice the membrane retains a quantity 
of unbound aptamers via non-specific target-filter interaction which is eluted along with target-binding 
aptamers as stringency is increased in process of elution, though this problem exists in all solid phase 
mode of partition. Conversely membrane filter retainment is never completely efficient, and a 
significant portion of target-aptamer complex may be lost. Aptamers selected by filter adsorption based 
separation include aptamers targeting Bacteriophage T4 DNA Polymerase [22], protein ERK-2 [51], and 
Escherichia coli Rho-factor [52]. 
Another classical method of partition is by affinity chromatography. Here the initial DNA library is run 
through an affinity column with bound target molecules. This process is one of the first used for SELEX 
partition, having been developed from methods very commonly used for antibody isolation. Sequences 
with affinity to target molecule binds to the target within the column, with the highest affinity being 
typically at the top of the column with affinity decreasing towards the end of the column, while the 
unbound sequences elute via the column drain. By allowing rapid flow of material althrough the affinity 
column, it is possible to select sequences by speed of binding and not just by affinity. Similar to 
membrane filter partition, the affinity column filtration can retain a quantity of unbound aptamers via 
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non-specific interactions. Affinity chromatography generally requires considerable target mass, making 
this method unattractive for selection against expensive targets. Aptamers selected by affinity 
chromatography based separation include organic dyes [21], Pro-gastrin-Releasing Peptide [53], and 
HIV-1 Tat protein [54]. 
A development of the Sepharose bead based affinity chromatographic partition technique is partition 
using target-bound magnetic beads. In this method the SELEX library is incubated with Target-MNP 
particles, resulting in the formation of Aptamer-Target-MNP complexes. In most cases biotin 
bioconjugated target is typically bound to streptavidin coated magnetic nanoparticles. Placement of a 
magnet results in the separation of Aptamer-Target-MNP complexes from the solution, which can then 
be drained out. Separation efficiency of MNP is very high, with >95% the MNP mass being retained in 
the process of partition. Non-specific interaction between unbound aptamers and platform remains a 
problem, but is it is significantly lesser than that noted in affinity chromatography. Due to the relatively 
simple handling and ease of implementation and control of an electromagnet, this separation method is 
highly amenable to automation. Aptamers selected by MNP based separation include Human Cancer 
Cell Membrane Antigen [55], Domain II of Hepatitis C Virus [56] and Thyroid Transcription Factor 1 [57]. 
Capillary electrophoresis is another popular mode of separation. Here unbound oligonucleotides are 
separated from target-bound sequences by electrophoretic mobility. Free oligonucleotides have lower 
MW than target bound sequences, and therefore migrate at a faster rate towards a positive electrode 
than target bound sequences. One of the key advantages of capillary electrophoresis separation is their 
amenability to miniaturization, making them highly suitable for integration into microfluidic SELEX 
operations. Aptamers selected by capillary electrophoresis based separation include aptamers targeting 
IgE [58], HIV-1 RT [59], protein kinase C δ [60] and, ricin toxin [61]. It should be noted that most of these 
are relatively large protein targets, which would further increase the difference between rate of 
migration between target-bound and unbound sequences. 
Other less commonly used or more recently developed modes of partition includes Electrophoretic 
Mobility Shift Assay [62], Surface Plasmon Resonance [63], Centrifugation [64], Flow Cytometry [65].  
While SELEX can be considered a cyclical process, the conditions of the selection process do not 
necessarily need to remain constant throughout the cycles. The stringency (which includes temperature, 
number and intensity of washes, pH, ionic strength and MgCl2) of the incubation and partitioning 
process is very commonly increased in proportion to the number of cycles performed. This allows the 
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earlier cycles to retain sequences with even relatively modest affinity to the target in the early round of 
SELEX when the population of the DNA library is largely non-specific, while allowing higher affinity 
sequences to be favored during the late stages of SELEX. 
 
1.07e Elution  
 
 
Fig 1.08 A representation of the Elution step 
In conventional SELEX, the process of partition is followed by the process of elution where the target-
aptamer complex is broken, releasing the binding sequences. There are a number of ways this could be 
achieved, but most of them basically result in an increase in stringency. Examples of the method of 
elution include heating [66], changing ionic concentration [21], and the addition of elution substances 
such as SDS, urea and EDTA [51]. Competitive binders could also be used as a means of elution [67]. 
A problem associated with all conventional SELEX affinity selection process is the selection of non-target 
specific sequences with high affinity to the selection platform. The selection process of conventional 
SELEX is an empirical process which selects sequences based solely on its ability to remain within the 
system in the face of increasingly stringent binding conditions. A sequence not specific to the target but 
which nevertheless could bind tightly to a component of the platform empirically fulfills this objective, 
and thus remain in the system to be amplified in the subsequent round of selection.  
This problem is typically solved by the addition of pre-selection and counter-selection rounds, where the 
library is incubated with the platform material of the selection assay. This results in the retainment of 
sequences with high affinity to the platform. The remaining sequence not bound to incubation vessel 
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wall is drained out and used in the subsequent rounds of selection, and the sequence bound to the 
platform material is discarded. 
 
1.07f Amplification  
 
 
Fig 1.09 A representation of the Amplification step, the complementary sequence here has been 
biotinylated for post processing.  
 
The selection steps result in the reduction from a highly diverse population in the initial library to an 
eluted DNA solution containing a significantly reduced population, both in terms of mass and variation. 
In order for further selection to take place, it is therefore essential that the eluted mass is amplified to 
bring DNA concentration in line with original concentration of initial library. This is achieved in 
conventional SELEX by using Taq Polymerase PCR. Temperature conditions are generally kept highly 
stringent, in order to reduce formation of non-specific amplicons which may accumulate in the SELEX 
cascade.  
 
1.07g Second Strand Removal 
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Fig 1.10 A representation of single strand separation, a common post-processing step 
 
The PCR process involves first creating complementary sequence to the original template during the first 
PCR cycle. During subsequent PCR rounds both forward and backward sequences are amplified. Thus 
half of the products of PCR are complementary sequences which have not been selected by SELEX 
affinity selection. These sequences can negatively affect the SELEX process for reasons discussed in the 
electromagnetic separation section of the Automated SELEX Device chapter. By using biotynalated 
(reverse) primer for sequence amplification, it is possible to remove the complementary sequence by 
partitioning using magnetic nanobeads [68]. Alternatively by using biotynalated (forward) primer for 
selected sequence amplification, it is possible to remove the complementary sequences using Lambda 
nuclease [69], which specifically targets double strand molecules in the 5’ to 3’ direction, with a strong 
bias in favour of the substrate with exposed 5’-phosphate group, which results in decreased cleaving of 
biotynalated selected sequences.  
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Phenol/Chloroform extraction and ethanol precipitation is typically performed to purify DNA pool from 
detritus from the PCR and upstream post-PCR conditioning steps. The purified single stranded library 
can at this point be used as library for the subsequent round of SELEX. 
 
1.08 Automated Selection 
The manual SELEX procedure can be reasonably characterised as long, manually intensive, and 
repetitive. It can also be considered a highly skill intensive process, requiring highly qualified personnel 
with a good understanding of molecular biology and highly developed sterile technique. Thus 
automating the SELEX process could be considered highly desirable. The repetitive nature of the SELEX 
process mean that the range of operational tasks that need to be performed by the SELEX device is 
fewer than the complexity of the manual operation and length of operation would suggest.  
A literature review of this topic reveals that most works have taken one of two approaches towards 
automating the SELEX process. These are the Manual-like automated SELEX assay, and the microfluidic 
automated SELEX assay. 
 
1.08a Conventional Automation of SELEX Process 
The first is to effectively replicate the human actions of a manual SELEX process entirely (we will call this 
the manual-like approach). In this study, the automotive process not only performs functions analogous 
to manual SELEX, but also largely replicates the same methodological process performed by the human 
hand. A good example of this mode of automation is the pioneering work performed by Cox and 
Ellington [70]. 
In this study a three axis robot with a pipette actuator was used to perform a modified manual SELEX 
operation. The automative machines used here are non-specialised, which makes sense in the context of 
a pioneering work in that most of the robotic tasks are performed by an commercial liquid handling 
robot (containing a three axis manifold, a liquid handling pipette head, and a carousel type tip reloader) 
adapted to perform the SELEX process. The heating element likewise uses a commercially available 
design, and a commercial recirculating chiller is adapted for enzyme preservation. The selection process 
is very similar to those described by the original Cox and Ellington paper [21], including the use of 
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nitrocellulose filter as a means of partition. This is a somewhat unusual choice, since the target is 
already immobilized on MNP, which would have made magnet based partition easy to implement. It 
should be noted that this experiment preceded the widespread usage of automated MNP based 
separation. Later automatic SELEX devices designed in this format typically utilizes magnetic separation, 
including further studies conducted by the Ellington team [71]. This would suggest that the separation 
method may not be based on protein-nitrocellulose adsorption but on MNP entrapment by filter. 
This paper does not detail the control software infrastructure of the device. Since both the thermal 
cycler and automated workstation have independent control software, the devices are presumably 
synchronized either with an integrated virtual environment platform such as Labview or simply by 
synchronized timing. The latter would not be practically feasible in highly complex operations.  
The manual-like approach has a number of advantages. Firstly since the process replicates human 
actions, it is possible to migrate already well-established SELEX protocols with minimal modification. 
SELEX is not the first manual work intensive activity to be automated, liquid sampling robots are already 
commercially available as off the shelf products. By replicating liquid handling in a conventional form, 
pre-existing automative components can be adapted for SELEX applications which implies that very little 
hardware fabrication is required, allowing the mechanical aspects of this approach to be limited to 
assembly and to the adaptation and integration of off-the-shelf parts to perform the SELEX process.  
However there are a number of weaknesses to the human-like approach to automation.  
Firstly while the use of off the shelf products allow for a fast development time, it is also relatively 
expensive. Off the shelf products are designed for the purpose of general use and have significant 
redundancies and excess features which may not be necessary in the SELEX process. This result in 
unnecessary high setup cost. The production of a prototype from scratch allows removal of excess 
features and enhancement of specialized features benefiting the SELEX process. It should be noted for 
example that one of the main hurdles noted by the Cox Ellington paper [70] in automating their SELEX 
process was the development of a filter separation process. While the prototype will take longer to build 
without using off the shelf material, and result in a potentially much more expensive prototype, the cost 
of production per unit will decrease with mass production.  
Another problem which typically affects automatic sampler is the potential of contamination, 
particularly of the sampling tip. Most automatic sampler control contamination by rinsing the sampling 
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tip either in a well or through a water flow stream. This sufficiently cleans the sampling tip for most 
general purpose, but SELEX is particularly vulnerable to contamination due to the relatively small mass 
of the eluted library compared to the initial library, as well as the cascading nature of the SELEX process. 
This problem could be bypassed by the use of a pipette tip loader, such as the pipette tip carousel loader 
used in the Cox and Ellington study, which completely renews the pipette tip during operation in a 
manner similar to that applied in the manual technique. Contamination from outside sources is difficult 
to control. This mainly involves the entry of contaminants to the reaction mix.  
Theoretically, most nucleotide contaminants should not be significant, as they would not be compatible 
with the SELEX primers and would therefore not be amplified by PCR downstream. However serious 
problems could arise in instances where contamination by sequences with common primers occur, such 
as sequences from another SELEX operation performed with another target, but utilizing the same initial 
library. It is important to note that for a sampling tip to access the reaction vessels and reagent vessels, 
it is necessary for these vessels to be open topped, creating point of entry for contaminants. Moving 
parts of mechanical hardware are simply not amenable to sterilization, thus causing the automatic 
sampler to become a reservoir of contaminants.  
All in all it is certainly not impossible to minimize contamination possibility in human-like automated 
SELEX, but doing so requires a significant amount of work and maintenance, as well as good sterile 
techniques. 
 
1.08b Microfluidic Automation of SELEX Process 
An alternative approach to manual-like automated SELEX is the microfluidic SELEX approach, of which a 
good example is the one described by Hybarger et al [72]. In this approach, the directional flow of the 
liquid handling process is regulated by actuator valves, whose pattern of opening and closing determine 
the direction in which the liquid is being driven by the pump. This control of liquid movement allows the 
correct reagents to be taken up from input reservoirs and delivered to the correct reaction channel. 
Micropipes of uniform diameter allow accurate calculation of the movement of the solution plugs. 
Complex valve behaviour is made possible by the use of Labview software, which enables integration 
and synchronization of SELEX device components.  
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Decontamination protocols based on flushing with the decontaminant ELIMINASE, which eliminates 
nucleases, followed flushing with MilliQ. ELIMINASE is sufficiently cheap to be used in scaled up 
mesofluidic automated SELEX processes. Since the system is completely enclosed, the inner surface of 
the device is completely isolated from the external surface. Therefore the external surfaces do not need 
to be cleaned, which is a major potential advantage. The report does not study the possibility of dealing 
with contamination during extended operation. It is therefore impossible to gauge how frequently a 
more thorough decontamination would be required to take place, and how long the process will take 
when it is required. 
An obvious benefit of microfluidic based selection is the reduction in scale of the SELEX process, which 
implies that this SELEX process is rendered highly economical. This will be useful for any SELEX process 
by reducing the cost of the stock reagents (primers, libraries, PCR mastermix) but particularly so for the 
selection of aptamer against rare targets that are difficult and expensive to produce.  
A potential weakness of microfluidic based SELEX process is that the reduction in the volume of 
incubation solution also reduces the maximum mass of initial DNA library that can be implemented. As 
mentioned above, the DNA library size is directly proportional to the mass of the initial library used. 
Thus by reducing the volume (and therefore mass) of the initial library, the complexity of the library in 
terms of total sequence variety is also concurrently reduced.  
The affinity-selection component of the SELEX process is achieved by driving the DNA library though 
microchannels by the control of valve actuators, which direct flow of liquid. To use the study by 
Hybarger et al as an example, for a standard segment of microchannel with the maximum gauge size 
used here (150um), the volume of the microchannel will only be 1.76ul. This means only relatively small 
amount of DNA can be used in the process of selection, and therefore relatively low library complexity. 
For example, a typical DNA concentration used for the process of selection is 1uM. This translates to a 
maximum of 1.06 x 1012 DNA sequences in a 1.76ul volume. This would mean that, for 30 random base 
pair library (1.2 x 1018 total variations), only 1 out of 1.1 x 106 sequences will be present in the library. 
In this thesis it is hoped that by increasing the scale of microfluidic channels from a micrometer to 
millimeter scale, it would be possible to gain the primary advantages of the large volume SELEX (large 
library and sequence variation), while also retaining the primary advantages of microfluidic SELEX 
(reduced contamination risk, low initial cost and maintenance). An comparison of Conventional 
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Automated SELEX, Microfluidic Automated SELEX and the proposed Mesofluidic Automated SELEX, can 
be found in the table below. 
  
Conventional 
Automated SELEX 
Process 
Microfluidic 
Automated SELEX 
Process 
Mesofluidic 
Automated SELEX 
Process 
Liquid Handling 
Sampling tip and 
(typically syringe) 
pump 
Solenoid valve and 
pump 
Solenoid valve and 
pump 
Scale ml ul ml 
Total sequences ~10^9 ~10^6 10^8 to 10^9 
Contamination 
risk High Low Low 
Initial Invested 
Capital High Low Low 
Typical mode of 
partition/elution 
Filtration (older 
systems)/magnetic 
(newer systems) 
Magnetic or 
electrophoretic Magnetic 
Table 1.01 A comparison of typical Conventional Automated SELEX Process and Microfluidic Automated 
SELEX Process. Mesofluidic automated SELEX process represents the automated SELEX device described 
in Chapter 6 of this thesis.  
 
1.09 Electrochemistry 
Having chosen aptamers as the type biosensory molecule to be used this study, it is then necessary to 
select a compatible transducer to it. For this project, electrochemical transducers were selected. 
Electrochemistry is the study of chemical reactions taking place between (generally) metallic or carbon 
electrodes and an electroactive species at the electrode/solution interface, resulting in the transfer of 
electrons. Electroanalytical techniques typically involve the measurement of current in response to an 
applied voltage.  
The electroanalytical method used for this study is voltammetry, the measurement of the current as a 
function of electrode potential. Thus by performing a voltammetric measurement for each 
concentration of a titration series, it is possible to measure changes in target concentration, thus 
enabling quantitative analysis of the biosensor response to concentration of redox label, which in turn is 
correlated to the target concentration of the biosensor, or the concentration of an redox active target 
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itself. Since the applied potential is varied, voltammetric techniques also yield information on the 
electrode process taking place at the electrode solution interface.  
The current response in a voltammetric experiment is controlled by two predominant factors, charge 
transfer and mass transport rates. Under conditions where charge transfer is fast (compared to both 
mass transport and the rate of change of potential) then the redox couple is in near thermodynamic 
equilibrium with the electrode.  
Charge transfer process involving electron transfer can be represented by the following equation: 
 
𝑂 + 𝑛𝑒−  ⇋ 𝑅 
 
O being the Oxidised form of a redox couple 
R being the Reduced form of a redox couple 
 
Thus the oxidised species receives n electrons in order to be converted to its reduced form. The 
electrons of the electrode have a maximum energy distributed around the Fermi level, and electrons can 
be donated or received into this level.  
For the process of reduction to take place, the electrons in the electrode must have sufficient energy to 
transfer to the lowest unoccupied molecular orbital (LUMO) of the oxidised species. Vice versa, in order 
for electrons to be donated from the reduced species to the electrode, the highest occupied molecular 
orbital (HOMO) must have an energy level higher than the Fermi level of the electrode. This can be 
visualized in the diagram below: 
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Fig 1.11 Visualisation of the electron transfer process at the electrode interface. 
 
In electrodes the electrons of the s and p orbitals of the metal atoms are delocalized, resulting in the 
effect commonly referred to as a “sea of electrons”. Potential applied to the electrode results in a 
change in the energy level of the electrode as a whole, with this energy level being known as the Fermi 
level. The Fermi level depends on the electrode potential as well as the material of which the electrode 
is made. For a system where electron transfer is fast, the current can be represented using the following 
equation: 
 
𝑖 = 𝑛𝐹𝐴𝑉 
i is the current 
n is the number of electrons transferred 
F is Faraday’s constant 
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A is area of electrode 
V is net rate of electron transfer 
Eq 1.01 Rate equation of an electrochemical system limited by electrode potential 
 
The net rate of reaction is the difference between the rates of forward (anodic) and reverse (cathodic) 
electron transfer thus: 
 
𝑖 = 𝑛𝐹𝐴(𝑉𝑓𝑜𝑟𝑤𝑎𝑟𝑑 − 𝑉𝑟𝑒𝑣𝑒𝑟𝑠𝑒) 
 
The rate of the forward and reverse reactions could be represented using the rate equation: 
 
𝑉𝑓 = 𝑘𝑓(𝐶𝑜) 
 
𝑉𝑟 = 𝑘𝑟(𝐶𝑟) 
 
kf and kr being forward and reverse rate constant respectively 
CO and CR being concentration of Oxidised and Reduced species at x=0 respectively 
 
The forward and reverse rate constant could be represented by the Butler-Volmer Equation, which 
describes the relationship of the current and potential for thermodynamically controlled reactions: 
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𝑘𝑓 = 𝑘0𝑒 [
∝𝑓 𝑛𝐹(𝐸 − 𝐸
𝑜)
𝑅𝑇
] 
 
𝑘𝑟 = 𝑘0𝑒 [
(1−∝𝑟)𝑛𝐹(𝐸 − 𝐸
𝑜)
𝑅𝑇
] 
 
ko is standard rate constant 
E is potential 
αf is forward transfer coefficient 
αr is reverse transfer coefficient 
EO is the standard potential of the reaction 
R is universal gas constant 
T is temperature in K 
 
Combining the above equations gives: 
 
𝑖 = 𝑛𝐹𝐴𝑘𝑜[𝐶𝑜𝑒 [
∝𝑓𝑛𝐹(𝐸−𝐸
𝑜)
𝑅𝑇
]-𝐶𝑟𝑒 [
(−∝𝑟)𝑛𝐹(𝐸−𝐸
𝑜)
𝑅𝑇
] 
Eq 1.02 the Butler-Volmer Equation 
 
At equilibrium (where i = 0), rearranging and using αf + αr = 1 yields the Nernst equation, which could be 
used to establish the concentration of the electrochemically active species at the electrode interface 
using the potential of the electrode. 
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𝐸 = 𝐸𝑂 + (
2.3𝑅𝑇
𝑛𝐹
) log (
𝐶𝑂
𝐶𝑅
) 
Eq 1.03 the Nernst equation [73] 
 
The current resulting from a change in the concentration of the reduced and oxidised states of the 
electrochemically active specie is referred to as the faradaic current. The faradaic current can be used as 
a means of quantifying of the rate of redox reaction, and therefore (since quantity of redox label at 
electrode interface is proportional to target concentration in affinity biosensors) of the concentration of 
the target analyte. 
 
1.10 Mass Transport Controlled Reactions 
Mass transport in an electrochemical cell is dependent on three factors: 
1) Diffusion: Movement along a concentration gradient 
2) Convection: Bulk movement of liquid 
3) Migration: The migration of charged particles along an electrical field. 
The rate of mass transport at a fixed point is known as the flux, described as the number of molecules 
arriving at a fixed surface area per unit time. In substrate depleted electrochemical systems it represents 
the rate at which reactant is being renewed at the electrode interface. Flux to the electrode is described 
using the Nernst-Planck equation. 
 
𝐽 =  −𝐷 (
𝑑𝐶
𝑑𝑥
) − (
𝑧𝐹𝐷𝐶
𝑅𝑇
) (
𝑑𝛷
𝑑𝑥
) + 𝐶𝑉 
Eq 1.04 the Nernst-Planck equation 
J is flux 
D is the diffusion coefficient, which in aqueous solution is generally between 10-5 and 10-6cm-2s-1. 
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(dC(x,t)/dx) is the concentration gradient 
z is charge 
C is concentration 
(dΦ /dx) is potential gradient 
V is Hydrodynamic velocity 
 
In unstirred cells (where there is no convection) with high salt concentration (no migration), the mass 
transport mechanism is predominantly diffusion down the concentration gradient. Thus Flux can be 
described using Fick’s First Law: 
 
𝐽 =  −𝐷 (
𝑑𝐶
𝑑𝑥
) 
Eq 1.05 Fick’s First Law 
 
1.11 Effect of distance on Transfer Kinetics 
One of the underlying principles of the conformation and configuration change aptasensors discussed in 
the subsequent section of this chapter is that signal is dependent on the distance between redox label 
and the electrode surface.  
The Marcus theory of electron transfer posits that the probability that an electron transfer will take 
place between an acceptor and donor couple during transition state decreases with increasing distance 
between the redox couple and electrode, and can be described using the following equation: 
𝑘 = (𝑒−𝛼𝑟)(𝑒
𝛼𝛥𝐺
𝑅𝑇 ) 
Eq 1.06 Marcus’ theory of electron transfer 
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r is the distance between donor and acceptor 
α is a constant representing the medium through which electron transfer takes place 
ΔG is the Gibbs free energy of activation, which determined by the standard reaction Gibbs energy and 
the reorganization energy. This can be described as: 
 
𝛥𝐺 =
(𝛥𝐺𝑜 + 𝜆)2
4𝜆
 
ΔGo is the standard reaction Gibbs energy  
λ is the reorganization energy 
 
Thus the rate of electron transfer is dependent on the distance between the redox label and the 
electrode surface. Labeled electrochemical biosensors signal is not the direct result of electrochemical 
change of biosensor target molecule, but as a result of altered separation distance between redox label 
and electrode surface. How this is achieved will be further discussed in the subsequent section of this 
chapter. 
 
1.12 The Charged Double Layer Theory 
The electrical double layer occurs at the interface of any solution and charged surface. In 
electrochemistry, this phenomena is caused by the attraction of particles of the opposite charge to 
charged electrode surface. This results in the formation of a charged layer on the electrode surface, 
which attracts more particles of the opposite charge to the layer. This process is repeated, forming a 
charge structure that is composed of two distinct sub-structures. The inner layers closest to the 
electrode surface, called the compact layer, is composed solvent molecules and specifically adsorbed 
ions on the electrode surface, as well as solvent ions attracted to the surface by long range coulombic 
forces. The compact layer is strongly held in place and organized by the electrode charge. The outer 
layer further from the electrode surface, is called the diffuse layer, is a less organized layer which 
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formed of scattered ions which extend from the compact layer into the bulk solution. The structure of 
the diffuse layer is a compromise between the organizing force of the electric field and the disruption 
caused by random thermal motions. The width of the diffuse layer is influenced by the ionic 
concentration of the solution. 
This charged double layer acts like a capacitor, storing charge when a potential is applied. This excess 
charge is electrostatically balanced between electrolytes and other charged molecules, in a manner 
similar to a parallel plate capacitor, with the total capacitance of the double layer being a combination 
of the capacitance of the compact layer and the capacitance of the inner layer.  
 
Fig 1.12 Diagram visualizing a simplified charged double layer (compact layer shown only). A 
conventional parallel plate capacitor is also displayed for comparison. 
 
The double layer’s capacity for charge storage is responsible for the current known is the charging 
current. This current is non faradaic (it does not involve the transfer of electrons) but occurs due to 
application of potential across the double layer, and is a significant factor in the detection limit of 
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controlled potential techniques. The charging current decays exponentially with time, and therefore 
could be minimized by the use of pulse voltammetric techniques such as DPV and SWV, which will be 
discussed below. 
 
1.13 Linear Sweep Voltammetry (LSV) 
Perhaps the simplest form of voltammetry is Linear Sweep Voltammetry (LSV). In linear sweep 
voltammetry, a potential sweep is applied as a steady ramp. Initially the applied potential at the 
electrode interface falls short of those necessary to drive redox reaction, and no reaction takes place, 
resulting in no flow of current. As the potential is swept towards the Standard Electrode Potential (see 
the Nernst equation above), the faradaic current begins to rise exponentially.  
Faradaic current continues to increase until a point is reached at which the current is a maximum. In an 
unstirred system, this peak is a result of the depletion of the surface concentration of redox substrate at 
the electrode interface. Redox species is renewed by additional substrate diffusing in from the bulk 
solution, thus the rate of electron transfer becomes limited not by the potential, but by the flow of 
substrate to the electrode interface (see Nernst-Planck equation above), resulting in a plateau. 
Unlike homogeneous chemical reactions, electrode reactions take place at a surface. This results in the 
formation of a concentration gradient between the solution at the electrode interface and that in the 
bulk solution. As the reaction exhausts the concentration of substrate at the electrode interface, the 
substrate concentration is replenished by diffusion from the bulk solution. As the reaction progresses 
this leads to an expanding thickness of the diffusion layer, and a decrease in flux. On the 
voltammograms this is represented by the current decreasing after the peak and ultimately reaching a 
plateau where the rate of the electrode reaction is balanced by the rate of diffusion. 
 
1.14 Cyclic Voltammetry (CV) 
Cyclic voltammetry is the combination of a forward and reverse linear sweep voltammetry. This results 
in the formation of the anodic peak as the reduced species formed in the forward sweep is oxidized back 
into the oxidized species. This allows the products formed from the forward reaction to be investigated 
in the reverse sweep. This results in cyclic voltammetric methods being able to rapidly determine 
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considerable information on the redox reactions, including simultaneously the kinetics of many different 
electron transfer reactions as well as adsorption processes, which can be exploited to transduce binding 
events into comprehensible electrochemical signals. The potential wave form of a CV and an example of 
the expected current-potential curve for a reversible redox couple undergoing a single forward/reverse 
cycle is shown below.  
 
Fig 1.13 Potential diagram of a 4 segment CV  
 
Fig 1.14 A typical cyclic voltammogram, simulated on Chi Instrument Inc, Chi 1030a potentiostat 
proprietary software. Peak separation is 0.056V which is indicative of a reversible system. 
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1.15 Square Wave Voltammetry (SWV) 
A potential weakness of cyclic voltammetry and other linear sweep voltammetry derived methods is 
interference from charging currents. Square Wave Voltammetry (SWV) is derived from Differential Pulse 
Voltammetry techniques, which is in turn derived from LSV. The difference between DPV and LSV is in 
the potential waveform. In LSV, the waveform is in theory analogue in nature producing a smooth 
potential ramp in direct correlation with potential increase over time.  
Since the potential is held at a steady stated between pulses, this results in the reduction of the 
capacitance current which decays at an exponential rate, but not the faradaic current which decays at 
an inverse square root of time. 
 
 
Fig 1.15 Potential diagram for Differential Pulse Voltammetry 
 
Square Wave Voltammetry is developed as an optimization of the mechanisms of pulsed voltammetry. 
In SWV a waveform composed of symmetrical square waves superimposed on a base staircase potential 
is applied to the electrode. The current is sampled twice per wave form, first at the end of the foward 
pulse, and second at the end of the reverse pulse. Due to the significant modulation in amplitude of the 
square wave, the product of the forward step is converted back to its original form by the reverse pulse. 
The net difference between the two measurements per wave form are then plotted against the base 
staircase potential. 
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Fig 1.16 Potential diagram for Square Wave Voltammetry 
 
 
Fig 1.17 A typical square wave voltammogram 
 
Since the net current, which is the difference between the forward and reverse pulses, is larger than 
both the forward or reverse component individually, this results in a sensitivity greater than that of 
differential pulse systems which only have a forward component, while retaining the benefit of reduced 
effect of capacitance, resulting in very high sensitivity, so that detection limits in the nanomolar range 
could be achieved. 
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1.16 Electrochemical Aptasensors 
There are a number of different formats in which electrochemically transduced aptamer biosensors 
have been be implemented and studied. These can be divided into two broad categories: 
1) Configurational-Change Aptasensors  
2) Conformational-Change Aptasensors  
 
Fig 1.18 Categorisation of electrochemical aptasensors  
 
1.16a Configurational-Change Aptasensors 
These are biosensors where target binding results in the assembly or disassembly of the sensor 
construct resulting in a change in signal. These can be subdivided into two subgroups. The first are 
sensors where target binding results in assembly of the biosensing construct. These are typically “signal-
on” sensors, where target-binding results in the formation of complex signal structures (sandwich 
structures, for example). The second are sensors where target binding results in the disassembly of the 
sensor construct. These are typically composed of two sequences of hybridised oligonucleotides, one of 
which is bound to electrode surface, where target binding results in the dissociation of Crick-Watson 
interaction, resulting in the release of the second strand.  
A good example of an induced assembly configurational aptasensor is the thrombin aptasensor 
developed by Numnuam et al [74]. In that study, two aptamers were used in a sandwich format, in a 
manner similar to ELISA. The surface-bound aptamer, performing a role analogous to the ‘primary 
antibody’ in ELISA, is immobilized onto gold substrate surface by thiol-gold interaction. The second 
aptamer is bound to CdS quantum dot label and performs a role analogous to the ‘detection antibody’ in 
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ELISA. The aptamer performing both roles is the TBA aptamer originally selected by Bock et al [149], 
which has multiple binding sites per thrombin molecule.  
The sensing mechanism involves first the incubation of thrombin on electrode surface, resulting in the 
binding of the thrombin target to the surface-bound aptamer. The label-bound aptamer is incubated 
with this structure, resulting in the formation of an aptamer-thrombin-aptamer sandwich. CdS is 
dissolved by hydrogen peroxide, resulting in a dilute electrolyte background suitable for the detection of 
released Cd2+ by an ion-selective microelectrode. A detection limit of 140pM of analyte was achieved. 
A similar aptasensor was designed by Polsky et al [75] using a sandwich-forming mechanism similar to 
that described by Numnuam et al. However, in the former study, the CdS label has been replaced by 
platinum nanoparticles, which generate signal by electrocatalysing the reduction of H2O2 to H2O. The 
greater the target concentration, the lower the concentration of redox active H2O2 which can be 
detected voltametrically as an intense cathodic current in the range of -0.1 to -0.6 V. Here a detection 
limit of 10nM was achieved. 
 
Fig 1.19 Example of an induced assembly configurational aptasensor. The aptasensor designed by 
Numnuam et al uses a similar binding mechanism, but with a different label method. 
The aptamer biosensors based on gold nanoparticles discussed in Chapter 5 of this thesis could be 
considered induced assembly configurational aptasensor (see page 162) 
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A good example of an induced disassembly configurational aptasensor is the ATP aptasensor designed 
by Zuo et al [76]. The construct of this aptasensor in the absence of target molecule is composed of an 
aptamer sequence, bound to electrode surface by thiol-gold interaction, hybridised to a complementary 
oligonucleotide. The label used is ferrocene, bioconjugated at the opposite end of the aptamer to the 
electrode-binding thiol group. The aptamer-complement hybrid has a linear helical structure due to 
Crick-Watson base-pairing, resulting in the displacement of the redox label far from the electrode 
surface (and therefore giving a low current) in the absence of target. The presence of target results in 
the displacement of the complementary sequence by the target, forming a target-aptamer complex. 
This target-bound aptamer structure results in the ferrocene redox label being moved closer to the 
electrode surface than the linear aptamer-complementary oligonucleotide hybrid, resulting in an 
increase in current.  
A similar approach was used by Lu et al [77]. Similar to Zuo et al’s study, the aptasensor here is also 
composed of an aptamer-complement hybrid containing a ferrocene label, bound to electrode surface 
by thiol-gold interaction. However, in the approach used by Lu et al, the surface bound, label-
bioconjugated sequence is the complementary sequence. Target binding results in the release of the 
target-bound aptamer into the bulk solution. The complementary sequence, in the absence of its 
linearising aptamer hybrid, has a hairpin loop as its most stable secondary structure. This results in the 
ferrocene label being relocated close to the electrode surface, resulting in high current. This sensor has 
a detection limit of 1 nM in undiluted environmental sample (blood serum), and 50pM in buffer diluted 
environmental sample. 
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Fig 1.20 Examples of induced disassembly configurational aptasensor design 
 
1.16b Conformation Change Aptasensor 
These are biosensors where target binding results in a spatial rearrangement in the folding of aptamer 
construct, resulting in a change in signal. Conformation change aptamers are typically composed of 
oligonucleotide sequences bound to the electrode surface, usually by thiol-gold interactions. These can 
be subdivided into two subgroups, one in which the redox label is covalently bound to the aptamer 
molecule and signal is generated by the spatial rearrangement of the redox label and the other in which 
the label is not bound to the aptamer molecule and signal is generated by the association or dissociation 
of the redox label from or to the bulk solution, respectively. 
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A good example of a conformational-change aptasensor with covalently bound redox label is the 
thrombin aptasensor designed by Xiao et al [78]. Their sensor construct is composed of a single 
oligonucleotide sequence bound to the electrode surface by thiol-gold interaction, with a methylene 
blue redox label bound on the opposite end of the sequence, in a manner similar to the aptamer 
sequence in Zuo et al (in the absence of a complementary strand). In the absence of target molecules, 
the aptamer molecules exist in an equilibrium of states, some of which could bring the redox label 
relatively close to the electrode surface, resulting in current. In the presence of target molecules, the 
aptamer folds into a G-quadruplex tertiary structure, resulting in the rearrangement of the redox label 
away from the electrode surface and, therefore, decreased current. Xiao et al’s aptamer biosensor has a 
detection limit of 6.4 nM. 
This sensor displays one of the most noticed advantage and disadvantage of the conformation change 
aptasensor with covalently bound redox label. The advantage is that this sensor could be regenerated 
and reused, due to the chemical and temperature stability of the DNA primary structure. The 
disadvantage is that this sensor has relatively high background signal to bound-state signal (the 
amplitude of the bound signal is 20% higher than that of the unbound signal), mainly as a result of 
unpredictability of the unbound state (this is atypical because it is usually the bound state which cannot 
be predicted); the use of this aptamer has the advantage of the well-studied interaction between 
thrombin and its aptamer.  
A similar approach was used by Lai et al’s platelet-derived growth factor aptasensor [79]. However, in 
this case, the target-bound state results in the redox label (ferrocene in this case) being relocated closer 
to the electrode surface relative to the unbound equilibrium. This results in a ‘signal on’ system where 
target binding results in an increase in current.    
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Fig 1.21 Examples of conformational-change aptasensor with covalently bound redox label. Note that 
unbound aptamers with non-specific structure exist as an equilibrium of both ‘signal on’ and ‘signal off’ 
states 
The conformation-change kanamycin and tetracycline aptasensors discussed in Chapters 3 and 4 of this 
thesis could be considered conformational-change aptasensor with covalently bound redox label, with 
the ‘signal off’ and ‘signal on’ formats, respectively (see page 90). 
A good example of a conformation-change aptasensor without covalently bound redox label is the 
lysozyme aptasensor designed by Rodriguez et al [80]. This sensor construct is composed of a single 
biotinylated oligonucleotide sequence bound to an indium tin oxide electrode surface via biotin-
streptavidin interaction. The sensor operates in a solution containing ferricyanide/ferrocyanide ions. The 
negatively charged oligonucleotides immobilized on the electrode surface prevent access of the 
ferricyanide/ferrocyanide ions to the electrode surface by same-charge repulsion. Binding of the 
aptamer to positively charged lysozyme results in the reversal of the surface charge, allowing access of 
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the electrode surface to ferricyanide/ferrocyanide ions. This results in a decrease in impedance, which is 
detected using electrochemical impedance spectroscopy.  
 
Fig 1.22 Example of conformational-change aptasensor without covalently bound redox label 
 
1.17 Field Biosensor 
At present, the primary methods of detection and quantification of trace concentrations of molecular 
targets, for the purpose such as regulation enforcement, are performed in centralised laboratories with 
sophisticated instrumentation, such as by HPLC or mass spectrometric techniques. Similarly microbial 
bioproduct discovery is typically performed at present in a central laboratory setting, typically by some 
form of spread plate based growth or inhibition assay [81]. Field operation are typically limited to 
sampling only [82]. Methods such as HPLC and mass spectrometry are highly sensitive and robust, but 
the former suffer from high initial capital investment, and the latter from labour intensiveness. Both 
have high operating costs and significant human resource skill requirements. The use of a centralized 
laboratory approach also potentially prevents, or reduces the accuracy of, detection of analytes which 
are not amenable to sampling, perhaps due to their short half-life. 
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A need therefore exists for the development of biosensors capable of operating in a real life setting 
under field conditions, with minimal requirement for human intervention. While the performance of a 
biosensor under laboratory conditions is indicative of the sensor’s ability to operate under optimal 
conditions, it is ultimately a very simplistic environment maintained under ideal conditions, and 
therefore is not wholly indicative of the sensor system’s efficacy in field operations. 
Ultimately the environmental challenges which will reduce the effectiveness of the biosensor in field 
application will be defined by the specific environment under which the biosensor must operate, which 
in turn will be defined by the target of the biosensor. The measures that could be taken to minimize the 
effects of these challenges will also be defined by the nature of the environment under which the sensor 
is operating, the target, and the nature of the biosensor itself.  
Some of the common potential environmental challenges to electrochemical biosensor operation are 
listed below: 
 
1.17a Competition 
A universal aspect of biosensor design is the specificity of a sensor to its target. Ideally a biosensor 
should not have high affinity to any species that is outside its targeted range, so that no false positive 
signal is generated from non-target/sensor interaction.  
In practical terms, it is obviously impossible to test the sensor against all potential contaminants present 
in most environmental samples. However the more closely related and structurally similar the molecules 
is to the target the greater the chance that it will have high affinity to the biosensor molecule. Thus a 
negative control tests can be performed using a molecule outside of the targeted range with structural 
similarities to the target.  
Potentially some of the most significant sources of competition are molecules with high ubiquity in the 
test environment matrix, since their high concentration in the environmental sample will translate into a 
false positive signal, even if they have modest affinity to target molecule. 
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1.17b Background noise 
Background noise is a signal distortion, usually the result of direct interaction of the cell solution with 
the electrode surface unrelated to the biosensor molecule, or as a result of non-faradaic current caused 
by the charged double layer phenomena. The former is caused the presence in the environmental 
solution of another redox species active within the same potential range as the redox label, resulting in 
the electrochemical reaction of redox species as a result of the potential ramp. Unlike competitive 
interference, since there is no formation with label conjugated biosensor at electrode surface, a 
relatively high concentration of background redox species must be present in order to generate a 
noticeable peak.  
Another major source of background noise is the charging current. This has been extensively discussed 
in the charged double layer theory section of this chapter (see page 54)  
 
1.17c Degradation of target 
Degradation of targets in environmental matrix results in a decreased sensor response to environmental 
samples as a result of the depletion of target molecules. This can be a significant problem for some 
targets, particularly proteins which typically have short unrefrigerated half-lives. Small organic 
molecules and inorganic targets are typically more stable.  
 
1.17d Degradation of sensor 
Degradation of sensor molecules in the environmental matrix leads to decreased sensor signal as a 
result of loss of signaling target-biosensor complexes. For most biosensors this is typically a factor of 
thermal damage and presence of degradative elements within the environmental sample. In the case of 
aptamer biosensors the latter is far more significant, due to the thermal stability of polynucleotides and 
its vulnerability to degradation by nucleases [83][84].  
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1.17e Fouling of Electrode Surfaces 
Fouling of Electrode Surfaces as a result of non-specific accumulation of redox inert species prevents 
access of electrode surface (and thus biosensor molecules) to the target species. Non-specific 
adsorption to the electrode surface thus results in a loss of sensor sensitivity [85][86]. Fouling is typically 
a more significant factor in environmental samples with greater dissolved and suspended particle 
density than less heavily loaded environmental samples. Fouling is a more significant problem in sensors 
designed to operate over long periods in environmental samples than sensors designed for relatively 
brief sampling. Potential solutions to fouling include the use of repellant semi permeable membranes 
and blocks, which reduce the rate of fouling by repulsion or exclusion of the electrode surface from 
fouling molecules.  
 
1.18 Optimising Biosensors 
While the ability of the sensor to operate in the field could be considered the key objective of this study, 
an ideal sensor must not only be functional but also meet a need and to do so at a cost and convenience 
acceptable to the user. While a field biosensor may be able to complete its basic objectives, in practice 
any biosensor will face competition from alternative methods of detection. In the case of biosensors 
against novel targets, the desirability increases the lifespan of the sensor technology before a better 
method of detection is discovered. In the case of biosensors against targets with existing sensors, the 
novel method of detection must be superior to the existing one at least in a niche function to be of any 
practical utility.  
 
1.18a Broadening Specificity 
This can be approached in one of two ways with regard to an aptamer biosensor. The first is to modify 
the selection component of the SELEX process in order to favor sequences which bind to multiple 
targets. This is typically achieved either by alternating the selection target between rounds of SELEX, or 
by performing selection of second target immediately after selection against the first target within a 
round of selection. The strength of this approach is that it allows for a single sensing electrode to detect 
multiple targets, thus increasing economic desirability and simplicity of platform. The weakness of this 
approach is that it increases the complexity of the Selection process, and thereby diluting the specificity 
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of the selection protocol, which will possibly result in the final product having greatly reduced affinity to 
either target compared to a sequence specifically selected against the one.  
An alternative approach is to immobilize specific one target sensors on a multi-channel electrode array. 
Conformational change aptamer are well suited for small volume cells in particular since in low volumes 
redox label released into bulk solution by configurational change aptamer could result in signal cross talk 
between electrodes. None of the disadvantages of the above mentioned sensor apply here. Since the 
sensors are based on multiple specific biosensors in array, broad specificity is not an issue as long as the 
specific biosensor for the target exist, and since these sensors produce independent signals 
quantification of specific targets is likewise not impeded. 
 
1.18b Sampling Automation 
Another potential avenue of optimization is sampling automation. Like the SELEX device, the most 
feasible modes of automatic sampling will probably be based on a 3 axis manual-like sampling process or 
a flow type assay controlled by pump and valve actuators.  
Automating the sampling process is desirable as it reduced the degree of human interaction needed to 
operate the sensor. In LEDC this is beneficial since a pool of skilled labor may not be available or 
plentiful for widespread biosensor deployment, in MEDC this would be beneficial for economic reasons 
since it reduces the number of human hours needed for equipment operation. Automating the sensing 
process also eliminates human error and thus provides a more consistent and reproducible mode of 
testing.  
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Chapter 2: Materials and Methodology 
2.01 Materials 
2.01a Reagent  
All reagents used were of analytical grade or better unless otherwise specified.  
All bulk chemicals and reagents, including target molecules were purchased from Sigma-Aldrich, VWR or 
Thermo Fisher Scientific.  
Molecular biology reagents were generally purchased from Thermo Fisher Scientific, with the exception 
of Taq Polymerase which is manufactured by RBC.  
18.2 MΩ water derived from Millipore system was used for all experiments unless otherwise specified. 
Buffer is flushed through a 0.2mm filter. 
 
2.01b Oligonucleotide Synthesis 
All oligonucleotides used in electrochemical aptasensing are synthesized by Genscript, with the 
exception of the 29bp Thrombin SPE side aptamer which is manufactured by Thermo. 
Unless stated otherwise, the 5’ ends of all the ordered oligosequences were modified with either thiol 
group (-SH) or dithiol group attached to hexane (-SS-C6H13). The 3’ end was modified either with an 
amine group or pre-conjugated ferrocene group.  
Early-phase energetic and structural modeling of DNA sequences were performed using Integrated DNA 
Technology OligoAnalyzer software. The University of Albany mFold software was then used for further 
analysis and confirmation.  
Further analysis regarding aptamer beacon designs are provided in the respective chapters.  
 
2.01c SELEX library 
The SELEX library used in the ASM chapter of this study was designed and synthesized by Trilink. The 
library is composed of 76-bp-long sequences, with the original library being composed of forward 
72 
 
sequences only. The random region of this library is 30-bp long and is flanked with a 23-bp-long forward-
primer binding-site complement with the sequence 5′ TAG GGA AGA GAA GGA CAT ATG AT 3′, and a 23-
bp-long reverse-primer binding site with the sequence 5′ TTG ACT AGT ACA TGA CCA CTT GA 3′.  
Thus, the forward and reverse primers were 5′ TAG GGA AGA GAA GGA CAT ATG AT 3′ and 5′ TCA AGT 
GGT CAT GTA CTA GTC AA 3′, respectively. 
 
 
Fig 2.01 Design of the original Trilink Library 
 
The rationale for the selection of this library can be found in the Automated SELEX operation section of 
this thesis (Chapter 6) 
 
2.01d Equipment 
All electrochemical experiments were performed on a Metrohm 910 PSTAT mini potentiostat. Data 
analysis was performed using proprietary software supplied with the potentiostat, Microsoft Excel 
spreadsheets, and Graphpad Prism 5 software.  
The potentiostat is a compact device and can be powered from a USB cable; this fits well with the 
sensors’ targeted role and allows it to be operated from mobile field units, without access to structural 
power supply. 
 
2.02 Molecular Biology Techniques 
2.02a Manual Polymerase Chain Reaction 
Mastermix is composed of DNA template; 1 µM of each primer; 0.5 mM of dNTP; 10x of buffer supplied 
by the manufacturer of TaqPol (50nM Tris HCl pH9.0, 100mM NaCl, 0.1 mM EDTA, 1% Triton X100, 5mM 
DTT, 50% Glycerol Stabilisers) and 5 U of TaqPol, which was added last. No additional MgCl2 was added 
beyond that already present in buffer. The mix was placed on ice until further use. 
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Heating process involves a 94°C, 2 min long, initial melting step. This is followed by cycles of: 
Melting at 94°C for 30s 
Annealing at 57°C for 30s 
Extending at 72°C for 30s. 
The melting temperature was selected for being sufficiently low to prevent boiling, while being 
sufficiently high to ensure efficient melting of the DNA pool. Annealing temperature was kept 
deliberately relatively high to prevent formation of large non-specific amplicons. Extending temperature 
was selected as this is the optimum temperature of Taq polymerase.  
30s can be considered a relatively short step duration for annealing and extending parts of the PCR 
process. However short annealing time is a means of minimizing the formation of large non-specific 
amplicons in the annealing step. Due to the shortness of the SELEX sequence, is sufficient for the 
extending step. 
Two scales and procedures of manual PCR were carried out, namely, trial PCR and large scale PCR. Trial 
PCR was performed on a 20-µl scale, while and large scale PCR was typically performed on a 2-ml scale 
(20 × 100 µl aliquots). 
After amplification, 5 µl of the PCR product was extracted for quality control (QC) testing by gel 
electrophoresis. In the absence of noticeable defects, mass PCR was pooled and subjected to post-
processing, typically phenol chloroform extraction, followed by ethanol precipitation. 
  
2.02b Phenol Chloroform Extraction 
Phenol Chloroform extraction is performed in order to purify nucleic acids by removing protein and lipid 
impurities. 
Dried mass of DNA was resolubilised with MilliQ water. The same volume of chloroform was then 
added. The solution was well shaken and then centrifuged at 10000 g for 5 min at 4°C. The upper-phase 
aqueous phase was then pipetted out and the lower organic phase discarded. This process was repeated 
three times.  
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2.02c Ethanol precipitation 
Ethanol precipitation is performed in order to purify and concentrate a nucleic acid solution by 
precipitation of nucleic acid out of solution.  
Next, 10% volume of sodium acetate (3M; pH, 5.2) was added to DNA solution, and 2 volumes of ice-
cold absolute ethanol was then added to the sample. The sample was incubated for a minimum of 2 
hours at -20°C, although overnight incubation is preferable. This was significantly longer than the 
duration described in most methods, but necessary due to the relatively short length of the DNA 
sequences investigated. Precipitated DNA was spun down at 10000 g for 30 minutes. Supernatant was 
then tipped out. The pellet could then be dried under vacuum. 
 
2.02d Gel Electrophoresis 
DNA samples were mixed with 6x loading dye at a ratio of 1:5, mixed thoroughly with the pipette and 
then kept on ice. Next, 3% agarose gel was created by adding 2.1 g of agarose to 70 ml of TAE buffer; 1 
µl of ethidium bromide was added to 10 µl per 20 ml agar to allow the sample to be viewed under UV 
light. This solution was then heated until fully fluid. Agarose was then poured into a tray with a comb set 
over.  
After hardening of the gel, it was submerged in 800-ml TAE buffer on electrophoresis station. Care was 
taken to ensure that the buffer was barely submerged in the gel and that no bubble was present.  
DNA sample and DNA ladder were then loaded. Either a 25-bp or 100-bp ladder can be used for the PCR 
products, while only the 25-bp can be used for the bioconjugation product. Electrophoresis was 
performed at a constant voltage of 120 V until the dye moved up a fair distance over the gel. After the 
completion of electrophoresis, the gel was viewed under UV light.  
 
2.02e ELONA Protocol 
ELONA was performed in order to determine the affinity of the selected and amplified DNA pool. 
Further details regarding the ELONA protocol can be found in section 6.10 of chapter 6. 
The library to be analysed is amplified by PCR using biotynalated forward primers. The PCR product is 
purified by chloroform extraction followed by ethanol precipitation.  
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The purified library is resuspended and hydrolyzed using Lambda nuclease, resulting in the removal of 
the unbiotinylated, unselected, reverse sequence. The Lambda nuclease cleaved product is purified 
again by chloroform extraction followed by ethanol precipitation, after which the mass of the remaining 
forward library is determined by spectrophotometry using a nanodrop machine.  
100ul of 1uM target solution in adsorption buffer (Carbonate/bicarbonate pH 9.6) is added to the 
ELONA plate per well (100pmole per well). The plate is covered in paraffin film and incubated for 12h at 
°C. After incubation the wells are washed by adding 100ul volume of wash buffer (PBS 7.4, 137 mM 
NaCl, 2.7 mM KCl, Tween 0.1%), followed by rinse. The wash is repeated twice.  
200ul of 2% BSA solution in adsorption buffer is added to the ELONA plate per well. The plate is 
incubated for 1h at 25°C. After incubation the wells are washed by adding 200ul volume of wash buffer, 
followed by rinse. The wash is repeated twice. 
100ul of 1nM Forward Biotinylated Aptamers (1nM) in adsorption buffer is added to the ELONA plate 
per well. The plate is incubated for 1h at 25°C. After incubation the wells are washed by adding 200ul 
volume of wash buffer, followed by rinse. The wash is repeated twice. 
100ul of HRP-Avidin (1ug per ml) in adsorption buffer is added to the ELONA plate per well. The plate is 
incubated for 1h at 25°C. After incubation the wells are washed by adding 200ul volume of wash buffer, 
followed by rinse. The wash is repeated twice. 
100ul of HRP substrate (TMB and hydrogen peroxide) is added to the wells. This catalytic sensing system 
is based on the oxidation of TMB catalyzed by HRP in presence of H2O2. The final TMB oxidation 
product is stable under highly acidic conditions. Therefore after 20 min of incubation 20ul of 2M H2SO4 is 
added, terminating the reaction. Final product is yellow and absorbs at 450nm. 
The plate is then analysed using a microplate reader. 
 
2.03 DNA-Label Bioconjugation 
2.03a Bioconjugation of ferrocene carboxylic acid to NH2-DNA 
This method derived from those of a previous study [87]. 
This process was only applicable for DNA sequences purchased with amine modification at the 3′ end. 
DNA sequences purchased pre-conjugated to redox label forego this procedure. 
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Fig 2.02 Overview of the Bioconjugation of ferrocene carboxylic acid to NH3-DNA 
 
Ferrocene carboxylic acid (5 mmol), Anhydrous N-hydroxybenzotriazole (HOBt) (5 mmol) and EDC (10 
mmol) 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (10mmol) was solubilized in 20 ml of 
dichloromethane, and cooled to 0°C. Aluminium foil was wrapped around the container to prevent 
photochemical reaction. This mixture was incubated while stirred for 1 hour.  
Organic solvent is removed by evaporation with a speedvac vacuum centrifuge, yielding a solid residue 
of Ferrocene-OBt, Urea and Excess EDC, as well as small amounts of unreacted HOBt and Ferrocene 
carboxylic acid. 
DNA (10 nmol) with NH2 modification at 3’ was solubilized in 0.5 ml of carbonate/bicarbonate buffer (pH 
9) and added to an excess solution of Ferrocene-OBt in 0.1 ml tetrahydrofuran. The solution was stirred 
at 0C overnight. Condensation reaction between the carboxyl group of the Fc-OBT and the amine group 
at 3’ end of the DNA sequence occurs, resulting in bioconjugation via a amide coupling of the Fcn and 
DNA molecules and the release of HOBT catalyst. This reaction yields a solution of Fcn-DNA, unreacted 
Fcn-HOBT, and other reagents of the reaction. 
Purification processes were carried out using phenol/chloroform extraction and ethanol precipitation.  
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No confirmation of stoichiometry was made, though an electrochemical comparison of conjugated and 
unconjugated aptamer in sensor format could be found on Section 3.07 of the third chapter of this 
thesis. 
 
2.03b Dialysis 
For the final steps of purification, the DNA solution is dialysed using a Harvard Apparatus 1-kDA cutoff 
Micro Dispodialyzer, capable of receiving sample volumes of 5 µl to 100 µl.  
The membrane of the microdialyser is first wetted with MilliQ. A corner of the microdialyser slide is then 
attached to a floatation device. The slide is then floated on a large beaker filled with copious volumes of 
the desired buffer. The solution is maintained under constant stirring. The buffer is replaced every 2–3 
hours. Typically, 3 changes of buffer take place. This should result in a dilution factor of 1011 (assuming 
0.1 ml starting volume in dialyser and 1000 ml of buffer). 
Concentration of DNA in sample was then analysed using a nanodrop spectrophotometer. The solution 
was then diluted down to 10 mM. Assuming a typical remaining DNA mass of 4 nmol after 
bioconjugation and purification, this would require  with storage buffer or MilliQ. The DNA is typically 
then aliquoted into 50-µl tubes for ease of use and stored at -20°C. 
 
2.03c Preparation of MNP-Lysozyme 
Next, 10 nmol of lysozyme was solubilized in 0.98 ml of PBS buffer (0.1 M PBS, 0.15 M sodium chloride, 
pH 7.2). 20 µl of 10 mM sulpho-NHS-SS-biotin is then added to this solution to create a 20-fold excess of 
biotin according to the manufacturer’s recommendations [88]. 
The mixture was incubated for 30 min. After incubation, excess sulpho-NHS-SS-biotin was removed by 
buffer dialysis using a method similar to that described above, by using a membrane with a <3000 mW 
cutoff.  
Stock streptavidin-MNP was thoroughly agitated, after which 100 µl of streptavidin MNP was extracted 
(this should be equal to a 1-mg mass of MNP). The streptavidin-MNP was washed by resolubilising in 1 
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ml bead buffer (PBS buffer, pH 7.4), followed by precipitation and removal of supernatant. This was 
repeated twice, after which streptavidin was resuspended in 0.9 ml of bead buffer.  
Excess biotin-lysozyme solution (100 µl) was then added to the MNP solution and left to incubate under 
rotation for 60 min. After incubation, target-MNP was precipitated and washed 3 times using the 
process described above, followed by resuspension in SELEX buffer. The binding capacity of the 
streptavidin-MNP was approximately 400 pmol of target for each milligram of the bead, according to the 
manufacturer’s specifications [89]. 
 
2.04 Electrodes and Electrode Maintenance 
2.04a Gold Disc Working Electrode 
Tempered hard, 99.99% purity Gold wire 
manufactured by Thermo was use. Typically 25-35mm 
length of gold wire is used. Gold wire is attached to 
copper wire with a small droplet of silver epoxy to 
provide a conductive link between the copper and 
gold wire. The gold wire is then encased in a mix of 
Araldite MY750 epoxy and Aradur hardener and 
heated at 50°C until solid. These will be referred to as 
‘homemade gold disc electrodes’. 
Alternatively gold disc electrodes were purchased 
from ALS. Electrode is 1.6mm diameter 20mm length, 
encased in PEEK. Such electrodes are purchased ready 
for use. 
Both encasement materials are of relatively similar hardness to gold, polishing abrades both encasing 
material and gold wire resulting in exposure of previously unexposed cross section of both material. 
Encasement material plays no role in electrochemistry, but is necessary in order to increase the 
structural strength of the electrode as well as making sure the cross sectional area of the gold disc 
electrode exposed is kept at a constant.  
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2.04b Electrodes Polishing 
Electrode polishing is performed in order to produce a smooth electrode surface, essential for the 
creation of a uniform layer of self-assembled aptamer molecule through thiol-gold interaction.  
The wire is initially cut with a sharp and hard blade, either a medical scalpel or a high grade craft knife. 
While medical scalpels are stronger and more resistant to breaking, some craft knife are thinner and 
therefore result in less deformation of electrode surface, while still being sufficiently sharp and robust. 
For freshly made electrodes, the surface of the electrode is first mechanically polished successively using 
P1000 and P2000 sand paper, average grain size 18.3 and 10.3 um respectively. The electrode was then 
thoroughly rinsed with MilliQ and sonicated for 5 min. Electrode must be held completely vertical 
throughout the polishing process to guarantee smooth surface. 
The electrode was then polished successively by 0.1um, 0.3um and 0.05um alumina powder in slurry 
form, with a 15 min period of sonication between the polishing steps to remove alumina grain from 
previous polish. Pattern of polishing should resemble a figure of eight to produce a uniform surface. 
Electrode should be periodically inspected under a light microscope for any signs of surface defects, 
especially scratches. Electrode should be dry for inspections as scratches are not easy to observe while 
surface is wet. 
In used electrodes, the initial steps of preparation are skipped, as the geometric surface area would 
already be relatively smooth from previous treatment. Here polishing is performed to remove the 
immediate gold electrode surface along with any molecules assembled onto it. For this purpose 
polishing starts directly at the alumina polishing step. 
 
2.04c Electrochemical Cleaning 
Electrochemical cleaning was performed in order to remove any residual impurities from the electrode 
surface via electrochemical oxidation and reduction of the metal. 
Electrochemical cleaning is achieved by applying a positive potential of 2V on the electrode for 5s, 
followed by negative potential of -0.35V for 10s, followed by repeated cyclic voltammetry cycles in 0.5M 
H2SO4, with a scan rate of 50mV/s, scan range -0.3 to 1.55V. 
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The electrode is then rinsed with large quantities of MilliQ and blown dry with nitrogen. The electrode is 
typically used for Immobilisation immediately. 
 
2.04d Reference Electrode 
Silver/Silver chloride reference electrode were used as reference electrode for all experiments 
conducted. Reference electrodes are purchased ready made from ALS, electrode is composed of a silver 
wire coated with a thin layer of silver chloride. This wire is suspended in a solution of KCl, held in a long 
glass tube with tapering end. Tapered end is sealed with a porous plug which enable interaction 
between the cell environment and the Ag/AgCl electrode.   
Reference electrode is tested periodically against a saturated calomel electrode to determine the quality 
of AgCl film. This is achieved by placing both reference electrodes in a cell containing a 3M KCl cell 
solution. Potential across the electrode is determined using a pH meter. 46mV difference is expected, 
with a tolerable variance of 10mV in both directions. 
 
2.04e Counter Electrode 
A counter electrode is either composed of a platinum mesh or platinum wire bonded to copper wire by 
baked conductive epoxy. Sealant material is electrical insulation tape. 
 
2.04f Dropsens Screen Printed Electrode 
The Dropsens SPE was purchased in a finished integrated state containing working, reference and 
counter electrode on a single slide surface. Electrode are arrange in circular pattern in order to optimize 
droplet cell deposition. Device is considered single use only. Best droplet cell size is 50ul. Dropsens SPE 
cannot be electronically cleaned by harsh treatment under 0.5M H2SO4, since it is noticed to strip the 
thin SPE surface. 
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2.04g Immobilisation of Biosensor Aptamer on Gold Disc Electrode 
Stock DNA solution is diluted down to 5uM. 500uM TCEP is added to reduce the thiol group, and the 
solution is incubated for 60min at RTP. pH9 TE buffer is typically used, composed of 10mM Tris-HCl, 
1mM EDTA. Prior to use solution is heated to 70°C for 5 min, in order to melt the DNA and produce a 
pool of disaggregated DNA molecule. 
A polished and freshly electrochemically cleaned gold disc electrode is selected. The electrode is held in 
a 90-degree vertical position (an empty 200ul pipette tip box is ideal for this application), and a droplet 
of the 5uM aptamer solution is deposited onto electrode surface using a Gilson’s pipette. 20ul has 
generally been found to be the optimal droplet size for ALS produced gold disc electrodes as this 
provides ample volume to cover entire electrode surface, without excess volume resulting in wastage, 
but this volume should be varied to fit the requirements of the specific electrode being used. The 
electrode is then incubated for at least 12 hours. An eppendorf cap is enclosed over the electrode tip to 
prevent contamination and retain humidity. Electrode was stored in a dry, dark place to prevent 
electrode from drying out.   
The electrode is rinsed with copious quantities of MilliQ water. Electrode is then incubated with 1mM of 
butanethiol in absolute ethanol for 30 min. This results in the formation of a self-assembling layer of 
butanethiol blocker molecules on the electrode surface, bound by thiol-gold interaction. Electrode is 
then copiously rinsed Ethanol, followed by another rinse with MilliQ water. 
 
2.05 Electrochemistry Methods 
2.05a Electrochemical Cell Setup 
The sensor electrode is characterized in a 5ml glass electrochemical cell. The electrodes are arranged 
spatially to allow maximum isolation of reference electrode. Special care is taken to prevent electrodes 
coming into contact in order to reduce risk of short circuit.  
Cell solution is composed of 10mM tris-HCl, 100mM KCl and 5mM MgCl2, pH is adjusted to 7.6 for all 
electrochemical run. This standard condition has been selected in advance so that electrodes, in 
particular conformation change aptamer sensor electrodes, can be modeled to operate in the same 
environment, making multichannel sensing feasible. pH and salt concentration is typical of 
electrochemical cell conditions for biosensing applications, with salt concentration being sufficient to 
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prevent effect of ionic migration as a relevant mass transport, while being low enough to allow flexibility 
in biosensor molecule design. 
Mixing was achieved using a magnetic stirring bar, rotated using a magnetic stir plate located 
underneath the electrochemical cell. Care is taken to ensure stirring bar is arranged in middle of 
electrochemical cell. Mixing was carried out for approximately 60 seconds at 100rpm per dilution in the 
titration. Since reaction kinetics could be influenced by effective concentration change as a result of 
mass transportation by solution convection, electrochemical measurements are not carried out till stir 
plate has been off for at least 30s.  
5ml volume was sufficiently large to reduce the dilution effect of added volumes as a result of titration. 
Cumulative increase of volume should not exceed 10% of the original cell volume (so 500ul, to 5.5ml).  
 
2.05b Automated Multi-Channel Aptamer Biosensor Protocol (AMCAB) 
The aptamer cell was set up in a manner similar to the single electrode electrochemical cell setup 
described above. However for AMCAB two working electrodes are present in the cell rather than just 
one. Due to the absence of a multichannel electrode at the time, the measurements were taken 
sequentially. Immediately after characterization of the first electrode the working electrode lead was 
detached from the working electrode and attached to the second working electrode, after which an 
identical scan protocol is run. Feed protocol is implemented using an automatic sampler constructed in 
house. Protocol is otherwise identical to those of the standard electrochemical setup above.  
 
2.05c Square Wave Voltammetry (SWV) 
SWV was performed to the following parameter Start Potential 0V, End Potential 0.7V, Potential Step 
0.01V, Step Amplitude 0.05V. Frequency selected was 15 Hz. This gives each run 70 data points. Quiet 
time is set at 30 sec, measured manually. The scan range was narrowed down based on peak 
observation of SWV runs to 0.1-0.6V during later experiments.  
This common electrochemical protocol was used for both conformation change and ELONA-like assays. 
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2.05d Soil Sample Preparation 
Soil sample was extracted from a garden near the university campus. Spot selected was soft soil near a 
tree. Sampling point has significant decomposition of plant material, while having significant moisture. 
Soil was observed to have a distinctly ‘earthy’ odour, which indicates presence of Geosmin, which can be 
a product of Actinomycetales activity.  
Soil was selected in this environment for a number of reason. Firstly these soil conditions are a classical 
environment for Actinomycetales growth. Actinomycetales are the mainstay of microbial bioproduct 
discovery, known for producing diverse secondary metabolites and with well-studied and simple growth 
conditions which would facilitate integration of bioproduct post-discovery. Secondly, decomposing plant 
material is a relatively poor nutrient medium, which is the condition under which secondary metabolites 
(which are non-growth products) are produced.  
Soil sample was extracted using a disposable plastic spatula, and stored in a corning tube. Soil sample 
was added to 100ml MilliQ, and agitated thoroughly. Sample was then divided between 2 corning tube. 
Target spike then takes place using appropriate target concentration. 
Sample was then spun down on a centrifuge briefly, resulting in the large insoluble particles being 
aggregated at the bottom of the corning tube. Supernatant was extracted, keeping care not to disturb 
the aggregate at the tube bottom. Supernatant was then filtered through a Millipore HAWP01300 filter. 
Sample is mixed with 2x concentration cell buffer for SWV analysis. This gives the soil matrix solution a 
theoretical soluble soil mass of 10mg/ml. 
 
2.06 Sandwich Type Aptamer Biosensor Methods 
2.06a Synthesis of Gold Nanoparticle 
Gold nanoparticles were synthesized using the commonly applied Frens [90] method. 
50 mg of Gold(III) chloride trihydrate (HAuCl4.3H2O) was added to 5ml MilliQ water, mixed thoroughly 
and added to 250 ml boiling MilliQ water stirred using a magnetic bar. 
125 mg trisodiumcitrate dihydrate (C6H5Na3O7.2H2O) was added to 15ml MilliQ water, then added to the 
boiling mixture. 
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Once particles of the desired size are formed (based on reference timing, for 10nm gold nanoparticles 
this typically takes 10 min after the addition of trisodiumcitrate dihydrate), the solution was allowed to 
cool slowly to room temperature. The final solution should be wine red. 
Due to the electrostatic nature of the dispersal mechanism of GNP, a sufficient change in the ionic 
strength of the dispersing medium or damage to the repelling surface of GNPs could result in the 
reaggregation of GNP. This results in the formation of large aggregated lumps of GNP at the bottom 
container. Special care was therefore taken to reduce potential contamination of GNP solution. All 
glassware were, at the very least, washed thoroughly, rinsed with piranha solution solution (3:1 H2SO4 to 
30% H2O2), followed by thorough wash with MilliQ water. Glassware was then dried at 70°C. 
The resulting solution was characterized through UV-Vis spectrophotometry for the purpose of quality 
control. Physical characterization of the shape and size of the nanoparticles was achieved using 
transmission electron microscopy. 
 
2.06b Assembly of Aptamer onto Gold Nanoparticle (GNP) 
This method was based on a previously described one [91]. 
Gold nanoparticle is concentrated using a centrifuge and the supernatant removed. The GNP solution 
was then resolubilised in TETBS buffer composed of 20mM Tris-HCl (pH 7.35), 300 mM of NaCl, 5 mM 
EDTA, and 0.05% tween 20. 
Oligonucleotide was added to the nanoparticle solution to a final concentration of 4 µM thiolated DNA. 
Since the short 15-bp thrombin aptamer was composed entirely of T and G bases, it had no 
complementarity, and therefore, pre-heating was not required.  The mixture was incubated for 24 h at 
room temperature in order to produce an ordered self-assembly.  
The solution was centrifuged and the supernatant was pipetted out gently in order to remove unbound 
excess oligonucleotides. The GNP pellet was then washed, followed by at least 2 more cycles of 
reconcentration and resuspension.  
According to data from investigations on the design of aptamer-coated gold nanoparticles, the shelf-life 
of aptamer-coated GNP should be no less than 2 months when stored under refrigerated conditions. 
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The resulting Ferrocenated-DNA-enriched GNP is then characterized by UV/Vis for the purpose of quality 
control. Fc-DNA-enriched GNP should have high peaks at 260 nm (as a result of DNA contribution) as 
well as 520 nm for particles of approx. nm in diameter. This is in contrast to bare GNP, which should 
have a high peak only at 520 nm, or supernatant, which has a high peak at 260 only, relative to the Fc-
DNA-enriched GNP sample. 
Dynamic light scattering was performed in order to determine presence of DNA on GNP surface. 
 
2.06c Assembly of Aptamer to Screen Printed Electrode (SPE) 
Immobilisation of the long 29-bp thrombin aptamer onto the SPE surface is carried out using the same 
protocol as that listed in the conformation-change aptamer section. It is important to note that the SPE 
should not be electrochemically cleaned, as this has been observed to damage the SPE gold film.  
 
2.06d Indirect Adsorption ELONA-Like Aptamer Biosensor (IAELAB) Protocol 
An SPE slide with immobilized long 29-bp thrombin aptamer was selected and placed on a flat surface. 
The desired titration of the target molecule in the cell buffer (Tris-HCl 7.6, 100 mM KCl, 5 mM MgCl2) 
was pipetted onto the electrode surface at a volume of 10 µl; this was expected to create a droplet 
significantly larger than the working electrode, but not expansive enough to cover the reference and 
counter electrodes. The target was allowed exactly 120 s to immobilize, this should be sufficient to allow 
specific adsorption of target molecule to electrode surface, while minimising non-specific adsorption. 
The slide was then tilted to an approximately 20° angle and rinsed thoroughly but very gently with 
approximately 5 ml of water. It is advised that a 5-ml Gilson’s pipette be used, with a drip mode of wash. 
Unlike ELONA, where the wash was carried out at least three times, the wash process was carried out 
only once. 
The slide was then placed again on a flat surface, and 20 µl of GNP was then pipetted to form a bubble 
over the working electrode. The GNP was allowed to immobilize for 300 s, after which the slide was 
tilted and rinsed with 5-ml buffer in the manner described above. The slide was then considered ready 
for electrochemical analysis processing. 
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2.06e Direct Adsorption ELONA-Like Aptamer Biosensor (DAELAB) Protocol 
DAELAB shares the same protocol as IAELAB described above, except that a clean SPE was used rather 
than one immobilised with the long 29-bp aptamer. 
 
2.07 Automated Sampling Platform Design and Fabrication 
Part of the process of enhancing the applicability of the conformation change aptamer biosensor 
includes automation of liquid handling via an automatic sampler.  
The Type 2 Automated Sampling Platform (T2ASP) was developed from a RepRap 3D printer. The 
electronics and hardware components of the 3 axis robot was largely retained. The most significant 
difference between a RepRap and the T2ASP is the replacement of the extruder with a sampling head 
attached to a syringe pump. The syringe pump was of in-house manufacture.  
The device avoids the unstable Y axis as a movement axis completely. Y axis (which has built in coded 
endstop) is used instead as the syringe pump motor axis. This can be considered a hardware downgrade 
from earlier two axis sampling model, and significantly reduces the surface available for sampling. 
However the device is more mechanically stable, has a practical software complexity, and still has 
sufficient sampling space for the task at hand. Sample tray weight is also less constrained as the sample 
bed no longer needs to be able to move without excessive shaking.  
Electrochemical cell which sits on sampling tray is now also complete static, which should reduce data 
anomaly caused by spatial rearrangement of cell components. Sampling tray wall also no longer need to 
be as tall to prevent spilling and thus allow the device z axis faster movements to clear cell tray 
obstacles.  
All plastic structural parts were designed on Solidworks, and converted to Gcode using sprinter 
software. All plastic structural components excluding timing belt were fabricated by 3D printing, settings 
are solid external parts with honeycomb interior (for best compromise between strength and weight). 
The only exception to this is the main lever, which is made of solid print only.  
Timing belt is T3 type, same as those used to control RepRap X and Y axis. Stepper motor is a generic 
NEMA 14 type.  
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Pumping syringe is a standard U-100 insulin syringe. This was chosen partly due to relatively standard 
size of such syringe and their ubiquity. The sampler is not expected to carry large volumes of liquid for 
the multichannel sensor tests (50-150ul being most likely estimate), thus there is no need for a syringe 
pump with large volumes. Also since the volume pumped is translated from linear timing belt 
movement, the smaller the syringe volume/length ratio the finer the pump resolution controlled by 
Gcode. A relatively small volume also means reduced friction on the sampler (Y-axis) motor. 
The primary weakness of the insulin syringe is relative lack of durability. This is understandable, since 
insulin syringes are strictly one use by original design. In practice, the syringe pumps are generally 
replaced after every 2-3 multichannel tests. Insulin syringes are cheap enough to be replaced frequently 
without excessive cost. Replacing insulin syringes at frequent intervals can also be considered to be a 
benefit as it reduces cross contamination as a result of retainment of residue between experiments, an 
important design aspect in automatic samplers.  
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Fig 2.03 A depiction of the mechanism of the syringe pump used in the T2ASP. Command is issued in 
GCode format resulting in motor shaft rotation, which pulls the syringe pump connected to the timing-
belt attached moving frame forwards or backwards. This results in suction, leading to liquid uptake. 
10ml HPLC syringe were also considered. This would have had a significant advantage over the 1ml 
insulin syringe in terms of both accuracy and durability, but was ultimately rejected as the friction of the 
syringe exceeded the power of the stepper motor even at slow speed. Also the increase in weight 
caused by a more powerful motor needed to drive this new syringe (in addition to the considerable 
weight increase of the syringe itself) may decrease the accuracy of the X axis movement whose weight 
now considerably exceed the extruder head of the original Reprap design. 
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Sampling head is composed of friction bonded 200ul pipette tip and CNC milled PTFE connector 
modelled around the dimensions of a 200ul Gilson’s pipette. This ensures a snug fit between the 
connector head and the pipette tip. 200ul pipette tip is sufficiently small to allow easy entry into smaller 
sampling wells, and its small aperture should reduce liquid loss in transportation process. 
PTFE is a relatively low friction material, so stretched paraffin film is typically wrapped around the 
sampling head to prevent slippages and seal any potential air gaps. The connector head is connected to 
silicone tubing by elastic bonding via an overlapping segment of PTFE tubing (which in turn has been 
bonded into the connector head by a compression joint). Silicone tubing is connected to the syringe by 
elastic bonding to the syringe nozzle.  
PTFE tubing was considered as a replacement for the silicone tubing. PTFE has the benefit of being a 
much lower friction material than silicone, potentially greatly reducing contaminant retainment. 
However PTFE is also a much less flexible material than silicone, which would result in considerably 
decreased flexibility of head placement, as well as increasing tube length, leading to an increased 
internal volume of the pumping system, decreasing suction. Pumping volume was expected to be 
between 50-150 ul, so sampled liquid is never expected to enter the connector head or tube in any case. 
Both material could be autoclaved prior to experiment, guaranteeing sterility at experiment start. The 
entire sampling head assembly (minus the paraffin film) could be sterilized via autoclave. This together 
with the insulin needle which are sold pre-sterilised, means that the entire fluid pathway of the sampler 
could be assembled from a sterile state. 
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Chapter 3: Conformation Change Aptasensors 
3.01 Introduction 
This part of the thesis describes the development of a second generation affinity biosensor based on the 
conformational change of single strand nucleic acid aptamers upon target-binding. Conformation 
Change Aptasensors (CCA) depend on the spatial rearrangement of the nucleic acid strand as a 
consequence of a target-aptamer binding interaction. This is in contrast to first generation 
configurational change aptamer biosensors which depends on the displacement of (typically label 
containing) sequence.  
Signal generation is the result of a change in the distance between label and electrode surface as a 
result of this spatial rearrangement, and can be either higher or lower than the initial (target free) signal. 
Positive signal change, typically referred to as a “signal on” system, can be considered an analogue of a 
“normally off (NO)” switch and results from the bound state bringing the label closer to the sensing 
surface. Negative signal change, typically referred to as a “signal off” system can be considered an 
analogue of a “normally connected (NC)” switch and results from the bound state taking the label 
further from the sensing surface (the beacon designs described below would be a good example of this).  
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Fig 3.01 Overview of CCA Sensing Strategy. A) represents a typical beacon type “signal off” 
electrochemical biosensor. B) represents a sensor with a “signal on” format. C) Represents a typical 
configurational change aptamer sensor. 
 
3.02 Advantages and Disadvantages of CCA 
Much of the competitive advantages of second-generation aptamer sensors can be linked to their 
relatively greater temperature tolerance as compared to the first generation (configurational change) 
aptamer sensors 
By attaching the redox probe to the same DNA strand as the sensing sequence, the sensing surface can 
be regenerated by thermal denaturation, followed by reannealing. The first generation structures are 
composed of hydrogen bond bound probe and sensing sequences which result in dissociation of the two 
hybridized structure upon heating. This represents a significant disadvantage in real-world application, 
since configuration change aptamer biosensors therefore may not be able to operate at all in hot 
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environments. This is unlikely to be a relevant issue with centralized laboratory based diagnostics, but 
could be a significant weakness in a sensor designed for field application. 
Thermal stability also significantly benefits the reusability of the conformation change sensor. It is 
possible to regenerate CCA by simple heating, as the single nucleotide strand would simply return to 
stable secondary structures after heating. Configurational change aptamers biosensors will require, at 
the very least, a replacement of the unbound sequence in order to renew the sensing surface, while 
most protein based antibodies will permanently lose viability after extensive heating, since post 
translational tertiary and quaternary structures needed for sensing may not be the most energetically 
stable configuration, or barriers may exist preventing reformation (see section 1.06, chapter 1) 
The most significant weaknesses of the CCA biosensor design is the limited distance in which the target-
aptamer binding event can displace the label. Since conformational change aptamers typically have the 
label located on a complementary strand, the displacement of the label containing strand results in the 
loss of the label to the bulk solution. In the case of CCA biosensors, the displacement of the label is 
limited by the length of the nucleic acid strand. Thus displacement remains within molecular distance of 
the sensing surface. Since charge transfer is a distance dependent phenomena, the difference between 
target-bound signal and resting signal of CCA is likely to be relatively small compared to those of first 
generation aptamers. 
Another weakness of the CCA vis-à-vis configuration change systems is the difficulty in designing the 
former. Nucleic acid-nucleic acid interaction has been well investigated, and many relatively robust 
modeling tools exist for the determination of nucleic acid secondary structures. In fact, it is possible to 
calculate the most energetically stable resting states of the nucleic acid stem loops (and therefore the 
location of the label in the resting state relative to the sensing surface) with a fair degree of certainty. 
Thus resting signal can be predicted at least qualitatively (in a “high” or “low” sense). Molecular beacons 
rely on this principle to create a stable background signal. 
However, the current state of knowledge of molecular physics does not allow the interaction between 
nucleic acid aptamers and other molecules to be modelled easily or with any degree of accuracy. This 
issue is exacerbated by the sheer range of targets of nucleic acid aptamers, which range from ionic salts, 
to large globular proteins, and virus particles. As such it is impossible to predict the “on” state of an 
aptamers-target interaction without resources far beyond the scope of this work (if it is possible with 
the current state of technology at all). This problem can be ameliorated to some degree by having a very 
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stable resting state. This is where the equilibrium of resting state greatly favours a single energetically 
highly stable form, which either brings the label very close to, or very far away from, the sensing surface. 
This makes it statistically unlikely the bound state will result in a form that is respectively even closer to 
or even further from the sensing surface, resulting in the bound state current decreasing in the former 
and increasing in the latter case. This is the underlying strategy of molecular beacon sensors which will 
be discussed below.  
 
3.03 Model for Surface Binding  
In this work, it was initially hypothesized that the aptamer-target-binding event occurs as a two 
molecule binding process. At condition of equilibrium the thermodynamic value of the target-aptamer 
complex could be estimated from the designated target titration.  
When using this model, several assumptions need to be made: 
1) It is assumed that the gold electrode does not influence target-aptamer interaction, and 
that this is a largely two molecule process.  
2) Concentration of target at the electrode surface is the same as that in the bulk solution.  
Thus based on the above assumptions, the influence of the surface does not affect target sensing (and 
thus behaves like a constant), and there is no further signal changes after the formation of the target-
aptamer complex. In this design aptamers are immobilized on the electrode surface. Therefore 
fractional occupancy of surface-bound aptamer (f) is directly related to target concentration at electrode 
surface. According to 2) the target concentration at the electrode surface is proportionally influenced by 
the concentration of the target at the bulk solution. Thus titration of the target solution into the 
electrochemical cell results in a correlating increase in f, which can be represented as follows: 
 
𝑓 =
[𝑆𝑇]
[𝑆0]
 
Eq 3.01 Fractional Occupancy of Aptasensor 
[ST] representing target bound aptamers 
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[S0] representing net aptamer concentration at electrode surface. 
In this electrochemical analysis, change in the bound state could be determined through the observation 
of change in peak current. Thus, peak current measurements could be used in order to determine the 
fractional occupancy of surface-bound aptamer. 
 
𝑓 =
𝑖 − 𝑖0
𝑖𝑠𝑎𝑡 − 𝑖0
 
i is peak current 
i0 is background peak current (i in absence of target) 
isat is the peak current at point of titration where the curve plateaus. 
 
Thus: 
 (i- i0) represents peak signal at investigated point [ST],  
(isat-i0) represents total signal of aptamers present at electrode surface [S0] 
 
The dissociation constant (Kd) can be expressed as follows: 
𝐾𝑑 =
[𝑆][𝑇]
[𝑆𝑇]
 
Eq 3.02 Expression of Dissociation Constant 
[S] is unbound aptamer density 
[T] is Target Concentration 
[ST] is target bound aptamer density 
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Unbound aptamer density is the total mass of aptamer not in a bound state: 
[𝑆] = [𝑆0 − 𝑆𝑇] 
 
Thus: 
𝐾𝑑 =
[𝑆0 − 𝑆𝑇][𝑇]
[𝑆𝑇]
 
 
Fractional occupancy can be described as a function of dissociation: 
1
𝑓
=
[𝑆0]
[𝑆𝑇]
 
Thus: 
 
𝐾𝑑 = (
1
𝑓
− 1) 𝑇 
 
The equation can also be re-arranged to include mass balance constraint. Net aptamer mass at the 
electrode surface can be described as the sum of bound and unbound aptamers. 
 
[𝑆0][𝐴] = [𝑆][𝐴] + [𝑆𝑇][𝐴] 
[A] represents the electrode surface area 
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Net mass of target can likewise be represented by the sum of the mass of aptamer bound target and the 
mass of target in the bulk solution. 
 
[𝑇0][𝑉] = [𝑇][𝑉] + [𝑆𝑇][𝐴] 
[V] represents the volume of the bulk solution 
By rearranging this equation, target concentration can be represented as: 
 
𝑇 = [𝑇0] −
𝐴
𝑉
[𝑆0]𝑓 
 
Thus, Kd can be rearranged as follows: 
 
𝐾𝑑 = (
1
𝑓
− 1) ([𝑇0] −
𝐴
𝑉
[𝑆0]𝑓) 
 
Under the abovementioned assumptions, A, V and [S0] remain constant throughout the experiment, and 
thus can be represented as a constant: 
𝐾𝑑 = (
1
𝑓
− 1) ([𝑇0] − [𝐾𝑎]𝑓)  
Eq 3.03 Expression of surface binding  
 
In practical terms, f could be calculated directly from the current peak provided by square wave 
voltammograms. The Kd can then be derived from the fit. 
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3.04 Molecular beacons 
The molecular beacon is a sensing molecule that relies on a hairpin structure. A nucleic acid hairpin is 
composed of two components, a single-stranded loop and a double-stranded duplex stem. This 
secondary structure is commonly seen in single-stranded nucleic acids as a result of self-hybridization at 
the strand terminus. The self-hybridized form is designed to be energetically stable, resulting in a resting 
configuration which greatly favors the hairpin. Target-binding results in the opening of this hairpin, 
resulting in the “on” state. While some of the ss DNA of the “on” state could potentially be adsorbed 
onto the electrode surface, statistically the majority of the label would be displaced further than its 
location in the unbound state. In practical terms for electrochemical aptamers this means that the 
resting state of beacon-based sensors will have a higher current relative to the target bound state.  
In many ways, the aptamers beacon is the logical extension of a typical sensing-strand/complimentary 
strand type configurational change aptamers. Here the complementary strand has simply been attached 
to the end of the sensing strand.  
Molecular beacons originated as optically labeled nucleic acids modified by a fluorophor and quencher 
at the 3’ and 5’ terminus [92]. This mechanism is initiated by the donor group being excited by a 
fluorophore and then relaxing into its lowest excited state by Kasha’s rule. The presence of the quencher 
in close proximity results in efficient non-radiative decay of the excited state. Formation of a hairpin 
loop result in the fluorophore and quencher couple being in van der Waal’s contact to enable efficient 
quenching. This results in reduced luminescence. Formation of a target-aptamer complex results in the 
beacon “opening up”, resulting in greater spatial distance between the fluorophore and quencher, 
resulting in luminescence. Fluorophore-Quencher couples are highly sensitive to separation distance. 
Thus even small changes to the spatial arrangement of the molecular beacon could result in significant 
changes in luminescence. 
For example the original DNA molecular beacon developed by Tyagi et al [92] would result in the 
backbone of the complementing nucleic sequences being located at a distance of <1 angstroms from 
each other in the closed configuration. In the open configuration, the maximum distance between the 
termini would be the length of each nucleotide multiplied by the number of nucleotide. While it is 
almost certain the ssDNA will form secondary structures, which will decrease distance due to increased 
arrangement density of the nucleotide sequence relative to the linear sequence, the distance between 
the quencher-fluorophore couple is greater in the open than in the closed form. 
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For practical purposes, the design of aptamer molecular beacon takes into consideration a number of 
factors: 
1) The sequence targeted by the complementary sequence must also bind target. Otherwise 
target-binding may not result in displacement of the complementary sequence. 
2) Complementary sequence must have significant affinity to its matching sequence. Overall the 
hairpin should be significantly more thermally stable than other resting forms. 
3) For obvious reasons the complementary sequence must not have a higher affinity to its 
matching sequence on the aptamers than the target molecule. Otherwise the target will not be 
able to displace the complementary sequence at all. 
4) The hairpin should not have significant affinity to any other sequences in the nucleic acid strand, 
especially one close to the matching sequence on the aptamer. Otherwise the displaced 
complementary sequence will simply bind to this site, resulting in minimal signal change. 
5) For obvious reason the added segment must not result in a loss of overall sequence affinity to 
target. However due to the difficulty in modelling target-nucleotide sequence interaction 
discussed above, the effect of added sequence on target affinity may not be discernable without 
practical experimentation. 
One of the essential divergence in the design of aptamer molecular beacons and conventional molecular 
beacons used as complementation probes is in the position of the target-binding sequences. For the 
molecular beacon the target complementary region is typically located within the loop of the single-
stranded hairpin secondary structure [92][93][94]. Binding of the target sequence to the molecular 
beacon results in the linearization of the molecular beacon-target sequence duplex as a result of Crick-
Watson interaction, thus resulting in a separation of the fluorophore-quencher couple. In aptamer 
molecular beacons, the target-aptamer interactions cannot be reliably modeled. Therefore target-
binding to a sequence located at the loop may not result in the dissociation of the stem structure of the 
hairpin, resulting in no separation of the 3’ and 5’ terminus. Thus the complementary sequence binding 
region should be the same region predicted to bind to the target molecule [95] [96], so that the target-
aptamer binding event would result in the displacement of the complementary sequence, resulting in 
the dissociation of the stem of the hairpin structure. 
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Fig 3.02 Comparison of the design aspects of conventional molecular beacon and aptamer beacons. 
Green represents target-binding sequence. A) Represents a well-designed molecular beacon, with 
target-binding event resulting in the linearization of the molecular beacon B) Represents a well designed 
aptamer beacon, with target-binding resulting in disaggregation of the hairpin stem C) Represents a 
badly designed aptamer beacon, with target-binding event failing to disaggregate the hairpin stem, 
resulting in no signal change.  
 
3.05 Titration against Spiked Environmental Sample 
3.05a Objectives of Sampling in Environmental Matrices 
The final goal of this study is to develop, as far as possible, a viable aptamer sensor for the detection of 
designated targets for real-world use. The nature of the environment in which this biosensor would be 
used will dictated largely by the target molecules of the biosensor developed under controlled 
laboratory conditions. A number of criteria were used in this selection process: 
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1) Sensor reliability. How reproducible and reliable the sensor is under controlled conditions. 
Ideally there should be a single dominant electrode variation, which responds predictably to 
target titration. 
2) Sensor signal strength. The magnitude of the sensor signal. This is likely to be particularly 
important in environmental samples since, unlike under controlled conditions, environmental 
samples can potentially contain solute substances which are electrochemically active within the 
applicable scan range which may result in significantly increased noise. 
3) Detection limit of the sensor. Ideally (in order to have potential real world significance) the 
developed sensor should have a detection limit better than, or at least comparable to, 
conventional techniques of similar complexity. Should the sensor not have a competitive 
detection limit compared to presently available conventional techniques, the sensor should be 
sufficient for a specific commonly needed task.  
4) Sensor dynamic range. A large dynamic range is desirable as it will potentially allow the sensor 
to not only determine the presence of target molecule, but also to quantify concentration of 
target molecules present. 
 
3.05b Selection of Targeted Environment 
Based on target potential and preliminary results of controlled environment experiments, the two 
sensors selected for use in further study were kanamycin aptamer and tetracycline aptamer.  
One of the benefits of selecting kanamycin and tetracycline is that it is reasonable, from a practical/real 
world viewpoint, to have both biosensing tips on the same sensor array. While being structurally very 
different and having different mechanistic targets, Kanamycin and Tetracycline have very similar 
practical functions, since both are characterized as broad spectrum antibiotics.  
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Fig 3.03 Flow chart displaying the treatment process of environmental samples 
 
The conventional microbial product discovery process discovers products based on function rather than 
chemical properties. Most antibiotic selection assays involve observation of growth inhibition of a target 
organism on spread plates [81][97]. These tests are empirical in nature, yielding very little theoretical 
information about the secondary metabolite being produced by the organism beyond the fact that it can 
inhibit the target species. Thus having an array of biosensors specific to the products of similar function 
in the context of microbial product discovery fits well with current doctrine. Both secondary metabolites 
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are also originally the product of Actinomycaetales extracted from soil (similar to the vast majority of 
the current catalogue of secondary metabolites), which gives us an ideal matrix for environmental 
sampling.  
Another potential area of interest for broad spectrum antibiotic sensing would be in the detection of 
antibiotic residues in agriculture. Antibiotics are used in livestock agriculture to increase feed conversion 
ratio [98] and to prevent spread of contagion among herds. Unlike in medicine where narrow spectrum 
antibiotics are employed for most purposes, agriculture tends to use broader spectrum antibiotics. Both 
aminoglycosides and polyketide antibiotics have been used in agriculture in this context [99]. 
Use of antibiotics for food animals are heavily regulated in most if not all More Economically Developed 
Countries (MEDC). Drug withdrawal periods are legally mandatory to prevent transfer of residual 
antibiotics to humans [100], which can result in problems such as antibiotic resistance and allergic 
reactions [101]. Thus there is a potential real world context for a biosensor capable of the detection of 
broad spectrum antibiotics in agricultural effluence. Effluence from livestock would be an ideal matrix 
for investigation, poultry faeces was selected since it is most easily accessed. 
The base environmental matrix was extracted locally. 5 g of soil or 2g of faeces were added to 100ml of 
MilliQ water. The solution was thoroughly agitated. Secondary metabolite target spike was then 
solubilized at the concentration desired. The solution was spun down briefly to eliminate the largest 
insoluble particles. The solution was then extracted, while avoiding the precipitate as much as possible. 
The solution was then filtered through a Millipore HAWP01300 filter. The filters may need to be 
replaced several times due to clogging by particles not eliminated by centrifugation. The sample was 
then mixed with 2x buffer solution at the same concentration. Analyte spike was then applied at desired 
concentration. Samples were then considered ready for use in assay. 
This protocol was designed specifically such that it can be feasibly carried out in the field. Filtration 
could be performed using a syringe through a filtration cassette. A number of portable centrifuges are 
commercially available powered by car battery. All reagents could be pre-autoclaved and stored for long 
periods without refrigeration. 
It was strongly considered that instead of mixing the environmental sample with a 2x buffer to make a 
50% environment solution, it may be better to add the buffer in a solid state directly into the 
environmental solution. This would allow the usage of a 100% environmental matrix, automatically 
103 
 
increasing the sensitivity of the aptamer biosensor by two fold. However to mix a buffer with the 
environment matrix would require a pH meter for pH adjustment and an alkaline solution, not a 
convenient thing to do in the field. Since the aim of this study is to produce a sensor capable of 
convenient field operation, this factor must be given considerable weight. 
 
3.06 Kanamycin Sensing with a Ferrocene Modified Aptamer 
The aptamer sequence around which the aptamer electrochemical biosensor is designed was previously 
published by Song et al. [102]. Kd of the aptamer was determined by Song et al’s publication to be 78.8 
nM by colorimetric analysis using 5’ fluorescein amidite modification. The detection limit was 
determined to be 25nM by using GNP based colorimetric method. The sequence was also determined to 
have significant affinity to closely related aminoglycoside tobramycin (Kd 103nM).  
In the original publication the sequence was hypothesized to have a beacon like structure based on 
mFold calculation (see section 3.07 of this chapter, page 104). After having confirmed that this is also 
the case under the conditions used in this study, by using mFold [103][104] and idtdna’s 
OligoAnalyzer[105], the sequence was selected for use as biosensory receptor without further 
sequential modification. 
 
Published Sequence: 
5’-TGGGGGTTGAGGCTAAGCCGA-3’ 
 
The sequence selected was adapted for electrochemical conformational sensing by the addition of a C6 
mixed disulphide group at the 5’ end terminus of the sequence and a ferrocenyl modified base at the 3’ 
end. 
 
Finalised Biosensor Sequence: 
104 
 
5’- C6H13-S-S-TGGGGGTTGAGGCTAAGCCGA-Fcn-3’ 
 
3.07 Kanamycin Aptasensor Titration against Target Molecule 
The finalised biosensor sequence was immobilized on planar gold electrode by thiol-gold interaction. 
Investigation of a target titration by SWV shows significant correlation between signal magnitude to 
target concentration. The titration plot profile is highly typical of a conventional binding curve, with the 
signal drop correlating to target concentration at lower concentrations before plateauing at high 
concentration as the sensing surface is saturated with target molecules at high concentrations.  
 
Fig 3.04 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer 
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All the SW Voltammograms display a significant baseline slope and this was corrected for by linear 
interpolation between the minima either side of the voltammetric peak. The peak current is the 
maximum magnitude of difference between the SW voltammogram and the interpolated slope between 
the minima.  
 
Fig 3.05 An example of peak current calculation by slope subtraction (the voltammogram is that of the 
buffer concentration from the titration series shown above). Blue represents the voltammogram, green 
represent the interpolated slope and red represents the magnitude of difference at point of greatest 
difference between the voltammogram and the slope. 
Using the aforementioned method, peak current response from the titration could be derived.  
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Fig 3.06 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer 
Fitting the peak currents as a function of the target molecule concentration by using a Langmuir-type 
fitting as discussed in the introduction section of this chapter (see page 93) yields an average Kd of 565.8 
+/-232.5 nM, which is significantly higher than the literature Kd of 78.8 nM. This could be attributed to a 
number of factors. One of most common causes of Kd variation between experimental sets is change in 
experimental conditions, however it must be noted that in this particular case the method utilized to 
obtain Kd in the original publication by Song et al publication is similar to those utilized in this 
experiment (binding buffer used was composed of 20 mM Tris–HCl, 50 mM NaCl, 5 mM KCl, and 5 mM 
MgCl2, pH 8.0, electrochemical cell solution utilized here is 10 mM Tris–HCl, 100 mM KCl, and 5 mM 
MgCl2, pH 7.6). The main difference between this study and the original publication is that the aptamer 
here is immobilized on a planar gold electrode surface which may potentially interfere with target 
binding. 
The structural and energetic modelling by the mFold software could be used to explain the change in 
current amplitude of the target-bound and unbound states. Based on Mfold, the majority of the 
kanamycin biosensor molecules exist in three stable states under electrochemical assay conditions. 
Form A and C greatly resembles a classical molecular beacon type hairpin. Form A has two 2 base self-
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annealing segments in close proximity near the terminus of the strand and Form C has a 2 base self-
annealing segment and a 3 base self-annealing segment in close proximity. dG for Form A is -7.8kJ/mol 
and a melting point of 41.7°C. dG for Form C is -6 kJ/mol with a melting point of 38.6 C. Form B has 
minimal self-annealing, with random placement of the ferrocenated terminus relative to the electrode 
surface. dG for Form B is -7.2 kJ/mol and melting point is 47.3°C.  
 
Fig 3.07 Structural diagram of the most energetically stable self-binding conformations of Kanamycin 
biosensor molecule as calculated using the mFold model, Form A being the most and Form C being the 
least stable. Modeling parameters: Temperature 25°C, Salt concentration 100mM NaCl, 5mM MgCl2 
It should be noted that the original Song et al paper [102] determined the melting point of this aptamer 
to be 71°C. Again however this could be attributed to differences in the conditions between the 
experiments described in this thesis and those of Song et al’s. Since Song et al’s melting point is 
determined by empirical methods based on relatively robust UV/Vis spectrometry, this difference could 
perhaps be attributed to the inherent inaccuracy due to the relative simplicity of mFold’s mathematical 
model.  
Based on the model, it is likely that the biosensor at the resting state would exist in equilibrium 
composed largely of the three stable forms (due to the relatively similar thermal stability of the forms, 
especially form A and B). The result would be that part of the population (composed of those in the form 
A and C configuration) would express strong electrochemical signal (label located close to the electrode 
surface, and therefore more charge transfer) while some part of the population (composed of those in 
form B configuration) would express a weak electrochemical signal (label located far from electrode 
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surface, resulting in less electron transfer). The signal direction of the bound state would depend largely 
on the conformation of the target-aptamer complex, with a configuration that results in spatial 
arrangement of the label closer to the electrode resulting in a positive signal trend (as form A and C 
sensor molecules are converted to a form more similar to form B), and a configuration that results in 
spatial arrangement of the label further from the electrode resulting in a negative signal trend (as form 
B molecules are converted to a form similar to A and C) 
Energetically the model supports the hypothesis that the target-aptamer complex displaces the self-
annealing segment of the target unbound bioreceptor molecule. The most energetically stable 
secondary structure calculated by mFold (Form A) has a dG = -1.86 kcal/mol or -7.8 kJ/mol  
Kd of Kanamycin to this aptamer is 78.8nM based on the original publication.  
Therefore using the Gibbs free energy equation [106]: 
𝑑𝐺 = 𝑅𝑇ln(𝐾𝑑) 
Eq 3.04 Gibbs free energy equation 
The dG for the target-aptamer complex is -39.8 kJ/mol, which is more thermodynamically stable than 
the most stable resting self-dimer. 
In total nine independent titrations were performed under simple matrix clean buffer conditions with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix A (page 
267). In all cases the quantitative behavior followed the same pattern, with the current falling in 
correlation with an increase in kanamycin concentration. However sensor to sensor variation meant that 
the Kd values varied from a Kmax of 955.9 nM to a Kmin of 291.3 nM. R squared was calculated to be 
greater than 0.9 in all cases, and in all but three of the titration the r squared was calculated to be 
greater than 0.98. 
Based on the results of the target titrations, the detection limit of this sensor is at least as low as 120 nM 
(many 75nM results in this set show decreased signal response compared to the remaining titration data 
points). This compares very favorably with conventional antibiotic productivity selection based on 
observation of zones of growth inhibition. Growth inhibition typically involves observation of areas of 
clearance on a spread plate around areas of applied antibiotic. Thus detection limit of such method is 
directly influenced by the toxic dose the secondary metabolite to plated microbes. Since toxic dose of 
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kanamycin to target organism is equal to or greater than 103 nM [107][108] sensitivity of this sensor is 
comparable to the most optimistic detection limit of conventional detection methods. 
 
3.08 Kanamycin Aptasensor Titration against Target molecule in Environmental Matrix 
3.08a Kanamycin Aptasensor Titration against Target Molecule in Environmental Matrix, Soil Sample 
Matrix 
Nucleases are ubiquitous in any natural environment. Much of sterile techniques developed for nucleic 
acid molecular biology are developed partly in response to the effect of sample degradation by 
nucleases as a result of contamination of sample. It was initially expected that in any environmental 
sample there might be signal loss over time due to nuclease activity. This was tested by preparing a soil 
sample as described in introduction section of this chapter (see 100). Therefore the assay protocol was 
conducted by SWV immediately after electrode was placed into electrolyte solution, and the experiment 
carried out promptly. Assay time typically takes less than 15 min, which was expected to keep nuclease 
influence on sensor response to a minimum.  
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Fig 3.08 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in soil sample matrix 
 
The titration curve trend under these conditions show minimal difference in comparison to that 
obtained for the assay performed under clean buffer conditions. Investigation of a target titration under 
environmental matrix enriched the cell solution by SWV shows significant correlation between signal 
magnitudes to target concentration. Similar to an assay under clean buffer conditions, the titration plot 
profile is typical of a conventional Langmuir-type fitting (a signal drop followed by a plateauing at high 
concentration).  
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Fig 3.09 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in soil sample matrix 
Based on the results of the target titrations, the detection limit of this sensor is at least 75 nM (this 
would suggest the 75nM data point with reduced signal on a number of clean buffer condition 
experiments are anomalous). This is equivalent to a 150 nM, or 72.6 ng/ul, prior to the addition of 2x cell 
buffer solution. Since the total mass of soil mixed with liquid was 5g, this translates to a detection limit 
of at least 1.452 ug/gram of soil, assuming complete solubilisation of soil based Kanamycin upon mixing 
with water.  
In total three independent titrations were performed in soil environmental matrix buffer conditions with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix B (page 
276). In all cases the quantitative behavior followed the same pattern, with the current falling in 
correlation with an increase in kanamycin concentration.  
Fitting the peak currents as a function of target molecule concentration using a Langmuir-type fitting  
yields an average Kd of 356.2 nM which compares closely to the results of the clean buffer samples 
described previously (average Kd of 565.8 nM),  and to a lesser extent the literature Kd of 78.8 nM. That 
being said the trend of this result may be skewed by one of the two results having a Kd of only 108nM, 
the lowest Kd data for this sensor. As the Langmuir fit for that curve is less has an r squared value of less 
than 0.98 (though only marginally so, the r squared here is 0.979) it is quite likely the Kd may be skewed 
by the lack of signal at higher concentrations (3 signals for this curve was not measurable).  
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The measured Kd values reflect the affinity of the aptamer rather than total mass of label bearing 
biosensory molecules on the electrode surface. Hence the latter can be more accurately judged from the 
signal intensity rather than Kd. The magnitude of the buffer signal (average 21nA) was significantly 
reduced compared to that observed in the experiment performed under standard titration protocol with 
clean buffer (average 56nA). The difference was not as significant as initially expected, and does not 
appear to affect titration profile. To confirm that the signal reduction is caused by formation of target-
aptamer complex and not nuclease activity, an assay was performed under the same conditions, with 
exception of a 2 hour incubation period in the environmental matrix enriched cell solution prior to 
experimentation. This is at least 800% greater than the time lag of the last concentration under the 
protocol without wait time. 
 
Fig 3.10 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in soil sample matrix following a 2h incubation 
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In total two independent titrations were performed in soil environmental matrix buffer conditions 
following a 2h incubation period, with separate sensors being used in each case. The results of these 
replicate titrations can be found in Appendix B (page 276).  
The results again show a profile very similar to that obtained for the titration under clean buffer 
conditions, with titration plot profile being typical of a conventional binding curve. Kd is 429.3 nM and 
423.7nM. Average peak amplitude at buffer is 35nA which is in fact higher than the average of the soil 
matrix results without the lag (21 nA), but lower than the results of the clean buffer condition titrations 
(55 nA). This is probably the result of simple batch variation (the clean buffer conditions test, which has 
the largest sample population, has a signal amplitude outlier ranging from 83.8nA to 22.6nA).  
 
Fig 3.11 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in soil sample matrix following a 2h incubation 
 
The magnitude of the peak signal after 2 hours under the environmental matrix enriched cell solution 
would indicate that the effect of nuclease degradation does not appreciably impact on performance. 
While the peak size was lower than that obtained for clean buffer condition, signal loss is not to a 
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degree that renders the sensor unworkable since the signal loss as a result of soil matrix conditions is 
significantly less than the signal decrease as a result of titration of target molecules. The lack of a signal 
loss in the incubated series of electrodes would support a conclusion that there is minimal loss of signal 
as a result of nuclease activity or other soil based interferences. 
There are a number of potential causes for the small effect of soil in the test sample. Perhaps the most 
likely reason is due to the pretreatment protocol which includes filtration through a Millipore 
HAWP01300 filter. The ability of nitrocellulose to adsorb protein is well known [109] [110], and is a core 
principle of western blotting [111]. This property was exploited by Tuerk and Gold’s pioneering 
publication [21] as a means of separation of protein target bound DNA from unbound sequences. 
There is also the possibility that the immobilization of the biosensor molecule to the electrode surface 
results in reduced susceptibility to, for example, nuclease activity. It is hypothesized that at least some 
nuclease activity depends in part on access of the binding site to target molecule in specific alignment 
[112]. Immobilization to electrode surface may restrict this access of the nucleic acid sequence to 
nuclease due to its proximity to a solid surface. This effect may be exacerbated by the shortness of the 
nucleic acid sequence, further reducing the length of nucleotide which can be affected by nuclease 
activity.  
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3.08b Kanamycin Aptasensor Titration against Target Molecule in Environmental Matrix, Chicken 
Faeces Matrix 
  
Fig 3.12 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performedin faecal sample matrix 
 
The titration curve is similar in overall shape to the titration curve obtained with clean buffer conditions 
titration and those of the soil sample assays. Investigation of the target titration under chicken faeces 
matrix enriched cell solution by SWV shows significant correlation between signal magnitude to target 
concentration. Similar to both previously assayed types, the titration plot profile is typically of a 
conventional binding curve (a signal drop followed by a plateauing at high concentration).  
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Fig 3.13 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in faecal sample matrix 
 
According to the results of the target titrations, the detection limit of this sensor was at least 75 nM (this 
would support the previously proposed suggestion that the 75nM data point with reduced signal on a 
number of clean buffer condition experiments are outliers not representative of general signal trend). 
This is equivalent to a 150 nM, or 72.6 ng/ul, prior to the addition of 2x cell buffer solution. Since the 
total mass of chicken faeces mixed with liquid was 2g, this translates to a detection limit of at least 3.6 
ug/gram of chicken faeces, assuming complete solubilisation. This is actually much more likely than in 
the case of soil, since the chicken faeces is dissolved much more easily than the soil sample, leaving 
much fewer residue visible to naked eye after significant agitation.  
In total three independent titrations were performed in faecal environmental matrix buffer conditions 
with separate sensors in each case. The results of these replicate titrations can be found in Appendix B 
(page 276). In all cases the quantitative behavior followed the same pattern, with the current falling in 
correlation with an increase in kanamycin concentration.  
Plotting the peak currents of target molecule response signals into the abovementioned mathematical 
models yields a Kd of 1238nM and 818 nM, with one titration indicating large standard error on the Kd 
value and poor r squared fit to the Langmuir binding model (the former being too wide to be calculated 
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by the Graphpad Prism software, and the latter being 0.89 respectively). All titration plot fits the 
Langmuir equation (fitted using model 2) to an r squared of at least 0.98 with the exception of the 
ambiguous curve mentioned above.  
It was noticed that this Kd is significantly higher than those obtained for either the clean buffer or the 
Soil matrix conditions (which have an average Kd of 566nM and 356nM respectively). There are a 
number of potential causes for this: 
1) The kannamycin target is being removed from the system by the chicken faeces matrix. 
One reason is that the kannamycin target is being destroyed by the chicken faeces 
matrix directly. It is reasonable to assume chicken faeces would contain a significant 
number of chicken gut flora bacteria and their products. Antibiotic resistance would be 
a significant advantage to a chicken gut bacteria, especially in the context of modern 
agriculture where use of antibiotics in feed as a means of improving feed to weight 
conversion ratio is widespread. At least three mechanisms of aminoglycoside resistance 
are dependent on enzymatic modification of aminoglycoside molecules [113], some of 
which are known to degrade Kanamycin [114][115]. 
 
2) An alternate cause of target molecule removal would be the loss of target molecule at 
the filtration stage of sample pre-treatment. Unlike the soil sample, the chicken faeces 
dissolves in water relatively readily, resulting in much fewer particles being removed at 
the centrifugation stage. However not all particles remaining suspended in solution after 
centrifugation is able to pass through the filter membrane pore (HAWP01300 filter has a 
membrane pore size of 0.45um). This results in a significant amount of blockage of the 
filter by suspended chicken faeces particles (indeed the filter has to be replaced many 
times in the filter process due to accumulation of blockage material on the membrane) 
which may result in the collateral entrapment of target molecule, resulting in decreased 
target concentration in the filtrate. 
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3) Another possible cause is the accumulation of non-target particles at the electrode 
interface, resulting in decreased access of the target molecules to the electrode surface, 
thus reducing effective target concentration at electrode interface.  
It is unlikely that the increase in Kd value is the result of nuclease interference, since nuclease 
contamination would have resulted in loss of a proportion of signaling molecules, resulting in a general 
decrease of peak magnitude but no change in Kd, rather than a change in the signal trend seen here. 
 
3.09 Electrode Reusability 
One of the major potential advantages inherent to the structure of conformation change aptamers is 
the possibility of electrode reuse without the need for significant electrode surface restoration, due to 
the conformational change aptamer having a highly stable primary structure and being composed of a 
single covalently bonded unit. Since the primary structure will be significantly more stable than the 
target-aptamer interaction, removing target molecules is a simple matter of heating. After heating, the 
aptamer will simply return to its resting configuration. 
This is not the case with configurational change systems, such as the Sandwich Aptamer Biosensor 
discussed in Chapter 5, where at the very least part of the structure (the component that is displaced 
into bulk solution, typically the redox label containing sequence) will need to be replaced in order for 
the electrode surface to be renewed. Antibody based sensing surface may not be renewable at all as the 
target-antibody separation temperature could also result in irreversible thermal degradation of the 
antibody coating.  
In order to test whether the electrode would remain viable after harsh heat treatment and extended 
storage, the working electrode was stored after a target titration under lab conditions. This involved 
heat treatment at 90°C for 5 min in buffer, after which it was washed with MilliQ and stored in the fridge 
in autoclaved MilliQ water for approximately 1 week. The kanamycin titration was then repeated.  
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Fig 3.14 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed using an pre-used electrode after heat based regeneration and one week of 
storage. SWV of this electrode during first use could be found in the Appendix A (Fig A.9, page 267) 
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Fig 3.15 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer. Blue) Profile using a fresh electrode after 12h DNA immobilisation 
and 24h storage, Red) Profile is the same electrode after heat based target dissociation and 1 week 
storage. 
 
Comparing the two curves above, a significant signal amplitude decrease was noted between the first 
and second iterations. This is not surprising; it has always been observed that electrode stored for long 
periods of time suffer from signal loss (this is the reason why operational protocol demands that sensor 
electrodes be used within 7 days of sensor molecule immobilization). Given the 1 week wait time 
between the first and second iterations, the second experimental run was conducted close to the outer 
edges of what is considered the expiry date in a run operated using standard protocol.  
Degradation over time can be linked to residual nucleases contamination during handling and storage 
process. In retrospect, storing the electrode in MilliQ may not have yielded optimal results. While MilliQ 
water can be assumed to be sterile, the electrode itself cannot. Any contamination introduced along 
with the electrode would retain activity due to the hydrated conditions of storage. In the future it may 
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be more beneficial to wash the electrode thoroughly with MilliQ and then covered up from air particles 
and stored after nitrogen blow drying. 
The relatively harsh heating regimen the electrode has been subjected to would also have resulted in a 
net decrease in viable signaling molecule, primarily due to breakdown of thiol-gold interaction on the 
electrode surface. 
However the trend of the data remains largely unchanged after heat treatment and 7 days of storage. 
Both show strong inverse correlation between target concentration and peak current signal strength at 
low target concentrations, followed by a target saturation induced plateau at very high concentrations. 
Sensor resolution remains unchanged at 75nM for both electrodes. Kd for the first week is 291 nM and 
the second is 374 nM. However this is likely to be a result of an abnormally low buffer signal in the 
second week, as well as non-detectible signals at high target concentration resulting in relatively skewed 
results.  
3.10 Kanamycin Aptasensor electrode to electrode variations 
Here the variation in signals trend and amplitude between the electrodes is reported. The nine 
electrodes used for standardised titration against target molecules under laboratory environment can 
be considered as baselines for study due to the well-controlled clean buffer condition used in all 
experiments. Also included are the soil sampled results, including those with the 120 min delay time, as 
the effect of processed soil sample on electrode signal appear to be minimal based on our results. Any 
negative effect to analysis of data as a result of soil sample matrix is compensated by the benefits of the 
increased sample size. For obvious reasons negative controls such as specificity control samples are not 
included as they are not expected to (and in the events did not) follow the signal trend of the target 
titration. Similarly variants to the soil matrix and clean buffer conditions titrations, such as electrode 
reusability tests, and poultry faeces matrix control were not included, since both tests showed changes 
in trends which could be explained by specific experimental variation factors. 
Significant variation in voltammogram signal magnitude, but not in Kd values, was observed between 
the titrations sets investigated. In almost all cases, the peak current response to target concentration 
followed the same trend, showing a decrease in signal as a result of an increase in target concentration, 
followed by a plateau as the saturation point is reached. However, there was a significant variation in 
the signal magnitude between the result sets, with the lowest observable buffer peak (the strongest 
signal based on the signal trend of this sensor) of the clean buffer conditions tests being 21 nA in 
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magnitude and the highest being 83.7 nA, almost a 4 fold difference. Including the soil matrix sample 
increases this range to 16.1nA to 83.7 nA.  
A total of 23 electrodes were used in assays against a titration of target molecule (12 under standard cell 
conditions, 8 against environmental sample). Fourteen electrodes in total displayed a signal trend typical 
of a Langmuir surface binding model (9 for the lab conditions target titration, 3 and 2 for the two types 
of soil matrix titrations). Two electrodes were lost as a result of accidents or human error. Of the 
remaining seven electrodes, four showed no signals at all, which can most likely be attributed to failed 
fabrication, either as a result of poor polishing or bad immobilization.  
It is important to note that none of the profiles showed a generally positive trend. The single electrode 
showing a linearly negative response to titration could simply be the result of multiple outlier data 
points resulting in a skewed data trend. In the four cases where the sensor signal was not obtained, it is 
likely that the signal was insufficient to be noticeable over the background noise. This would suggest the 
electrode variation is the result of QC problems in sensor fabrication rather than a failure of the sensor 
design itself.  
Attempts were made in order to determine the cause of signal amplitude variation between the data 
sets which have a signal consistent with the Langmuir binding model. Badly polished and prepared 
electrodes were noticed early to result in defective sensors with reduced or unreliable signals. Since 
badly fabricated and prepared electrodes have irregular sulphuric acid electrochemical cleaning profiles, 
they are discarded for reprocessing by default without undergoing the sensor molecule immobilization 
stage. Otherwise polishing should not have changed significantly between batches, and production 
methods were consistent.  
 
3.11 Gel Encapsulated Electrodes 
As discussed in the previous section, complex samples such as soil or faeces extract may contain 
nuclease enzyme. Nucleases are enzymes capable of hydrolyzing the phosphodiester bonds of nucleic 
acids. They are ubiquitous in nature, and they are therefore hypothesized to play a possible role in the 
degradation of surface bound nucleic acid molecules. In the environmental analysis section of this study, 
we have shown that the sensor retains most, if not all, of its signal amplitude even after extended 
incubation with environmental samples. This can be attributed to a number of reasons, such as low 
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nuclease concentration in the sample, obstruction of nuclease activity by the sensing surface or removal 
of nucleases by the pretreatment process. However these factors may not always apply, for example 
some samples may have greater nuclease concentrations than those of soil. The pre-treatment process 
in particular is not feasible or applicable for all sensing situations, for example in long term continuous 
sensing (no pre-treatment possible), such as in bioreactor monitoring, or extended environmental in situ 
monitoring for the presence (for example) of toxins. 
It is therefore proposed that nuclease protection be implemented which does not require pre-
treatment. Agarose gel is a commonly used tool, both in the SELEX affinity selection and many molecular 
biology processes. Agarose gels can entrap target molecules by forming three dimensional matrices of 
supercoiled masses of helical agarose molecules [116]. This results in a mesh like structure which 
inhibits the transport of materials larger than the average pore size. This nuclease exclusion strategy is 
analogous to the membrane filtration process used in environmental sample pretreatment, but with the 
barrier being at the electrode surface rather than as a separate pretreatment step. 
 
Fig 3.16 Hypothesized mechanism of biosensor surface protection as a result of gel encapsulation. 
Excluded particles include nucleases and redox active, noise generating large particles 
 
The gel-coated electrode is fabricated first by preparing the kanamycin biosensor in a manner identical 
to that used for its preparation under regular laboratory and environmental conditions. Agarose is then 
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added to an electrolyte buffer pre-heated in a microwave oven for 5 min, to a final concentration of 3%. 
Then the aptamer-immobilised electrode is dipped to a length of approximately 30mm in the molten 
agarose solution for 5s, and the removed, inverted, and allowed to set. Dipping the gel up to at least 
30mm in length is essential since it was noticed that a smaller cap will disaggregate from electrode tip 
when rehydrated in cell solution during use. The pore size of 3% agarose is 289nm [117]. While this is 
insufficiently dense to entrap large globular proteins, the density of the mesh should be sufficient to 
obstruct transport of large globular proteins to the electrode surface. However small molecules such as 
aminoglycoside secondary metabolites should be relatively unimpeded. The electrode is then stored in a 
cool, humid location to reduce dehydration of the gel tip. 
The nuclease selected was S1 nuclease derived from Aspergillus oryzae. This nuclease was selected as it 
a non-specific nuclease that primarily targets single stranded DNA substrates [118]. The pre-prepared 
electrode is incubated in 1U/10ul solution of nuclease in nuclease buffer (20mM Tris-HCl pH 7.5, 50mM 
NaCl and 0.1 mM ZnCl2) containing Zinc cofactor of S1 nuclease, at 37°C for 2 hours. The electrode is 
then used in a cell setup identical to the laboratory condition assay.  
A series of negative control assays were also carried out to determine the degree of activity of S1 
nuclease on an unprotected electrode. These assays were conducted in a manner similar to the gel 
coated assays, including nuclease incubation time, but without the presence of the gel coat.  
Two key objectives must be fulfilled for the gel encapsulation of electrode to be considered a viable 
process from a practical standpoint:  
1) The gel encapsulation process must not decrease the signal amplitude and sensitivity of 
the electrode to the point where the electrode is no longer feasible as a kanamycin 
sensor. 
2) The gel encapsulation process must be useful, in that the absence of gel encapsulation 
leads to a significant loss in sensor signal. 
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Fig 3.17 SWV of gel encoated kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
 
The results of the gel encapsulated electrode show an average signal amplitude comparable to that 
obtained in laboratory condition assays, which would indicate that the encapsulation process does not 
significantly interfere with the signaling process. Signal amplitude of gel coated biosensors range 
between 51nA to 84nA, with an average of 70nA. This is slightly higher than the average amplitude of 
electrodes performed under laboratory conditions (54nA), although the difference is not statistically 
significant. The range of amplitude was much narrower than those obtained in the clean buffer 
experiments (max 84nA, min 23nA), although this can be attributed to the much larger dataset of the 
clean buffer experiment compared to the gel encapsulated experiment (9 to 4). 
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In total four independent titrations were performed under gel encapsulated clean buffer conditions with 
nuclease pre-incubation. The results of these replicate titrations can be found in Appendix C (page 282). 
The results of the gel encapsulated electrode also show similar quantitative behavior to the clean buffer 
condition, with the current falling in correlation with an increase in kanamycin concentration. Fitting the 
peak currents as a function of target molecule concentration using a Langmuir Isotherm yields an 
average Kd of 385.6 nM which compares closely to the to the results of the clean buffer samples 
described previously (average Kd of 565.8 nM). R squared was calculated to be greater than 0.9 in all 
cases, and in all but one of the titration the r squared was calculated to be greater than 0.98. 
Based on these observations it is possible to conclude that the gel encapsulation process did not 
significantly interfere with the sensing process, and that gel encapsulated electrode therefore remains a 
feasible kanamycin biosensor. 
 
Fig 3.18 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, gel encoated electrode in blue and unprotected electrodes in red. All electrodes are limited 
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to two consecutive production batches, and performed using ALS electrode only, to further decrease 
intrabatch variation. 
The negative control continue to show a significant signal amplitude after 2 h of incubation in 1U/10ul 
nuclease without gel protection. This is in contrast with gel electrophoresis of the sensing molecules in 
solution, incubated for the same duration, which no discernable bands at all (which would indicate 
significant hydrolysis). This would support the conclusion raised in the environmental matrix assay 
section of this chapter, that the immobilisation process provides some inherent protection to the 
immobilized biosensor molecule even in the absence of gel encapsulation (additional details can be 
found in section 3.08 of this chapter). 
However it should be noted that while negative control signal remained clearly discernable, the signal 
amplitude of the negative control is consistently lower than that of the gel encapsulation protected 
electrode. Eight electrodes, including four electrodes of each type, were assayed in this test in total. Of 
these eight the four electrodes displaying the highest maximum signal (for this molecular beacon type 
biosensor this is in the absence of kanamycin) are all gel protected, while the four lowest are all 
unprotected electrodes. Out of all data points obtained (64 total) only two data points of the gel 
encapsulated sets were not within the 50th percentile in terms of signal amplitude at any given 
concentration, and these are found at the highest concentration (lowest signal amplitude) where the 
effect of noise would be greatest.  
Signal trends for the negative control is comparable to those of the gel encapsulated sample and the 
laboratory condition assay, with an average Kd of 452nM. This is not surprising as nuclease digestion 
would result in a decrease in density of biosensing molecules on electrode surface (and therefore signal 
amplitude), but otherwise should not interfere with the signaling process, resulting in no change in the 
signal trend.  
As a whole, these results would indicate that while gel encapsulation clearly does not inhibit sensor 
activity, and may reduce loss of signal amplitude as a result of nuclease hydrolysis, it is not strictly 
essential for the preservation of the sensing surface even with extended exposure to high nuclease 
concentration. Therefore the lack of nuclease activity is not exclusively the result of exclusion by 
molecular weight partition, but is also the result of other factors discussed in the environmental sample 
section of this chapter. 
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3.12 Sensor Specificity 
Control experiments were conducted in order to determine whether the sensing molecule would bind to 
non-target molecules structurally similar to the kanamycin target. Controls selected for these purpose 
were other antibiotics of the aminoglycoside class, all of which have the same basic amino groups 
attached to glycosides rings structure. Although chemically distinct, all aminoglycoside have the same 
mechanism of action, binding to the aminoacyl-tRNA ribosomal site (commonly referred to as the A site) 
of the 30S subunits, a highly conserved feature of many gram negative bacteria. This gives 
aminoglycosides a very broad spectrum of activity.  
Typically high specificity can be considered a positive characteristic in a biosensor. It should be noted 
however that specificity to kanamycin could be a double edged sword. Aminoglycosides in general is 
already a fairly restrictive category. Whether high specificity is a positive or negative characteristic 
depends significantly on what the sensor’s particular function will be. In the case of microbial product 
discovery it is a positive trait if the aim of the assay is to find a new producer organism of kanamycin, 
but it can also be a negative trait if the aim of the assay is to find a novel aminoglycoside antibiotic with 
relatively subtle differences to kanamycin. Even relatively small structural differences could result in a 
significant difference in practical value of an antibiotic (beta lactams ampicillin and methicillin for 
example have very similar structures but methicillin is beta lactamase resistant). Similarly for an 
environmental pollutant sensor specificity is a positive trait if the aim of the assay is to identify a specific 
antibiotic residue, but a negative one if the sensors purpose is to discover aminoglycoside residues in 
general. In the case of sensors for industrial bioproduct synthesis quality control (such as a QC sensor in 
a bioreactor for example), specificity is a highly positive characteristic, since a specific product is the 
operational aim.  
For obvious reasons response to non-aminoglycosides could be considered a universally negative 
characteristic. However ‘non-aminoglycoside’ is too broad a category to be practically tested. Should the 
sensor not respond to other aminoglycosides there is no reason to assume that it will respond to a 
random non-aminoglycoside either. 
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3.12a Specificity Control 
Control experiments were conducted in order to determine the specificity of the biosensor to kanamycin 
target. Aminoglycosides streptomycin and gentamycin were selected, largely due to ease of access. All 
three molecules are of comparable sizes (MW of 581.6 for streptomycin, 477.6 for gentamycin and 
484.5 for kanamycin, and similar solubility (references generally state 50mg/ml for all three). All three 
are built around of amine-rich triplet sugar ring. Streptomycin is slightly larger, with a pentose without 
amine groups on the second ring, the third ring contains two guanidine groups, resulting in a molecule 
with more proton acceptors than donors (19/16). Kanamycin and gentamycin are structurally quite 
similar, although gentamicin’s active groups and rings has significantly greater degree of methylation, 
proton acceptor/donor ratio for both are quite balanced at 15/15 and 12/11 respectively. 
 
Fig 3.19 From left to right, the chemical structures of Kanamycin, Streptomycin and Gentamycin, quoted 
without modification from [119] 
 
3.12b Kanamycin Aptasensor Titration against Streptomycin 
The concentration range was selected to be similar to that of the target titration, with the highest 
concentration doubling the highest target concentration investigated.  
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Fig 3.20 SWV of kanamycin fcn-aptamer biosensor’s response to Streptomycin titration vs Ag/AgCl 
In total three independent titrations were performed against Streptomycin negative control with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix D (page 
291).  
Analysis of the data shows no clear correlation between peak current and concentration of streptomycin 
control. Change in signals as a result of streptomycin titration is relatively low in amplitude compared to 
the target titration. Comparison of the peak response of the voltammogram of the Streptomycin 
titration shows no reproduced trend in signal. This would support the conclusion that there is no 
comparable affinity between the sensing molecule and streptomycin under these conditions.  
Highest to lowest signal ratio was respectively 1.09, 1.56 and 1.13, again significantly lower than the 
high/low signal difference of the kanamycin titration. Standard deviation within data set is 1.9, 1.1 and 
3nA, a comparatively very small deviation within data set which indicates low signal difference between 
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data points (by comparison the standard deviation of the same nine working electrodes show a standard 
deviation average of 18.7nA). This indicates that titration of non-target molecule does not result in 
significant signal change relative to target titration. Concentration with highest signal was respectively 
0nM (1st), 75nM (2nd) and 300 nM (3rd), lowest signal was respectively 4800nM (5th), 0nM (1st) and 
9600nM (6th), indicating a more or less random data trend. This would indicate there is no significant 
correlation between streptomycin concentration and peak current. 
 
 
Fig 3.21 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to Streptomycin 
titration vs Ag/AgCl. 
 
3.12c Kanamycin Aptasensor Titration against Gentamicin 
The concentration profile of the gentamicin control is limited by the highest concentration which could 
be obtained, which was 47.8 mg/ml (100 uM). This meant the highest concentration realistically 
achievable was 1000 nM. The concentration range was selected to be similar to that of target titration, 
with the highest concentration being 1000nM. 
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Unlike most tests, which were repeated in triplicate, only two assays were performed due to limitations 
in stock availability of gentamicin. 
 
Fig 3.22 SWV of kanamycin fcn-aptamer biosensor’s response to Gentamicin titration vs Ag/AgCl 
In total two independent titrations were performed against Gentamicin negative control with separate 
sensors in each case. The results of the replicate titration can be found in Appendix D (page 291).  
Analysis of the data shows no clear correlation between peak current and concentration of gentamicin n 
control. Like in streptomycin titration change in signal as a result of gentamicin titration is relatively low 
in amplitude compared to the target titration. Comparison of the peak response of the gentamicin 
titration shows no reproduced trend in signal. This would support the conclusion that there is no 
comparable affinity between the sensing molecule and gentamicin under these conditions.  
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Highest to lowest signal ratio was respectively 1.47 and 1.12, which is a significantly lower signal 
difference than that observed in the target titration, where the lowest signal was generally below 
detection limit. Standard deviation within the data set is respectively 1.9 and 1.6 nA respectively, a 
comparatively small deviation within the data set, indicating low signal difference between data points. 
Highest signal was respectively 150nM (3rd)and 0 nM (1st), lowest signal was respectively 0nM (1st) and 
75nM (2nd), indicating a more or less random data trend. This would indicate there is no significant 
correlation between gentamicin concentration and peak current. 
 
Fig 3.23 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to Gentamicin 
titration vs Ag/AgCl. 
 
3.13 Tetracycline Sensing with a Ferrocene Modified Aptamer 
Unlike the aptamer sequence for kanamycin described by Song et al [102], where the priming sequence 
had been removed, that of tetracycline (Niazi et al [120] still contains the priming sequences. The Kd of 
the aptamer as published was determined to be 64 nM by equilibrium membrane filtration, which 
separates aptamer bound from unbound tetracycline. The SELEX protocol of the original paper 
specifically includes counter-selection against the similar molecule, oxytetracycline, with the aim of 
increasing specificity of the aptamer for its target.  
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The combinatorial library from the original publication was 75 bases in length, which is considered too 
long for an ideal molecular beacon, since binding a small target to such a long sequence may not result 
in the dissociation of the molecular beacon. Sequence in a SELEX library is composed of randomized 
region flanked by primer binding region. The target binding affinity of a sequence isolated by the SELEX 
process is driven by the randomized region of the sequence, with the flanking region being present 
primarily for the amplification process. While it is possible that the flanking region may play a role in 
target binding (and in some cases the flanking region is indeed essential for successful target binding 
[121]), truncating the flanking region is less likely to damage the ability of the aptamer to bind target 
molecule than truncating the random region. There are a number of previous studies where the 
truncation of a SELEX selected sequence at the primer binding region results in significant increase in 
target affinity [122][123]. Analogous studies to silence the fixed sequence of selected nucleotide 
libraries have also been undertaken, resulting in increased affinity to target [121]. A recently published 
SELEX protocol attempts to minimise the effect of fixed regions on the sequence by performing affinity 
selection with such regions silenced by complimentary binding [124]. 
Thus in order to reduce the length of the sequence, the sequence was truncated by removing primer 
binding sites flanking the random region.   
 
Published Sequence: 
5’-
CGTACGGAATTCGCTAGCGGGCGGGGGTGCTGGGGGAATGGAGTGCTGCGTGCTGCGGGATCCGAGCTCCACGT
G-3’ 
Original aptamer was selected to bind tetracycline taken from original paper published by Niazi et al 
[120], and contains flanking primer binding sequence needed in the process of SELEX for amplification 
via PCR. The sequence utilized for this study is shown in green. 
Complementary sequences were then added in order to produce a hairpin loop secondary structure. 
 
Molecular Beacon Design: 
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5’-GGGCGGGGGTGCTGGGGGAATGGAGTGCTGCGTGCTGCGGCCGCCC-3’ 
 
The beacon-forming added sequence is displayed in red, and was designed to be complementary to the 
5’ sequence present in the aptamer and shown in blue. In the original paper of Niazi et al, the target 
binding sequence is predicted to be at the 5’ end of the truncated sequence, based on its presence in 
sequences isolated from the final SELEX library with high affinity to the target molecule. This makes it an 
attractive region for design of a hairpin loop, since involvement in target binding would result in a 
dissociation of the redox label bearing complementary strand. 
Like the kanamycin biosensing molecule, the sequence selected was adapted for electrochemical 
conformational sensing by the addition of a C6 mixed disulphide group at the 5’ end of the sequence 
and a ferrocenyl modified base at the 3’ end. 
 
Finalised Biosensor Sequence: 
5’-C6H13-S-S-GGGCGGGGGTGCTGGGGGAATGGAGTGCTGCGTGCTGCGGCCGCCC-Fcn-3’ 
 
3.14 Tetracycline Aptasensor Titration against Target Molecule  
The results of the tetracycline aptamer titration show a significant signal increase in response to an 
increase in target concentration.  
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Fig 3.24 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer 
While at present there are no available nucleic acid structure model which predicts G-quadruplex 
secondary structures thermodynamically, computational tool are available which compare DNA 
sequences to a database of sequence motifs that are believed to be associated with G-quadruplexes. 
One such resources is the G-Quadruplex Resource Site’s QGRS Mapper [125] [126]. 
The results of a search of the database yielded 1 exact match, and 227 similar sequences including 
overlap, which would indicate a strong likelihood of the sequence forming a G-quadruplex structure. The 
sequence can be found below in fig. 3.24. 
 
5’-GGGCGGGGGTGCTGGGGGAATGG-3’ 
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5’-GGGCGGGGGTGCTGGGGGAATGGAGTGCTGCGTGCTGCGGCCGCCC-3’ 
Fig 3.25 The exactly matching G-quadruplex forming sequence discovered by a search of the QGRS 
mapper database, its location on the truncated tetracycline aptamer biosensor is in red. 
Like the kanamycin aptamer the titration plot profile is typical of a Langmuir type binding curve, with the 
signal drop correlating to target concentration at lower concentrations before plateauing at high 
concentration as the sensing surface is saturated with target molecules.  
Peak current was acquired using the same method as that used in the kannamycin aptamer biosensor 
study. Fitting the peak currents as a function of target molecule concentration using a Langmuir type 
fitting yields an average Kd of 6.8 nM, which is significantly lower than the literature value for the Kd of 
64 nM. This is not unexpected since the sequence has undergone significant change by the truncation of 
primer binding region and addition of a stem forming sequence. It is also possible that, like the 
kanamycin aptamer, variation between experimental condition such as the addition of 5’ and 3’ end 
modification and change in environment (buffer conditions and immobilisation to electrode surface) 
may also play a role in influencing Kd.   
 
Fig 3.26 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in clean buffer 
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In total five independent titrations were performed under simple matrix clean buffer conditions with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix E (page 
295). In all the cases the dose response behavior followed the same pattern, with the current rising in 
correlation with an increase in tetracycline concentration. However sensor to sensor variation meant 
that the Kd values varied from a Kmax of 17nM to Kmin of 2.6 nM. The Kmax is a probably an outlier as the 
average Kd (including the Kmax) is 6.8 nM (second highest Kd is 5.7nM) and also has a relatively poor fit to 
the Langmuir binding model (r squared of 0.96). R squared was calculated to be greater than 0.95 in all 
cases, and in all but the outlier the r squared was calculated to be greater than 0.98. 
Based on the results of the target titrations, the detection limit of this sensor is at least as low as 4 nM. 
This level of sensitivity is considerably superior to even the most optimistic detection limit of 
conventional antibiotic productivity selection based on observation of zones of growth inhibition (toxic 
dose of Tetracycline to target organism is equal to or greater than 203 nM [127]). 
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3.15 Tetracycline Aptasensor Titration against Target Molecule in Environmental Matrix 
 
Fig 3.27 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in soil sample matrix 
 
Like the environmental matrix enriched target titration of the kanamycin aptamer, the titration curve 
under these conditions show minimal difference in trend to the titration curve of the assay performed 
using clean buffer. Investigation of target titration in an environmental matrix enriched cell solution by 
SWV shows significant positive correlation between signal amplitude to target concentration. Similar to 
an assay under clean buffer conditions, the titration plot profile is typical of a conventional Langmuir 
type fitting (a signal increase followed by a plateauing at high concentration). 
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Fig 3.28 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in soil sample matrix 
 
From the results of the target titrations, the detection limit of this sensor was determined to be at least 
4 nM. This is equivalent to 8 nM, or 3.6 ng/ul, prior to the addition of 2x cell buffer solution, or 72 
ng/gram of soil. The same assumptions regarding solubilisation and water accessibility discussed in the 
kanamycin biosensor section also applies here.  
In total four independent titrations were performed in soil environmental matrix buffer conditions with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix F (page 
301). In all cases the quantitative behavior followed the same pattern, with the current rising in 
correlation with an increase in tetracycline concentration.  
Fitting the peak currents as a function of target molecule concentration using a Langmuir type fitting  
yields an average Kd of 5.9 nM, which compares closely to the to the results of the clean buffer samples 
described previously (Kd average of 4.8 nM). Like the clean buffer sample, this Kd is significantly lower 
than that reported in the literature of 64 nM.  
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Signal amplitude at the highest target concentration (typically the maximum signal amplitude within the 
titration set) of the environmental condition titration (average 130nA) is slightly higher than, but still 
comparable to, those performed under clean buffer conditions (average 88nA). This would support the 
conclusion noted in the kanamycin biosensor section that the presence of the soil environment matrix 
does not significantly affect the performance of the sensor.  
Since the protocol used here are similar to those used in the analogous Kanamycin environmental 
condition titration, and both sensors display (with reverse signal direction) the same signal trends, it can 
be reasonably assumed that the analysis discussed in the Kanamycin section concerning the effect of the 
environmental matrix on the biosensor also applies here. 
 
3.16 Tetracycline Aptasensor Electrode to Electrode Variations 
Variation in the signal magnitude between titration sets is significantly smaller between tetracycline 
sensors than between kanamycin sensors. Resting signal averages at 62.3 nA, with an upper and lower 
quartile of 81.8 nA and 50.4 nA, and a standard deviation of 28.2. Saturation signal (7th concentration, 
128nM) averages at 112nA, with upper and lower quartiles of 138 nA and 95 nA respectively, and a 
standard deviation of 41 nA. This represents a relatively greater consistency in signal magnitude 
compared to most other sensors investigated in this study. As in the case of kanamycin sensors, all cases 
where peak could be observed show the same trend of peak response to target concentration, though in 
this case showing an increase as opposed to a decrease in signal as a response to target concentration 
increases. 
A total of thirteen sensors were created, of which three yielded no detectable signal. In this case 75% of 
the failed electrode came from the same production batch, which makes it highly likely this is a batch 
based phenomenon. The remaining electrodes displayed a signal trend typical of a Langmuir surface 
binding model. In total four out of thirteen electrodes displayed irregular signals, giving a failure rate of 
31% 
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3.17 Tetracycline Aptasensor Specificity 
Control experiments were conducted in order to determine whether the sensing molecule would bind to 
non-target molecules structurally similar to the tetracycline target. Controls selected for this purpose is 
Erythromycin, another antibiotics of the polyketide class. Unlike the aminoglycosides which all have the 
same basic structure, polyketides is a highly diverse family structurally, therefore care was taken to 
ensure the control is structurally similar to Tetracycline.  
 
3.18 Tetracycline Aptasensor Titration against Erythromycin 
Control experiments were conducted in order to determine the specificity of the biosensor to 
tetracycline target. Erythromycin were selected, largely due to ease of access and low price. 
erythromycin and tetracycline have similar solubility (references generally state 2 mg/mg for 
erythromycin vs 10mg/ml for Tetracycline).  
 
Fig 3.29 From left to right, the chemical structures of Tetracycline and Erythromycin, referenced without 
modification from [119] 
 
Concentration range was selected to be similar to those of target titration, with the highest 
concentration doubling the highest target concentration investigated. 
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Fig 3.30 SWV of tetracycline fcn-aptamer biosensor’s response to erythromycin titration vs Ag/AgCl, 
performed in clean buffer 
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Fig 3.31 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to erythromycin 
titration vs Ag/AgCl, performed in clean buffer 
In total three independent titrations were performed against Erythromycin negative control with 
separate sensors in each case. The results of these replicate titrations can be found in Appendix G (page 
306).  
Analysis of the data shows no clear correlation between peak current and concentration of 
Erythromycin control. This would support the conclusion that there is no comparable affinity between 
the sensing molecule and erythromycin under these conditions.  
Highest to lowest signal ratio was respectively 1.26, 1.56 and 1.88, again significantly lower than the 
high/low signal difference of the Tetracycline titration (2.63 average between 5 results). Standard 
deviation within data set is 4.6 nA, 5.1 nA and 3nA, a comparatively small deviation within data set, 
indicating low signal difference between data points (by comparison standard deviation for target 
titration is 20.3nA). Concentration with highest signal was respectively 128nM (4th), 512nM (5th) and 512 
nM (5th), lowest signal was respectively 0mM (1st), 8nM (2nd) and 1025nM (6th), indicating a more or less 
random data trend. This would indicate there is no significant correlation between erythromycin 
concentration and peak current. 
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3.19 Concluding Remarks: 
This study has shown the potential of using conformation change aptamer to sense antibiotic targets not 
only in the controlled laboratory environment in simple solutions, but also in relatively complex 
environmental matrix. 
Author 
Bioreceptor 
molecule Sensor Format Sensing Mode 
Detection 
Limit Target Nucleotide Ref 
Kannamycin 
CCA Aptamer 
Conformation 
Change 
Aptasensor Electrochemical 75 nM Kanamycin A DNA NA 
Tetracycline 
CCA Aptamer 
Conformation 
Change 
Aptasensor Electrochemical 4 nM Tetracycline DNA NA 
Zhang et al Aptamer 
Target-Aptamer 
complex mediated 
impedence of 
electrode surface 
access to redox 
label Electrochemical 1 nM Tetracycline DNA [128] 
Dong et al Aptamer Competition Assay SPR 1.55 nM Chloramphenicol NA [129] 
Zhang et al Aptamer 
Target-Aptamer 
complex mediated 
impedence of 
electrode surface 
access to redox 
label Electrochemical 2.17 nM Tetracycline DNA  [130] 
Zhou et al Aptamer 
Target-Aptamer 
complex mediated 
impedence of 
electrode surface 
access to redox 
label Electrochemical 5nM Tetracycline RNA  [131] 
González-
Fernández 
et al Aptamer 
Target-Aptamer 
complex induced 
assembly of 
transducer enzyme Electrochemical 100 nM tobramycin RNA  [132] 
Wochner et 
al Aptamer Competition Assay Optical 159 nM Duanomycin DNA  [133] 
Nikolaus et 
al Aptamer 
Induced assembly 
configurational 
aptamer biosensor Optical 5 uM Kanamycin A DNA  [134] 
 Table 3.01 A comparison of the Conformation Change Aptasensors  and a selection of recent antibiotic 
aptamer biosensors. 
Based on the results of the target titrations, the detection limit of this sensor was determined to be at 
least as low as 75 nM and 4nM for the Kanamycin and Tetracycline CCA biosensors respectively. This is 
comparable to published literature of antibiotic aptamer biosensors, which typically describes aptamer 
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biosensors with nanomolar detection limits.  Sensors with limits of detection within the micro and 
picomolar range exist, but these tend to be the exception rather than the norm.  
Both kanamycin and tetracycline sensors showed high specificity to their targets, showing no significant 
response to structurally similar molecules.  
Further enhancement of the sensor by gel encapsulation has shown that it is possible to prevent signal 
loss from extended exposure to high nuclease concentrations. However tests of electrodes exposed to 
high concentrations of nucleases in the absence of protection by gel encapsulation also shows 
significant resistance against signal loss.   
Some of the well-known factors which adversely affect biosensor performance in practical applications 
have been listed in the Field Biosensor Section of the First Chapter (see page 66). The results would 
indicate that these issues have been successfully addressed with the aptasensor designs presented here, 
either by sample pre-treatment and/or electrode design. All these countermeasures could be easily 
implemented in the field, even with limited availability of resources.  
Potential interfering factors  Mitigation 
Competition by target-similar molecules Negative control against target-similar molecules 
Background Noise 
Noticeable difference between background and 
target-bound signals 
Degradation of Target Pre-treatment (cool storage of solution sample) 
Degradation of Sensor 
Gel encapsulation, suitable sensor storage 
practices 
Fouling of Electrode Surface 
Sample pre-treatment (centrifugation and 
filtration) 
 
Table 3.01 Potential factors affecting biosensor performance and countermeasures undertaken to 
reduce their effect. 
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Future work conducted following this line of investigation is described in the fourth chapter of this 
thesis, where the kanamycin and tetracycline aptamer biosensor has been merged into an automated 
multichannel sensing system.  
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Chapter 4: Automated Multichannel Aptamer Biosensor 
4.01 Introduction 
The previous sections of this study has established the basic functionality of the kanamycin and 
tetracycline aptamer biosensors, both in simple clean buffer solution and in the relatively more complex 
matrix of likely investigated environments. Here an attempt was made to increase applicability of the 
aptamer biosensor system by increasing the sampling range of the sensor and decreasing the 
operational steps of the sensing requiring human intervention. The ultimate aim of which should be a 
more versatile sensor setup with decreased operational human-hour requirement.  
 
4.02 Type 2 Automated Sampling Platform 
Decreasing the steps requiring human intervention was achieved largely through the fabrication and 
integration of an automated sampling platform into the sensing device. 
The Type 2 Automated Sampling Platform (T2ASP) was developed directly from a RepRap type 3D 
printer. The electronics and hardware components of the 3 axis robot was largely retained, since the 
mechanical functions of a 3D printer and a mechanical automatic sampler share similar purposes, 
namely the movement of an effector head (an extruder nozzle in the 3D printer, a sampling tip in the 
case of the autosampler) to a desired location over an area of activity (a printing plate for a 3D printer, a 
sampling surface for an automatic sampler). Details regarding the design and fabrication of the 
automatic sampler can be found in the methodology section. 
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Fig 4.01 Early T2ASP being used to conduct electrochemical assay of ferrocene control.  
(left) Fig 4.02 The 
sampling component, 
composed of a 
syringe pump and 
sampling head.  
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The above displayed model uses the same sampling head as the autosampler used for the multichannel 
aptamer biosensor, and largely similar operational layout. This device could be considered more 
complex than those used in the final multichannel aptamer biosensor experiment, with a 3 axis 
movement capability (it utilizes both the X and Y axis of the 3D printer). Control scheme is much more 
complex (perhaps unpractically so) utilizing two Melzi control boards, one controlling the 3 axis scaffold 
and one controlling the sampling pump, and controlled by two time synchronized software interfaces. In 
the final multichannel sampler, only one Melzi control board is used, controlled with one interface.  
 
4.03 T2ASP Performance 
In order for the T2ASP to be a successful liquid handling robot the sampler must be able to achieve its 
main objective, which is firstly to reliably uptake a set volume of liquid from a starting point, secondly to 
transport that liquid to an end point, then to eject the volume of liquid at that point.  
Thus a Gcode script is written with the following feature: 
1) To move from start (X0) to sampling point (X20) 
2) To lower sampling tip into the well and uptake sample (Z40 to Z10) 
3) Raise sample head height to clear the sample well (Z10 to Z40), move to sample release 
point (X 70). 
4)  Sample head is lowered (Z 40 to Z 10) and liquid is released to a pre-weighted 
measuring boat. 
The measuring boat is then weighted on a Sartorius balance, weight difference indicating the volume of 
pumped liquid. Liquid used in entire process was MilliQ water.  
A trial run was conducted prior to mass testing (results not included). Two key errors were noticed on 
these runs. Firstly small amounts of liquid may be lost during transportation (step 3) by dripping from 
sampling tip during movement. This was resolved by adding a 1mm syringe movement step after tip is 
raised from sampling point, creating an air bubble between the liquid and the sampling tip during 
movement. The second is that the liquid ejection at release point was occasionally incomplete, leaving a 
small droplet of unreleased liquid at pipette tip. This was resolved by adding a 4mm air uptake stage 
prior to the liquid uptake stage. At the release stage the liquid is ejected followed by the air in the 
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cylinder resulting in the expulsion of any remaining liquid droplets via air pressure. This should minimize 
the volume of residual liquid within the sampling tip, thereby reducing chance of cross-contamination. 
Contamination could potentially be minimized by mechanical pumping with the sampling tip in a 
reservoir containing buffer solution, a practice commonly used in commercial liquid handling robots. 
This was not implemented in the protocol described, however, as the number of sampling points is 
relatively small and generally results in the saturation of the first sampled biosensor (details can be 
found in section 4.06 and 4.07 of this chapter).  
Results: 
Three syringe movements were tested, 2.7mm, 5.4mm and 8.1mm, equivalent to 50ul, 100ul and 150ul. 
Improved Gcode were used for all runs. 
 
Fig 4.03 Syringe output in weight of liquid transferred per 5.4mm effective movement. This translates 
Gcode based movement commands into syringe movement, which should in turn determine volume 
pumped. Volume is measured in weight due to mode of measurement (a Sartorius scale) 
In general the pump would appear to be suitable and to meet its requirements. The results would 
indicate that there is a loss of a relatively fixed amount of volume during each transfer. This is most 
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likely as a result of the stepper motor missing some steps as a result of overcoming friction on the 
syringe piston. Alternately this could be as a result of loss of volume during transport, either in raising or 
lowering sampling head or one of the lateral movement steps. No obvious liquid loss was observed in 
transit however. 
In any case loss of volume is relatively small. Even the highest error in smallest sampling volume, total 
volume lost was 14ul per 100ul draw, with the average volume error for 2.7mm movement being 7.2 ul. 
Average volume errors for 5.4mm and 8.1mm movement are respectively 96.8 ul and 97.2 ul per 5.4mm 
movement, a 3.2% and 2.8% decrease from calculated volume, with the biggest deviation being 96ul per 
5.4mm movement for both 5.4mm and 8.1mm results. This means a maximum difference from estimate 
of 4%. This compares favorably to ISO-8655 standards for a 1000ul Gilson’s pipette which allow for an 
error of 8% at 100ul, though by the same standards a 200ul Gilson’s pipette should have an error of no 
more than 1.6% at 100ul.  
 
4.04 Test of T2ASP for single electrode on/off assay. 
The T2ASP was tested in a single electrode assay. This test was conceived partially as a more real-
operation condition test of T2ASP, and also as a pilot run for automated cell to be used in the 
multichannel assay.  
In order to streamline the number of steps in the multichannel sensor, it was decided that a full range 
titration should be replaced by a single concentration on/off type titration. Sampling occurs purely by 
automation. Stock solution is composed of a 250uM Kannamycin solution. Pipetted volume is 100ul, 
creating a 5uM solution in a 5ml cell. Electrode conditions are otherwise identical to those of the 
laboratory condition experiments as described in the CCA section of the Third Chapter. 
Kanamycin aptamer was selected as it was the most well studied conformation change aptamer 
available at the time. As a stirrer could not be directly incorporated into the current automatic sampler 
design, a 5 min wait time was provided for the solution to mix by diffusion and convection. 
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Fig 4.04 Comparison of SWV derived peak current response of Kanamycin Fcn-aptamer biosensor vs 
Ag/AgCl to buffer and a 5uM Kanamycin solution, used to display feasibility of automatic sampling 
system. 
The result indicates a significant signal decrease as a result of target addition. The amplitude of the 
signal change between buffer and target solution is 25nA, which is somewhat smaller than the average 
signal change seen previously. The average amplitude change between Buffer and 5uM Kanamycinin the 
comparable sensor format was 47nA on average, with a range of 22nA to 72nA. The signal amplitude in 
the absence of Kanamycin target was which is not considered statistically significantly different from 
that observed previously (54nA). 
Based on these results it can be concluded that migration of the Kanamycin biosensor to the T2ASP 
automatic sampling platform does not significantly affect the performance, and that this process could 
be evolved further for multi-channel testing. 
 
4.05 Test of T2ASP for Multichannel assay against multiple test samples 
Having established the functionality and reliability of the T2ASP, the sampling platform was the used in a 
multi-electrode assay with multiple samples. Kanamycin and Tetracycline aptamer biosensors were 
selected since they have been used in previous studies conducted by this project using the same 
electrochemical cell conditions, particularly regarding cell buffer. Thus it is known that these two 
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electrodes will be able to operate under common conditions. Electrode assay protocol used was the 
same as the T2ASP single electrode test (see above), with the exception of an additional reservoir added 
for a 2nd sample solution and additional cycle of SWV for added test samples.  
Like the single electrode automated assay, sampling occurs purely by automation. Stock solution is 
composed of a 250uM Kannamycin and 6.4uM Tetracycline solution, thus 100ul of pipetted stock 
creates a 5uM and 128nM solution in a 5ml cell respectively.  
 
4.06 T2ASP Multichannel Test 1 
Test 1 of the multichannel assay automatically adds 100ul stock Tetracycline to buffer to produce the 
first and 100ul stock Kanamycin to produce the second solution. 
 
Fig 4.05 SWV of ferrocene labeled Kanamycin biosensor vs Ag/AgCl, performed in clean buffer in a multi 
electrode cell. First solution added results in a 128nM Tetracycline solution, Second solution added 
results in a 5uM Kanamycin and 128nM Tetracycline solution 
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Fig 4.06 SWV of ferrocene labeled Tetracycline biosensor vs Ag/AgCl, performed in clean buffer in a 
multi electrode cell. First solution added results in a 128nM Tetracycline solution, Second solution added 
results in a 5uM Kanamycin and 128nM Tetracycline solution 
The result shows a significant increase in current by the tetracycline biosensor, and an insignificant 
signal change by the kanamycin aptamer, as a response to addition of tetracycline solution. Conversely 
the result shows an insignificant response by the tetracycline biosensor, and a significant decrease in 
current by the kanamycin aptamer, as a response to addition of kanamycin solution. These result would 
indicate that the multichannel arrangement does not result in cross reaction between the sensors and 
that the respective sensors are still able to selectively detect their target molecule.  
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Fig 4.07 SWV derived peak current response of Kanamycin and Tetracycline Fcn-aptamer biosensor vs 
Ag/AgCl to a 128nM Tetracycline cell solution, and a cell solution containing both 5uM Kanamycin and 
128nM Tetracycline. 
A single replicate of this experimental setup was conducted, with similar results. This result can be found 
in Appendix H (page 309). 
 
4.07 T2ASP Multichannel Test 2 
To test whether the order of the sample addition has an effect, a second series of measurement were 
made in which the order of addition of samples was reversed. The results are shown below. 
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Fig 4.08 SWV of ferrocene labeled Kanamycin biosensor vs Ag/AgCl, performed in clean buffer in a multi 
electrode cell. First solution added results in a 5uM Kanamycin solution, Second solution added results 
in a 5uM Kanamycin and 128nM Tetracycline solution 
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Fig 4.09 SWV of ferrocene labeled Tetracycline biosensor vs Ag/AgCl, performed in clean buffer in a 
multi electrode cell. First solution added results in a 5uM Kanamycin solution, second solution added 
results in a 5uM Kanamycin and 128nM Tetracycline solution 
The result shows a significant decrease in current by the kanamycin biosensor, and an insignificant signal 
change by the tetracycline biosensor, as a response to addition of kanamycin solution. Conversely the 
result shows an insignificant response by the kanamycin biosensor, and a significant increase in current 
by the tetracycline aptamer, as a response to addition of tetracycline solution. These result would 
confirm test 1’s observations, which indicate that the multichannel arrangement does not result in cross 
reaction between the sensors and that the respective sensors are still able to selectively detect their 
target molecule, irrespective of the order of addition. 
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Fig 4.10 SWV derived peak current response of Kanamycin and Tetracycline Fcn-aptamer biosensor vs 
Ag/AgCl to a 5uM Kanamycin cell solution, and a cell solution containing both 5uM Kanamycin and 
128nM Tetracycline.  
A single replicate of this experimental setup was conducted, with similar results. This result could be 
found in Appendix H (page 309). 
 
4.08 Additional Analysis 
The results of test 2 confirm that the change in signal is not a time or non-target condition induced 
phenomena. The addition of target results in a significant response exclusively in the biosensor specific 
to that target, with much less significant response in the other electrode. Due to the specific binding 
properties of the aptamers discussed in their respective sections the Kanamycin aptamer could be 
considered Off in High, and On in Low, and vice versa in the case of Tetracycline aptamer, with the signal 
0
0.01
0.02
0.03
0.04
0.05
0.06
Buffer 4.8uM
Kannamycin
128nM
Tetracycline,
4.8uM
Kannamycin
P
e
ak
 C
u
rr
e
n
t 
(u
A
)
Cell  Solution
SWV derived peak current of an automated Kanamycin 
and tetracycline Aptasensor, in multi target assay
Tetra Aptamer
Kana Aptamer
160 
 
being On in High and Off in low. The results of the multichannel tests can be summarized in the table 
below. 
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Test 3 Tetra Buffer 36.8 LOW OFF Tetra 52.6 15.8 Yes HIGH ON T/K 52.3 -0.3 No HIGH ON 
Test 3 Kana Buffer 52.9 HIGH OFF Tetra 45.5 -7.4 No HIGH OFF T/K 20.7 -24.7 Yes LOW ON 
Test 5 Tetra Buffer 30.6 LOW OFF Tetra 51.6 21 Yes HIGH ON T/K 56.3 4.8 No HIGH ON 
Test 5 Kana Buffer 50.2 HIGH OFF Tetra 45.5 -4.7 No HIGH OFF T/K 20.1 -25.4 Yes LOW ON 
Test 6 Tetra Buffer 15.6 LOW OFF Kana 16.5 0.9 No LOW OFF T/K 33.9 17.4 Yes HIGH ON 
Test 6 Kana Buffer 58.4 HIGH OFF Kana 28.3 -30.1 Yes LOW ON T/K 26 -2.2 No LOW ON 
Test 8 Tetra Buffer 23.3 LOW OFF Kana 18.7 -4.6 No LOW OFF T/K 42 23.3 Yes HIGH ON 
Test 8 Kana Buffer 54.1 HIGH OFF Kana 34.3 -19.7 Yes LOW ON T/K 33.7 -0.6 No LOW ON 
 
Table 4.02 Summary of Results for Multichannel Aptamer Bosensor 
 
The results show an off signal for both biosensors in target absent buffer. Addition of the first solution 
(Tetracycline solution in Test 1, Kanamycin solution in Test 2) result in On signal for Tetracycline 
biosensor in Test 1 and Kanamycin biosensor in Test 2 respectively and no signal change in the other 
electrode. Addition of second solution result in the switching on of the second electrode, Kanamycin 
biosensor in Test 1 and Tetracycline biosensor in Test 2.  
 
4.09 Concluding Remarks 
This study has shown that the aptamer biosensors discussed in the Conformation Change Aptamer 
Biosensors chapter of this thesis could be integrated into an automated multichannel system, thereby 
increasing the applicability of the sensors in a real world setting. 
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Future work conducted following this line of investigation should concentrate on diversifying the 
multichannel aptasensor onto other potential targets of interest. These sensor should target analytes 
whose detection would be beneficial in the environment investigated, such as valuable secondary 
metabolites for microbial product discovery, or toxic contaminants for agricultural regulation. 
Another potential area for future works for CCA based systems is to test this sensor format in other 
environments where antibiotic detection could be useful, such as bioreactor monitoring for example. 
Alternatively the sensor could be tested against a more diverse range of soil and agricultural effluence 
samples. 
While the gold disc electrode is useful for prototype sensor testing due to its simplicity, it is not 
amenable to scaling up for commercial scale production. Using multiple large GDEs in a multichannel 
array also necessitates a large electrochemical cell, which results in wastage of reagents. It may be 
beneficial in future works to integrate multiple biosensors into microelectrode arrays.  
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Chapter 5: Aptamer Biosensors based on Gold Nanoparticles 
5.01 Introduction 
This part of the thesis describes the development of a biosensor based on Enzyme-Linked 
Oligonucleotide Assay (ELONA) technology utilized as part of the affinity selection component of the 
SELEX process (see page 243). Two sub-types of ELONA-like biosensors were originally envisioned, based 
respectively on direct and indirect ELONA. Both sub-types depend on the aggregation of redox label rich 
Gold Nanoparticles (GNPs) at the electrode as a means of signal generation.  
 
Fig 5.01 Hypothesized sensing mechanism of DAELAB and IAELAB, the sensing mechanism is described in 
section 5.09 and 5.10 of this chapter. 
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5.02 Gold Nanoparticles (GNP) 
Metal nanoparticles have generated considerable interest in recent times [135] [136][137] particularly 
regarding their use as components of biosensors. A number of different metal nanoparticles have been 
integrated into biosensor systems. Nanoparticles based on metal oxides [138] and semiconductor [139] 
have also been investigated.  
Metal nanoparticles, due to their small size, can exhibit unique properties not present in bulk material 
made from the same metal [140][141]. The final properties of these nanoparticles are influenced by the 
particle size, concentration and material of the composite nanoparticles, as well as the modifications 
present on the nanoparticle surface. 
Perhaps the most common metal nanoparticles to be used in the field of biosensing are Gold 
Nanoparticles (GNPs). GNPs are most commonly used with a size range of 1nm-100nm [142], and have 
high surface to volume ratio compared to the bulk structures (such as a conventional gold electrode). 
Methods of GNPs synthesis are well researched and reproducible [90] [143], with proven consistency in 
inter and intra-batch nanoparticle size.  
GNPs are frequently used in electrochemical sensing applications, because of their high conductivity 
[144], which allows relatively uninterrupted electron transfer between redox species and the electrode 
surface. The biosensor design explored in this part of the study seeks to exploit this property and the 
high surface area of GNPs in order to increase the loading of redox label at the electrode surface. By 
immobilizing multiple redox labeled aptamer biosensor molecules on the GNPs, it is hoped that the 
signal of a single target molecule-aptamer interaction would be amplified due to the enhanced mass of 
redox labels present. GNPs has been used successfully to increase the quality and surface area of 
electrode biosensors including, for example, thrombin sensing [145]. 
GNPs have been used in the past to provide a conductive core through which charge could tunnel to the 
electrode surface [142]. This is in contrast to non-conductive nanoparticles (for example latex) where 
electron transfer can only take place with redox label spatially located close to the electrode surface. 
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Fig 5.02 Schematic comparison of conductive and non-conductive nanoparticle sensors. 
GNPs are also compatible with immobilisation of thiol modified aptamers [146], providing a short path 
between the redox label and the conductive GNP core. 
 
5.03 Sensing Mechanism  
Signal change is the result of change in the density of redox label at the electrode interface as a result of 
target-aptamer complex induced aggregation. Based on the known mechanisms of ELISA and ELONA on 
which this design is based [147][148], sensing mechanism occurs in two phases. For the Indirect 
Adsorption ELONA-Like Aptamer Biosensor (IAELAB) the first step involves the specific binding of target 
molecule to the electrode surface by surface bound target specific aptamer (analoguous to the primary 
antibody on a sandwich assay). The second step involves the specific binding of a different, GNPs bound, 
aptamer (analogous to the detection antibody on a sandwich assay) to the target molecules immobilized 
at the electrode interface (see fig 5.01 above). This aptamer contains bioconjugated redox label, 
allowing it to generate electrochemical signal at electrode interface. This is in contrast to ELISA and 
ELONA, which typically uses HRP or similar enzymes as signal amplifier. 
Therefore in IAELAB the function of the primary aptamer is to enhance the target affinity and specificity 
of the electrode surface, thereby effectively increasing the concentration of target molecules at the 
electrode interface. The concentration of ferrocenated, GNPs bound, detection aptamer which binds to 
the immobilized target should determine the signal amplitude. The amount of immobilized target is in 
turn dependent on the target concentration, as well as its binding affinity to and the number of primary 
aptamer molecules at electrode surface (see Section 3.03 of the 3rd Chapter, page 93).  Thus both sensor 
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molecules affinity for the target molecule play a role in signaling. Without the immobilized aptamer the 
target may not be bound sufficiently tightly to electrode surface, to be retained during the wash, 
resulting in a low surface concentration.  
The Direct Adsorption ELONA-Like Aptamer Biosensor (DAELAB) is similar, but the first step involves the 
direct adsorption of target molecule to electrode surface. 
 
5.04 Thrombin Aptamers TBA and HD22 
The IAELAB format requires a pair of aptamers that bind the target at different sites on the molecule. 
The best established example of this are thrombin binding aptamers. The aptamer sequence selected for 
immobilisation on GNPs is the 15 bp long TBA aptamer sequence originally published by Bock et al [149]. 
The SPE side aptamer is the 29 bp long HD22 aptamer sequence originally published by Tasset et al 
[150].  
 
TBA 
5'-GGTTGGTGTGGTTGG-3' 
HD22 
5'-AGTCCGTGGTAGGGCAGGTTGGGGTGACT-3' 
Fig 5.03 Published sequence for selected thrombin binding aptamers. 
 
The TBA sequence selected was adapted for binding to gold by the addition of a C6 mixed disulphide 
group at the 5’ end of the sequence and for bioconjugation with ferrocene carboxylic acid through an 
amine group at the 3’ end as shown in fig 5.04.  
Since the HD22 is also immobilized onto gold it too needs to be modified with the mixed disulphide 
group at the 5’ end. An amine group was added to the 3’ to increase the versatility of this aptamer 
should additional functionalization be required (e.g. by the addition of a fluorophore). 
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TBA, disulfide and NH2 modified (pre-bioconjugation with ferrocene carboxylic acid)  
5’-C6H13-S-S- GGTTGGTGTGGTTGG -NH2-3’ 
TBA, disulfide and ferrocenyl modified (post-bioconjugation) 
5’-C6H13-S-S- GGTTGGTGTGGTTGG -Fcn-3’ 
HD22, disulfide and NH2 modified  
5’-C6H13-S-S- AGTCCGTGGTAGGGCAGGTTGGGGTGACT -NH2-3’ 
Fig 5.04 Finalised Thrombin Biosensor Sequences. 
 
These two sequences have been extensively studied [151][152][153], including the 3D structure of the 
aptamer-target interaction [154][150]. HD22 and TBA do not share a common target binding site, so it is 
unlikely that competition for binding site will take place, which is important for IAELAB. Further evidence 
of this is that HD22 and TBA when dimerised, through a linker, display an avidity effect resulting in 
significant increase in binding [155] to Thrombin. Due to the extensive literature already available on 
these two aptamers as well as the fact that, unlike the conformation change aptamer, this mode of 
sensing does not rely on detailed knowledge of aptamer structure, no further study by modeling was 
deemed necessary.  
 
5.05 Negative Control Selection 
Two negative controls were selected for the assays, these being bovine serum albumin (BSA) and 
lysozyme. BSA was selected due to its high concentration in most the likely sample of a practical human 
thrombin biosensor, which is blood plasma in a biomedical sensor setting. Lysozyme was selected due to 
its highly positive charge, which should result in significant non-specific affinity to negatively charged 
DNA bioreceptor molecule. Thus the lysozyme titration would represent a good worst case scenario for 
non-specific false positive results [156].  
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5.06 Determination of success of Bioconjugation Process and Confirming the Electrochemical 
Characteristics of Ferrocene 
Unlike conformational change aptamer biosensor, thrombin aptamer was purchased without pre-
attached ferrocenyl group. These control experiments were conducted in order to determine the 
success of the process of bioconjugation, as well as to confirm the utility of ferrocene as a redox label. A 
complete sensor tip containing sensing surface immobilized on a gold disc electrode was set up in an 
electrochemical cell, and SWV was conducted in a manner similar to that used for conformational 
change biosensor process.  
Five electrodes, each containing different oligonucleotides immobilized on the surface, were tested. 
First an electrode with immobilized NH2 capped thrombin aptamer was tested to provide a baseline for 
an electrode with a self-assembling monolayer of DNA but in the absence of a redox label; this acts as 
label-free negative control. The second electrode had thrombin aptamer bioconjugated with Ferrocene 
carboxylic acid using the method provided in the methodology section. For comparison electrodes with 
commercially supplied ferrocene conjugate kanamycin and tetracycline aptamer were used. The fifth 
electrode is blank electrode. 
Special care was taken to ensure all electrodes used in this test had been extensively rinsed in order to 
remove any oligonucleotide sequences not covalently bonded to the electrode surface.  
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Fig 5.05 SWV of ferrocene labeled biosensor and control electrodes vs Ag/AgCl, in under target-free 
(buffer only) conditions. 
A voltammetric peak was clearly observed at in all the ferrocenated aptamer electrodes. Since no other 
peaks of similar magnitude were noted within this potential scan range, and the peak being sufficiently 
close the literature value, it is concluded to be the ferrocene peak.  
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Fig 5.06 Peak current amplitude of the biosensor and control electrodes in buffer vs Ag/AgCl 
 
Peak magnitude is within the same order of magnitude as those of Ferrocenated Kanamycin aptamer in 
resting (unbound) state. Our study of conformation change aptamer show that electrodes could display 
considerable variation in maximum signal amplitude, most likely as a result of quality of electrode 
polishing. Comparison of thrombin electrode signal to tetracycline aptamer in its resting state shows 
significant difference in signal magnitude, though this comparison would perhaps be less useful than a 
comparison of the signal of thrombin aptamer to a target saturated tetracycline biosensor electrode 
(which is in its maximum signaling state).  
 
5.07 Characterizing Synthetic GNPs 
In order to determine the uniformity in shape and size of gold nanoparticles, samples were observed in 
a transmission electron microscope (TEM).  
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Fig 5.07 Transmission Electron Micrograph of GNPs particles fabricated using the Frens Method  
By measuring several samples of GNP using TEM, the average size of GNP was determined to be 10.2 
nm, with fewer than 1% of the particles being outside the 9-11 nm range. The shape of the nanoparticles 
appear to be uniform enough to be utilized in aptamer coated GNPs production. 
The GNPs were also observed by UV/Vis spectrophotometry as the wavelength of the absorbance 
maximum depends on the particle diameter and the absorbance peak magnitude on the concentration. 
Spherical GNP with particle size of <40 nm is well studied to have absorbance peak at close to 520nm 
[157].  
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Fig 5.08 UV/Vis spectrograph of bare GNPs particles fabricated using the Frens method [90].  
The result of the UV/Vis spectrograph would indicate that GNP within the correct size range has been 
successfully synthesised. 
5.08 Determining the Presence of Aptamer on GNPs 
Dynamic Light Scattering (DLS) is a technique for measuring the hydrodynamic radii of particles in the 
submicron region by measuring the change in the intensity of scattered light as a result of the influence 
of Brownian movement on the drift of particles. The larger the particle, the slower the Brownian 
motion. The diffusion coefficient measured by DLS does not depend solely on the size of the particle 
core, but also on the co-transported mass (such as for example the double layer which forms on any 
charged surface in liquid) on the surface of the investigated structure, as well as the concentration and 
type of ions in the medium. This combined size is known as the hydrodynamic diameter. This results in a 
measured hydrodynamic size larger than the actual GNPs core. 
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Fig 5.09 DLS results for bare gold nanoparticles 
 
 
Fig 5.10 DLS results for aptamer coated GNP 
 
The results show a noticeable increase in the size of the hydrodynamic radii from 15.6 to 19 nm, which 
supports the assessment that the gold nanoparticles have been successfully loaded with aptamer. An 
increase in the size distribution suggests greater variation of particle sizes. 
There is a considerable difference between the radii of the unmodified GNPs determined by TEM and 
DLS. This could be explained by the presence of the hydrodynamic layer, which would be detected by 
the DLS but not the TEM. The significant change in DLS measured diameter could also be the result of an 
organic layer formed during citrate dependent GNPs synthesis such as the Frens method. Further, the 
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DLS method of data analysis is dependent on the particle model, and may therefore generate 
anomalous results if the model is not a good representation of the actual particles being measured. 
Another method for determining successful DNA immobilization on GNPs is through UV/Vis 
spectrophotometry.  
 
Fig 5.11 UV/Vis spectrograph comparing DNA enriched and bare GNPs particles. The “drop” located 
between 340 to 380 nm is due to a filter change in the spectrometer. 
Both GNPs and DNA-GNPs displays a clear peak at 550nm as a result of GNPs’s contribution to solution 
adsorption. This peak is more pronounced in the original sample than in the DNA-GNP sample. This was 
expected since the dilution factor of the DNA-GNPs is at least 250% greater than of the original GNPs 
sample (the resuspension ratio is typically 250ul for every 100ul original GNPs solution), and it is almost 
certain that some loss of GNPs would have occurred as part of the immobilization process (either due to 
adhesion to surfaces or loss with supernatant).  
However the DNA-GNPs shows a significantly more pronounced peak at 260 nm as a result of DNA’s 
contribution to adsorption, which would support the conclusion that significant DNA is present in the 
DNA-GNP sample. Peak at 260 nm for the original GNPs sample is very small compared to the height of 
the 260 nm peak of the DNA-GNP sample.  
In order to prove that the DNA mass in the DNA-GNP sample has been successfully immobilized onto the 
GNPs and not simply present in the solution, the DNA-GNP is spun down using a centrifuge. This is 
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should not result in the precipitation of unbound DNA along with GNPs sample, since the very short 
17bp aptamer precipitation protocol requires 10000g centrifugation for at least 10 min, preceded by at 
least 2h (preferably 12h) incubation in 100% ethanol at -20°C. The supernatant is then extracted and 
sampled in a nanodrop device. The results show no noticeable concentration of DNA, which would 
support the conclusion that the concentration/resuspension cycles have been successful in removing 
unbound DNA, and that the only remaining mass of DNA in the DNA-GNP sample is bound to the GNPs 
surface.  
 
5.09 Direct Adsorption ELONA-Like Aptamer Biosensor (DAELAB) results 
Investigation of a target titration by SWV shows no clear correlation between observed current to target 
concentration. Indeed 3 out of the 4 full target titration DAELAB runs investigated yielded no 
quantifiable signals at all. In one instance of DAELAB, a peak was observed, but only at the highest target 
concentrations. A further 7 test runs were conducted at the highest thrombin concentration only (no 
titration below a concentration of 1000nM), two of these runs yielded quantifiable signals (peak 
magnitude of the three peaks were 115.5 nA, 8.7 nA and 76.5 nA. This would indicate that the DAELAB 
sensor is capable of detecting Thrombin at the highest concentration with a 30% reliability. 
Voltammograms derived from both electrode variation, one showing no signal response to 
concentration and one where signal is only observed at the highest concentration, is displayed in the 
figure below. 
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Fig 5.12 SWV of Thrombin fcn-aptamer biosensor with direct adsorption configuration (DAELAB)’s 
response to Thrombin titration vs Ag/AgCl, showing both observed electrode variations. 
 
Direct ELONA (and the much more ubiquitous direct ELISA from which ELONA is developed) is 
considered a robust technology, and is frequently used in the determination of Kd for SELEX process. 
This technique has been used by this study itself to determine increase in target affinity of DNA library in 
the automated devices section. The success of direct ELONA proves that it is possible to bind large 
globular protein targets to non-specific surfaces. However in the case of using a redox label rather than 
an enzyme the additional constraint of the former is that it requires the label to be close to the surface. 
Additional factors that could result in no detectable signal include the following: 
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1) Differences in binding surface unrelated to the binding protocol could also have played a 
role in decreased adsorption. SPE surface is a gold film, microplate reader plates are 
usually fabricated out of polypropylene or polystyrene. This could result in a number of 
reasons for loss of signal. It is possible that the gold surface simply has a lower affinity 
for the thrombin target than the polymer surfaces. It is also quite possible that 
thrombin-gold interaction does not result in adsorbed molecules that can interact with 
the GNPs-bound aptamer. One of the benefits of IAELAB’s specific adsorption of target 
molecule onto the electrode surface is that any target retained by this method is likely 
to have a relatively uniform deposition on the electrode surface, as a result of 
orientation of the 29 aptamer binding site towards the 29 bp aptamer immobilized at 
the electrode surface. Deposition of target onto the SPR surface would be harder to 
predict, and also potentially more random. This could result in the adsorbed molecules 
losing their binding sites to the 15 aptamer as a result of denaturation in the process of 
adsorption. Alternately gold-Thrombin direct interaction could favour an interaction 
which hides the 15 aptamer binding site, effectively burying it in the process of 
adsorption. 
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Fig 5.13 Potential causes for the failure of DAELAB sensing method. 
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2) Immobilisation conditions. Indirect ELONA of the protocol used in the SELEX device part 
of this study was optimized to facilitate adsorption. This includes immobilization 
temperature (4°C in ELONA vs 25°C in DAELAB), Immobilization buffer (ELONA 
adsorption buffer for lysozyme had same charge as target, increasing precipitation, 
Thrombin has a relatively net neutral charge at pH7 (compared to lysozyme, for 
example)) and immobilization time (12h for ELONA vs 60 sec for DAELAB).  
 
3) In the ELONA assays a much less stringent washing procedure was used as compared to 
that used with the sensors. 
Thus it could be concluded that the conditions of direct ELONA are not comparable to those of DAELAB. 
Any of the factors above could result in the loss of effective target concentration at the electrode 
interface. In the absence of target molecules at electrode surface after the first wash, there is a 
decreased affinity to the Fcn labelled GNPs, leading to the loss of redox label during the 2nd wash, 
resulting in decreased signal.   
 
5.10 Indirect Adsorption ELONA-Like Aptamer Biosensor (IAELAB) results 
Investigation of a target titration by SWV shows significant correlation between signal magnitudes to 
target concentration. The titration plot profile is typical of a conventional binding curve, with the signal 
drop correlating to target concentration at lower concentrations before plateauing at high 
concentration as the sensing surface is saturated with target molecules at high concentrations.  
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Fig 5.14 SWV of thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
thrombin titration vs Ag/AgCl 
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Fig 5.15 SWV derived peak current response of thrombin Fcn-aptamer biosensor with sandwich 
configuration (IAELAB) to thrombin titration vs Ag/AgCl. The data point at 500 nM has been eliminated 
as an anomalous data. 
Mathematical processing using Graphpad Prism 5 Software yields an average Kd of 46.2 nM, with an 
upper and lower quartile values of 50.7nM and 32.2nM respectively, and a Kd standard deviation of 
22.7. The reference Kd for the GNPs bound aptamers used in this assay is complicated by the popularity 
of this aptamer, and therefore the range of techniques used to estimate its Kd, which ranges from 2.68 
to 450 nM [158]. 
Estimates of the Kd based on the results of this study would be within the typical range shown in 
previous publication for the GNPs based aptamer, but much higher than the Kd of the SPE based 
aptamer. It is unclear how relevant literature Kd is relative to the Kd of this experiment however, as 
conditions of this assay is significantly different from most Kd determination protocols. The wash step 
for example will almost certainly result in a decrease in signal as a result of removal of surface adsorbed 
particles by hydrodynamic shear.  
R squared value of the data sets fit the linear regression of the one site binding – saturation, one site –
total model of the prism software by >0.98 for 4 result, >0.95 for 1 result and >0.90 for 1 result.  
All data sets show consistent signal increase between 0 to 100 nM. There is much less agreement in the 
magnitude of signals and signal trend between 250 nM to 1000 nM. Three results show a clear non-
linear trend of increase between 0-150nM, followed by a linear increase between 250 to 1000 nM, five 
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results show an increase between 0-150nM, followed by a signal plateau between 250 to 1000 nM. 
These results can be found in Appendix I. 
 
Author 
Bioreceptor 
molecule Sensor Format Sensing Mode 
Detection 
Limit Reference 
IAELAB Aptamer 
Induced assembly configurational aptamer 
biosensor Electrochemical 15 nM  
Liu et al Aptamer 
Induced assembly configurational aptamer 
biosensor Optical 89 pM [159] 
Xiao et al Aptamer Conformation change aptamer biosensor Electrochemical 6.4 nM [160] 
Li et al Aptamer 
Induced assembly mediated retainment of 
transducer enzyme Optical 20 nM [161] 
Zhang et 
al Aptamer 
Induced disassembly configurational aptamer 
biosensor Optical 20.5 nM [162] 
Mir et al Aptamer 
Induced assembly configurational aptamer 
biosensor Electrochemical 80 nM [163] 
Zheng et 
al Aptamer 
Target-Aptamer complex imhibition of enzyme 
digestion Optical 680 nM [164] 
 Table 5.01 A comparison of the IAELAB sensor relative to a selection of recent thrombin aptamer 
biosensors. 
Based on the results of the target titrations, the detection limit of this sensor was determined to be at 
least as low as 15 nM. This is comparable to published literature of Thrombin aptamer biosensors, which 
typically describes aptamer biosensors with low nanomolar detection limits.  Sensors with limits of 
detection within the picomolar range exist, but these tend to be the exception rather than the norm.  
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5.11 Thrombin Titration with full IAELAB setup in the absence of redox label 
 
Fig 5.16 Binding mechanism of redox-label free negative control 
These control experiments were conducted in order to determine whether the voltammetric responses 
observed in the IAELAB results were due to the presence of the ferrocene label at the electrode surface. 
Controls were set up using the same protocols as that listed in the methodology section for IAELAB, with 
the only exception being that the aptamer immobilized onto the GNPs was not conjugated with 
ferrocene label prior to the assay. 
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Fig 5.17 SWV of unferrocenated Thrombin aptamer with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl 
The result showed no noticeable peak in the absence of redox label. The lack of any distinct peak 
indicates that the target is not oxidised in the range and conditions of the experiment, and that the 
distinct peak detected at approximately 0.45 V in titrations are the result of charge transfer to the redox 
label. While the effect of the charging current could be observed, the magnitude relative to a typical 
ferrocene signal is minimal within the investigated range, and could therefore be considered negligible 
for the purposes of data analysis. 
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5.12 Sensor Specificity 
Control experiments were conducted in order to determine whether the sensing molecule would bind to 
non-target molecules similar to the Thrombin target. Lysozyme and Bovine Serum Albumin (BSA) were 
eventually selected, for reason of low cost and availability. Lysozyme was selected due to its strong 
overall positive charge, which was expected to give it at least some degree of non-specific affinity to 
negatively charged oligonucleotides. This should provide a near maximum baseline non-specific signal 
for non-target globular proteins. BSA was selected due to its prevalence in the serum, which is the 
natural working environment of a practical real-life thrombin biosensor. Both specificity controls were 
also chosen due to their relatively similar size to target molecule (14.3kDa for lysozyme and 66kDa for 
BSA, compared to 37.4 kDa for thrombin), allowing them to represent globular proteins in general.  
 
186 
 
Fig 5.18 Hypothesised mechanism of BSA and Lysozyme negative control 
 
5.12a Titration against Bovine Serum Albumin Negative Control 
Concentration range was selected to be similar to those of target titration, with the highest 
concentration being double the highest target concentration investigated.  
 
Fig 5.19 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
BSA negative control titration vs Ag/AgCl 
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Analysis of the data shows no clear correlation between peak current and concentration of BSA control. 
This would support the conclusion that there is no comparable affinity between the sensing molecule 
and BSA under these conditions.  
No discernible signal was detected on this control at all, which would indicate that there is very little (if 
any) non-specific binding of at least the GNPs end of the aptamers to BSA. This is very desirable as 
albumin is the primary protein component of serum [165] (typically forming half of blood protein mass 
in a healthy human, the vast majority of the remaining being globulins). From a real world perspective, 
any practical application of a thrombin sensor will almost certainly be in a biomedical context, with the 
environmental matrix being composed of blood plasma, which is the medium of activity for the 
coagulation cascade.  
Serum albumin concentration in blood varies from person to person, potentially with very significant 
outliers as a result of illness, but 34 to 54 mg/ml is considered typical. 54 mg translate to 818 uM, which 
makes the 1uM result particularly significant.  
  
5.12b Titration against Lysozyme Negative Control 
Concentration range was selected to be similar to those of target titration, with the highest 
concentration be double the highest target concentration investigated.  
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Fig 5.20 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
lysozyme negative control titration vs Ag/AgCl 
 
Analysis of the data shows no clear peak in the current response as a result of a titration of lysozyme 
control. This would support the conclusion that there is no comparable affinity between the sensing 
molecule and lysozyme under these conditions.  
The contrast between the voltammetric responses in the presence of thrombin and those in the 
presence of albumin and lysozyme supports the lack of non-specific binding. 
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This result is supported by the results of the DAELAB assay, which display a very low signal response as a 
result of target concentration, indicating that adsorption is insufficiently strong for the thrombin to 
adhere to the electrode through the wash process. In the case of DAELAB it is almost certain that it is 
the electrode-target interaction has failed (rather than the target-GNPs component, which would be 
identical to those used in the IAELAB, which displays clearly defined signals). Here the failure could have 
occurred at either of these points, with the same empirical result of reduced signal response. 
 
5.13 A Comparison of Sandwich Aptamer Biosensor and Conformation Change Aptamer (CCA) 
The two sensing modes described in this thesis are quite different. And table 5.01 summarizes these 
differences.  
Factors affecting sensor 
performance 
Conformation Change 
Aptamer (CCA) IAELAB 
Signal to baseline ratio Low High 
Effect of electrode quality 
Highly dependent on 
smoothness and cleanness of 
electrode surface 
Can work with lower 
quality/less smooth 
electrodes such as SPE 
Assay complexity 
Low after initial sensor 
electrode preparation Complex, multi-step assay. 
Ease of automation Easy Relatively more difficult 
Potential for miniaturization Simple More difficult 
Potential for expansion to 
other targets 
Simple, wide range of 
potential targets 
Potentially limited to large 
targets with multiple binding 
sites.  
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Table 5.02 A comparison of DAELAB sandwich aptamer biosensor to Conformation Change Aptamer 
biosensor discussed in chapter 3 
 
Perhaps the greatest weakness of the sensor discussed in this chapter is its lack of potential for future 
development. The IAELAB design takes advantage of the extensive knowledge available regarding 
target-aptamers both the 15 bp long Bock et al TBA aptamer [149] and the 29 bp long HD22 Tasset et al 
[150] aptamer, as well as the fact that both aptamer do not compete for the same binding site or 
otherwise obstruct the binding of the other aptamer. This degree of knowledge is uncommon for most 
aptamers, making it hard to extend this design philosophy to other targets, where two aptamers capable 
of binding to the potential target may not exist at all, let alone possess already studied target bound 
structures.  
The need for two aptamer binding sites on the target also makes it unlikely this design philosophy could 
be used for the sensing of small molecular targets, which would limit the realistic potential targets for 
this sensing philosophy to relatively large molecules such as globular proteins. 
These factors are in contrast to the CCA which could be expanded onto other potential targets, including 
low MW targets or targets with highly repetitive subunits, with relative ease. Indeed the third chapter 
chapter of this study has already shown that this mode of sensing could be expanded onto two different 
targets. 
The IAELAB system is also more complex compared to CCA, requiring both more reagents and more 
human hours per operation, and therefore increased cost of assay. In particular CCA requires minimal 
skill to operate after successful fabrication of the sensor device (so simple in fact that the previous 
chapter has shown that target sensing operation could be performed using a minimally modified 3 axis 
robot). IAELAB on the other hand require extensive human interaction even after sensor assembly. This 
can prove to be significant problem should the device be expanded to a commercial production, since 
operating the sensor will require technical skill on the user end. This could make the device less 
applicable in LEDCs due to shortage of human resources, and increases the cost of operation to some 
extent in both LEDCs and MEDCs. 
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On the other hand the IAELAB has a number of significant advantages of over the CCA mode of sensing. 
Compared to CCA, IAELAB’s signal to noise ratio is relatively high, with the buffer signals being uniformly 
low or undetectable compared to its target bound states. This is most likely because the CCA’s redox 
label is tethered to the electrode surface, and thus spatial relocation of the redox label is at most equal 
to the length of the aptamer molecule. In IAELAB, unbound biosensor molecule is completely removed 
from the system by the wash, resulting in decreased noise.  
This also makes the IAELAB sensor less sensitive to badly polished or less smooth electrode surfaces. 
Smooth and chemically cleaned electrode surfaces on the other hand are essential for the successful 
application of CCA. Reduced sensitivity to electrode surface quality could facilitate the scaling up of 
IAELAB based sensing method, since methods of mass producing electrodes (such as screen printing) 
could be used. 
Signal amplitude in general for IAELAB is also significantly higher than those of CCA, which would 
indicate a greater redox label load than those of CCA. Maximum peak amplitudes for IAELAB (average 
1uA, max of 1.18, min of 0.9) is typically over an order of magnitude higher than those of CCA (average 
of 54 nA, max of 84nA, min of 23nA). This could be a significant advantage in environments where there 
is a significant amount of redox noise. 
 
5.14 Concluding Remarks 
In this section of the study, it is shown that the sandwich aptamer biosensor (IAELAB) format can be 
used to detect thrombin target at a concentration within the nanomolar range. It is also possible that 
the direct adsorption (DAELAB) mode of sensing could detect thrombin target at a higher (at least 
micromolar) range, though this could not be determined with the resources available to this study. 
The sensor showed high specificity to its target, showing no significant response to other globular 
proteins, including both BSA (highly ubiquitous in target environment) and lysozyme (positively charged 
and therefore a good representative of a worst case scenario for non-specific false positive results). 
Sensor Setup Format Ligand Molecule Detection Limit 
DAELAB DAELAB Thrombin (1uM)* 
IAELAB IAELAB Thrombin 15nM 
Label-Free Control IAELAB Thrombin No Signal 
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Albumin Negative Control IAELAB Albumin No Signal 
Lysozyme Negative Control IAELAB Lysozyme No Signal 
*Signal present in 30% of electrode variations only 
Table 5.03 Summary of Results for Aptamer Biosensor based on GNP 
Future works could take one of two directions. The first would be to test the sensor in its most likely 
target environment (simulated by animal serum perhaps). The second would be to automate the 
IAELAB, which should reduce the effect of one of its greatest weaknesses (human hour needed for 
operation).  
Automation of IAELAB would without doubt be more difficult than those of CCA, but should still be 
relatively easy. The wash steps could be implemented using a peristaltic pump similar to those discussed 
in the LHS section of Chapter 6 (see 212), and the drying could be performed through the 
implementation of a valve actuator controlled nitrogen source.  
However the ability to generate aptamer pairs is still the major limitation in the more general use of 
IAELAB. Until a method becomes available that can reliably produce such aptamer pairs it is likely to 
remain a niche format. 
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Chapter 6: Automated SELEX Device (ASD) 
6.01 Introduction 
This part of the thesis describes an attempt to design and fabricate an automated mesofluidic flow 
device to perform Systematic Evolution of Ligands by Exponential Enrichment (SELEX), the process 
commonly used for the isolation of aptamers sequences [21][22].  
In Chapter 1 it was discussed that automation could be of great benefit in increasing throughput, 
decreasing cycle time and reducing human time and financial expense of the SELEX process. Based on a 
literature review of automated SELEX devices it is also possible to conclude that at present automation 
of the SELEX process generally takes one of two design directions, one of which is mimicking human 
action with an automatic sampler [70], the other uses microfluidic based systems [72]. The inherent 
advantages and disadvantages of both systems were discussed and evaluated in the introduction and it 
was concluded that there may be some potential benefit in attempting to create an automated SELEX 
device based on mesofluidic channels. It is hoped that by increasing the scale of microfluidic channels 
from a micrometer to millimeter scale, it would be possible to gain the primary advantages of the large 
volume SELEX (large library and sequence variation), while also retaining the primary advantages of 
microfluidic SELEX (reduced contamination risk, low initial cost and maintenance). 
Numerous configurations of SELEX devices have been studied, however all Automated SELEX Devices 
(ASD) share a number of common components that perform the following operations: 
1) Liquid handling 
2) Flow Rate Control  
3) Temperature Control  
4) Partition and Separation  
Under suitable software control. 
Liquid handling and flow rate control determine the movement of liquid to the correct reaction 
chambers. This is typically either a pipette actuator and 3 axis robot in a conventional (auto-sampler 
based) SELEX device or a pump and solenoid valve manifold in a fluidic SELEX device.  
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Temperature control is primarily required for thermal cycling for the PCR amplification, and is typically 
implemented using a simple thermostat. Temperature is also frequently used for the dissociation of 
bound DNA from target.  
Partition and separation system is involved in the removal of low affinity sequences from the target 
bound library, and subsequent separation of target bound from unbound sequences. The design of 
these system is by far the most diverse, since target properties play a significant role in determining 
partition and separation protocols.  
In addition to these components, an important aspect in the design of any ASD is the electronics 
hardware and software which power and control the ASD. 
Contamination and the control thereof is one of the central aspects of automated molecular biology 
process system design. As such contamination control is considered one of the key considerations in 
device design, despite not being a direct part of the SELEX process. 
These components could be implemented in a diverse variety of ways. How they are implemented 
would necessarily depend on the overall format of the automated SELEX device which will be discussed 
in the following section. 
 
6.02 Operational Protocol 
The essential design of the Automated SELEX Device (ASD) is based on a manual SELEX protocol which 
has been successfully and widely employed in the past by many research groups to isolate aptamers 
[64][71]. The automated protocol is analogous to the manual one, with the central difference being that 
a flow type liquid handling robot is used to perform the tasks typically carried out using a manual 
pipette.  
Initially most cases of SELEX were performed using the original protocol of [21][22], where the retention 
of the target-nucleic acid complex is by filter binding or affinity chromatography. In the work described 
here a protocol using target molecule covalently bonded to magnetic nanoparticles (MNP) is used 
instead, since it is much easier to implement MNP based separations by automation. Several groups 
have successfully used SELEX protocols with an MNP based partitioning step [55][56][57].  
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A comparison between a typical Manual SELEX protocol and the automated SELEX protocol used in this 
thesis are as follows:  
  Manual SELEX Protocol Automated SELEX Protocol 
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Library is heated at 90°C for 2 minutes within 
a thin wall eppendorf tube on a heating block, 
then allowed to cool for 10 min. 
DNA is fed into the PCR chamber and heated 
to 90°C for 2 min, and then allowed to cool for 
10 min. 
A
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 Target bound MNP suspension in buffer is 
placed in a reaction vessel. Denatured DNA 
solution is then added to the target-MNP 
solution and incubated for 2 hours. Solution 
may be agitated manually by Gilson’s pipette.  
Target bound MNP suspension is pumped 
gently into the Affinity Selection chamber (AS 
chamber), and MNP deposition is achieved by 
turning the electromagnet on, after which 
liquid is pumped forwards and backwards 
over a short distance (this will be referred to 
as “shaking”) several times to ensure as much 
MNP is retained as possible. Denatured DNA 
in the PCR chamber is pumped into the 
affinity selection chamber, after which the 
MNP is released by turning the electromagnet 
off, followed by “shaking”. Solution is left to 
incubate with the DNA library for 2 hours. 
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After incubation a magnet is placed at the 
bottom of eppendorf, resulting in deposition 
of DNA-Target-MNP at the bottom of the 
eppendorf. Supernatant is pipetted out, and a 
fresh buffer is added, MNP is resuspended 
and the solution is heated at 90°C for 2 min. 
MNP is deposited using magnet. Solution 
containing DNA is pipetted out and retained. 
Magnet is switched on, and the MNP 
deposited out of solution. AS chamber is then 
washed with buffer, after which the AS 
chamber is filled with PCR mastermix. MNP is 
resuspended, after which the solution is 
heated at 90°C for 2 min to release target 
bound DNA. MNP is then redeposited, and the 
Selected-DNA/Mastermix Solution is pumped 
into the PCR chamber.  
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 The enriched library is added to PCR 
mastermix. Solution is divided into thin walled 
PCR tubes and placed into a thermocycler. 
PCR is carried out in PCR chamber containing 
selected DNA template and mastermix. 
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 After PCR is completed, PCR product is pooled 
and streptavidin coated MNP is added. 
Solution is left to incubate for 1 hour. Solution 
is then heated at 90°C for 2 min. A magnet is 
then used to deposit MNP, and the solution is 
extracted for post processing. 
After PCR is completed, the reaction mixture 
is pumped to the affinity selection chamber 
containing streptavidin coated MNP, and left 
to incubate for 1 hour. Solution is then heated 
at 90°C for 2 min. MNP is then deposited, and 
the solution could be either pumped forward 
for post processing or alternately backwards 
to the PCR chamber so that affinity selection 
chamber could be refreshed with new Target-
MNP, and allow another round of SELEX to 
take place. 
 
Table 6.01 Comparison between Manual SELEX protocol and Automated SELEX protocol 
 
The sequences resulting from the SELEX process should be a pool of relatively more homogenous than 
the initial selection library, and with greater affinity to target molecule. 
The post processing protocol is shared by both the automated and manual PCR procedures. The 
amplified sequences undergo phenol chloroform extraction followed by ethanol precipitation. This 
yields purified DNA. Some of this is either used in the following round of SELEX or retained as a stock 
sample, either for reference purposes in case of further analysis (such as by ELONA, Gel electrophoresis 
or UV/Vis spectrophotometry) or as fallback stock in case of contamination or general decrease in 
affinity in subsequent rounds. 
In order achieve the above automated protocol, the actions steps needed are as follows (absolute 
essential steps are shown only, optimization is excluded): 
 
 
Diagram labels 
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Red represents active solenoid valves or heating elements 
Pink represents position of Target-MNP  
Orange represents position of unenriched streptavidin-MNP 
Dark Blue represents location of original DNA library 
Yellow reperesents Selected DNA sequence without master mix 
Green represents Mastermix containing Selected DNA template 
 
Starting State: For the starting state, the device is purged with one or more solutions as a means of cleaning the flow tubes and 
reaction vessels of potential contaminants, followed by thorough wash with sterile buffer. 
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Denaturation: DNA library valve open, pump forward, DNA library valve close, Buffer valve open, pump forward, Buffer valve 
close, heat to 90°C 2 min, wait 10min 
A comparatively small quantity of DNA library is pumped into the system. This creates a segment of tube containing DNA library 
flanked with buffer solution called a “plug”. A volume of buffer is pumped, pushing the plug of DNA library into the PCR 
chamber. 
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Affinity Selection: Target Enriched MNP valve open, magnet on, pump forward, Target Enriched MNP valve close, Buffer (2nd 
Manifold) valve open, pump forward, Buffer (2nd Manifold) valve close, Magnet on, “shaking”,  
A plug of Target-MNP is pumped into the system. A volume of buffer is pumped, pushing the plug of DNA library into the PCR 
chamber. Magnet is then turned on and the MNP solution deposited to affinity chamber wall. 
Buffer valve open, pump forward, Buffer valve close, magnet off, “shaking”, wait 120 min 
DNA library plug is driven into the affinity selection chamber. MNP is then resuspended in the DNA library solution. Solution is 
incubated for 120 min. 
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Post Selection Extraction: Magnet on, “shaking”, Buffer valve open, pump forward, Buffer valve close,  
Aptamer-Target-MNP particles deposited onto affinity selection chamber wall, wash removes any unadsorbed DNA library. 
Mastermix valve open, pump forward, Mastermix valve close, Buffer valve open, pump forward, Buffer valve close, “shaking” , 
magnet off, Heat on 90°C 2 min, magnet on, “shaking”, reverse flow valve open, pump reverse, reverse flow valve close, 
PCR mastermix minus template is driven affinity selection chamber as a plug. Aptamer-Target-MNP is resuspended in mastermix 
solution. High affinity sequence is driven into mastermix by heat, MNP is redeposited, master mix containing selected template 
is driven into PCR chamber by reverse flow. 
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PCR: Heat on 90°C 2 min, Repeat X cycles [Heat on 90°C 30s, heat on 57°C 30s, heat on 72°C 30s] 
PCR thermal cycle operation, no final extension as sequence fairly short/avoid non-specific long sequence 
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ssDNA separation: Fresh MNP valve open, pump forward, fresh MNP valve close, Magnet on, Buffer (2nd Manifold) valve open, 
pump forward, Buffer (2nd Manifold) valve close 
Fresh MNP plug is driven into affinity selection chamber (buffer for this operation comes from 2nd manifold buffer feed). 
Buffer valve open, forward pump, buffer valve close, magnet off, “shaking”, wait 60 min, heat on (affinity chamber) 90°C 2 min, 
magnet on, “shaking" 
Amplified solution driven to affinity selection chamber. Fresh MNP resuspended and incubated for 60 min. DNA sequences not 
covalently bonded to MNP resuspended by heat, MNP redeposited. 
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Fig 6.01 Photograph shows arrangement of the components of this protocol on a late model ASD, below 
is a simplified diagrammatic representation of the device photographed. 
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If process is immediately followed by another round of selection: 
Reverse flow valve open, pump reverse, reverse flow valve close, target-MNP valve open, pump 
forward, target-MNP valve close. 
If process is followed by post processing, solution is collected from drain: 
Buffer valve open, pump forward, buffer valve close. 
 
 “Shaking” is a multiple step process involving a short forward pulse followed by a short reverse pulse: 
Repeat X times [Buffer valve open, pump forward (short), buffer valve close, reverse flow valve open, 
pump reverse (short), reverse flow valve close]  
 
The automated protocol described above is a very broad overview of the process. Optimization and 
other essential tweaking during development has resulted in a relatively complex final Gcode protocol 
with several hundred actions steps (the majority of it essential optimization steps such as “shaking”), the 
full version of which would be impractical to describe here. Examples and description of the action steps 
which form the building block of the final Gcode script can be found in the software section of this 
chapter (see page 235). 
Having proposed a basic operational outline for the SELEX device, it is now possible to determine the 
optimal configuration in which the SELEX automation components discussed in the previous section 
could be implemented. Since these systems (other than the software and electronics control 
components) operate in a largely modular nature, the design and development of these components 
would be discussed below separately. 
  
205 
 
6.03 Temperature Control and the design of PCR protocol 
SELEX is comprised of repeated cycles of selection and amplification. Since in conventional SELEX 
amplification is achieved by PCR (a thermal cycling process), it follows that any SELEX device must have 
accurate temperature control.  
Temperature was also used in the final model of the ASD as a means of separating affinity selected 
aptamers from Target-MNP, and also (after second strand synthesis and PCR with a biotinylated reverse 
primer) in removing the biotinylated ssDNA strand prior to another round of selection. 
 
6.03a Model 2 Temperature Control System (TCS) 
While some success was achieved using heating block based Temperature Control System (TCS) (based 
on the extruders of 3D printers), practical test showed that these earlier models were incapable of 
sufficiently rapid heating.  
In the final design of the TCS, a concentric thin walled aluminium pipe (4.2 mm ID, 5.8 mm OD, 140mm 
long) was used as the heating element around the glass tube of the PCR and AS chamber. This minimizes 
the mass that needs to be cooled and heated while maximising surface of area of contact with the flow 
tube, thus optimizing both heating and cooling times.  
A feedback thermistor is placed into a 1mm x 2mm, 0.6mm deep trench cut into the pipe surface made 
using a CNC milling machine. Thermal paste was applied to fill this trench, in which a Murata Electronics 
NXFT15XH103FA2B100 [166] thermistor was embedded. The entire aluminum pipe was covered with 
adhesive PTFE tape to provide electrical insulation from the nichrome heating tape. This reduces the 
rate of heat transfer, but is essential in order to prevent short circuit. 
The heating element is a nichrome tape, 5mm wide which is twisted around the PTFE coated aluminum 
pipe, with an even gap of approximately 8mm between turns. A tag was left at each end of the nicrome 
wire where contact with the circuit wire could be made. The heating tube is then wrapped in another 
layer of PTFE tape to provide thermal insulation, as well as to reduce the danger of contact. Special care 
is taken to prevent nichrome wire coming into contact with any element of the thermistor’s leads, and 
that a gap is made in the outer PTFE sheath to enable access to the thermistor leads.  
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In later production runs, rigid metal wire was tightly wound around intervals of the heating element to 
prevent PTFE tape splitting as a result of heat expansion. 
 
Fig 6.02 A Model 2 TCS 
 
6.03b PID Controller 
Although the 3D printer thermal head was not suitable as a heat source, as described at the start of this 
section, its control firmware, Sprinter, was integrated with a third party open source PID software which 
had been developed by B Beauregard [167] in an unmodified state as a custom library. This PID software 
was selected due to its stability, good temperature response and ease of integration into a preexisting 
Arduino firmware. It is also one of the most commonly used PID libraries developed for the Arduino 
system, and is thus well known among the 3rd party community, making the system both well tested and 
documented.  
Another essential improvement imported from previous models was the addition of a fan in order to 
reduce the cooling time. This fan is powered directly from the main power supply, and left in an always 
on state.  
 
6.03c Feedback Control Mechanism 
Heat sensing for signal feedback is similar to that used in 3D printers, and utilizes a pull-up/pull-down 
resistor couple, with the pull down resistor being a thermistor. Temperature is calculated by the voltage 
at an analogue pin (Vout) compared to reference data. For this system, Vout can be represented with 
this equation: 
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𝑉𝑜𝑢𝑡 = 𝑉𝑐𝑐 (
𝑅𝑇ℎ𝑒𝑟𝑚𝑖𝑠𝑡𝑜𝑟
𝑅𝑇ℎ𝑒𝑟𝑚𝑖𝑠𝑡𝑜𝑟 + 𝑅2
) 
R2 being the resistance of the fixed value resistor coupled with the thermistor.  
Eq 6.01 Determining the value of voltage at analogue pin  
 
Since R1 is kept at a constant (10kOhm), the only variable governing Vout is the resistance of the 
thermistor, which in turn is governed by the environment temperature. 
Temperature is determined by the PID program by comparing of the feedback signal at the analogue pin 
to a database of known signal response to temperature, and using it to extrapolating an estimate of the 
temperature of the heating tube. Since the data points of the database is 1 degrees wide, the resolution 
of the temperature sensor can be assumed to be 1 degree wide at most.  
The feedback signal at the analogue pin is used by the PID controller to determine the difference 
between the set temperature and the actual temperature, which in turn allows it to generate a response 
in order to bring the temperature back to target. The overall schematic of feedback regulation could be 
found in fig 6.03 below. 
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Fig 6.03 Summarised scheme of feedback temperature regulation.  
 
6.03d Results of Model 2 TCS 
Heating unit was able to achieve all 3 key PCR temperatures, and could maintain the temperatures once 
target is reached with reasonable stability.  
The heating unit was able to perform the correct thermal cycling profile required by the PCR conditions, 
in terms both of the speed of temperature change and the stability of the temperature once attained. 
This is illustrated in fig 6.04 below. 
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Fig 6.04 Heating profile of the final model TCS (18 coils). 
All temperatures could be definitively reached within 25s of initial heating, faster than original target 
design specification of 45s. This is considered acceptable, and is comparable to the specifications of 
commercial PCR machines [168].  
The temperature control was resistant to changes in ambient thermal fluctuations. 
 
6.03e Aspects of PCR 
Originally the PCR temperature targe was 60s at 90°C, 60s at 54°C and 60s at 72°C, for 40 cycles. During 
initial testing it was determined that the results of this protocol yielded a significant number of non-
specific bands larger than the template.  
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Fig 6.05 Gel Electrophoresis of products of original PCR protocol  
These sequences are generally caused by non-specific binding of primer regions to the N30 sequences. 
TaqPol is not sequence specific, thus hybrid formed of two non-specific binders sharing complementary 
sequence will result in the extension and eventual conjugation of the couple into a single long sequence. 
This sequence will contain primer binding sites, and thus is capable of reproduction in the process of 
PCR. Since non-specific binders generally has less affinity than primer to its complementary sequence, 
increasing stringency could be said to be a good method of decreasing non-specific amplicons. Potential 
areas of improvement, both avoidable and unavoidable, as well as action taken are listed below: 
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Causes Reason Countermeasure 
Too much 
template 
High concentration of initial 
template results in higher chance 
of template hybridisation.  
This cannot be avoided in sequential SELEX, as 
there would be no way to investigate template 
concentration and remove template 
concentration between rounds of automated 
SELEX. 
Too many PCR 
Cycles 
Excess PCR cycles provide 
opportunity for non-specific 
amplification. Primers generally 
used up in earlier cycles. 
Reduced initially planned 40 cycles down to 22 
(number reached by trial and error) 
Extension time 
too long 
Enables non-specific 
amplification. Less an issue in this 
case due to shortness of 
sequence. 
Extension time reduced from 60s to 30s. May not 
be applicable here due to shortness of aptamer 
sequence. 
Annealing 
time too long 
Increase chance of non-specific 
annealing. Annealing time reduced from 60s to 30s.  
Annealing 
temperature 
too low 
Increase chance of low affinity 
non-specific binders.  
Primer have theoretical Tm of 59°C. Thus 
temperature was raised to 57°C during annealing 
phase of PCR.  
Thermal cycler 
heat increase 
too slow 
Same as above. Creates period of 
low temperature during ramping. 
Optimization of temperature control system from 
a previous block format into tube format 
described in this chapter. 
 
Table 6.02 Causes of large non-specific amplicons, and measures taken to prevent their formation 
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Implemented PCR improvement countermeasures resulted in a significant decrease in non-specific 
bands (results can be seen below). Reduction in template extension time may have resulted in a small 
amount of noticeable short sequence smear located below the desired sequence band. This is not 
considered a major problem, since lacking a primer binding site complement the sequence would simply 
not be amplified in the next SELEX run and is therefore not a long term problem. The single distinct thin 
band represents the exponentially amplified target sequence and is the typical products of successful 
PCR.  
 
Fig 6.06 Gel Electrophoresis of products of new PCR protocol Left to Right Well 1) DNA Ladder Well 2) 
PCR products from pilot PCR runs using new protocol 
6.04 Liquid Handling System (LHS) 
The liquid handling system, together with the flow rate control system, ensure the correct reagent is 
transported to the correct location at the correct time. The liquid handling system also covers the flow 
channel design aspect of this study. 
 
6.04a Solenoid Valves 
Solenoid valves are ubiquitous electromechanical devices commonly used as control components in 
many fluidic applications. Multiple solenoid valves are frequently arrayed in a manifold in order to 
regulate flow between pumps and actuators. Different combinations of open/closed states of these 
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valves allow for complex fluid regulation behavior to be controlled electronically. Solenoid valves are 
generally considered to have fast response, long operational lifespan, and high reliability. Flow direction 
and rate is controlled by the motor pump, which will be described in the next section of this chapter. 
The most common type of hydraulic solenoid valves are composed of a solenoid coil, a plunger and a 
counter spring. The plunger is very commonly encased in a plunger tube, and closed on the liquid end 
with a heat and chemically resistant rubber seal. This assembly sits on top of a chamber, directly atop of 
the source and drain port. In an NC resting state solenoid valve, the compression spring pushes down 
the plunger into a (closed) position in the absence of power to the electromagnetic coil. This results in 
the source and drain ports being disconnected. Application of power to the electromagnetic coil results 
in the magnetic force overcoming the compression spring, resulting in the plunger being pulled up. This 
creates a flow chamber which connects the source and drain port, enabling flow. Solenoid valve selected 
was a Roundstar RSC-2 RO, specifications for which can be found here [169]. 
 
 
Fig 6.07 This diagram shows the operation mechanism of a typical NC Solenoid Valve. Left) a solenoid 
valve in the closed “off” state, Center) a solenoid valve in the open “on” state, Right) a photograph of a 
disassembled solenoid valve.  
 
6.04b Design of Solenoid Valve Manifold 
It was decided that the primary material for manifold (including all parts in contact with liquid flow) 
should be made out of PTFE. PTFE is known to have excellent resistance to both thermal and chemical 
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stress, as well as being a relatively non-adsorptive material. PEEK was also considered as a manifold 
material [170].  
Ideally the manifold would be composed of solenoid valve flow chambers placed above a single long 
flow tube drilled through the manifold. However this proved impossible to implement, since it was 
impossible with the resources available to drill a straight 300mm long channel though a block of PTFE, 
with a uniform diameter of 2mm. The friction on drill bit overcomes the grip of the chuck on the bit 
typically within 10cm of drilling, preventing further drilling. It was also noticed that, due to elasticity of 
PTFE, there is significant twisting of the drill bit which results in noticeable increase in drilled chamber 
diameter after 5cm.  
In practice the manifold was composed of two PTFE blocks, the top blocking containing the solenoid 
valve chambers and a drain connected to vents leading down to the second block. The second block 
contains only the single long channel, surrounded by a 1 mm wall surrounded in turn by a 2mm groove. 
An EPDM Rubber O ring is pressured into this groove, and acts as sealant when the two parts are 
compressed when the manifold is assembled, producing an object analogous to a single block containing 
a single straight 2mm channel. On the primary manifold, the solenoid valve chamber located at the 
opposite end to the drain is aligned in a reverse direction (with the chamber’s source connected to the 
long flow channel and the drain leading away from the manifold) and acts as a reverse drain.  
 
Fig 6.08 Part 1 (top) of solenoid valve manifold, containing vents and solenoid valve chambers. 
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Fig 6.09 Part 2 (bottom) of solenoid valve manifold, 2mm flow channel and O-ring groove. 
 
It should be noted that PTFE proved to be an exceptionally difficult material to machine, since it is soft 
and elastic enough to not be abraded easily by a tool bit. This makes the creation of precise machine 
parts out of PTFE difficult, since the plastic deforms and flakes on contact with tool bit, rather than being 
abraded. Nevertheless all requisite PTFE parts were successfully fabricated after extensive optimization, 
primarily by CNC milling. Some design compromises which should minimally affect performance was 
also undertaken to allow replicate parts to be fabricated reproducibly within realistic time frames (for 
example the wall separating the 2mm flow channel from the groove, a particularly difficult part to 
machine, was expanded from 0.5mm in the original design to 1mm in width). 
 
Fig 6.10 The primary solenoid valve manifold in fully assembled state. 
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6.04c Overview of important considerations in the design of solenoid valves and flow tubes 
It should always be remembered that the flow system is a means of transportation, either of reactants 
into reaction vessels or of waste materials to drain. While an enclosed flow system is isolated from 
outside contamination, some mixing can occur as a result of simple diffusion at the boundaries between 
two solutions at the flow tubes. This is not a major concern for wash solutions and buffers, which are 
cheap and employed in large volumes. However, DNA solutions and PCR mixes must be fed as solution 
segments pushed by buffer or other solutions (plugs) for reasons of economy. In operational terms this 
generally means a relatively short segment of fluid flanked on either end by a buffer solution. The plugs 
envisioned for this SELEX device will be approximately 500 ul in volume, which equates to 79.58 mm3 of 
volume per mm2 of diffusional interface with a 2mm inner diameter tube. Thus the degree of diffusional 
mixing of the system at a static state, or even during movement along a smooth tube, should be 
relatively insignificant. The absence of significant (>2mm) expansion of the solution boundaries 
observed during long static phases of device operation (the 2 hour long affinity selection for example) 
would support this conclusion. 
In theory the degree of mixing taking place in the flow system could be predicted using the Reynold’s 
number [171]. The Reynolds number is a dimensionless quantity used to categorize of whether a fluid 
flow will in a laminar or turbulent. A Reynold’s number of <2000 is typically considered laminar, and 
>2000 is generally considered turbulent. Reynold’s number can be defined as the ratio of the inertial 
force to viscous force, and can be represented using the following equation: 
 
𝑅𝑒𝑦𝑛𝑜𝑙𝑑′𝑠 𝑛𝑢𝑚𝑏𝑒𝑟 =
𝑝𝑉𝐷
𝑢
 
Eq 6.02 Definition of Reynold’s number 
D being Hydraulic diameter (m) 
V being flow rate (m/s) 
p being fluid density (kg/m3) 
u being viscosity of the fluid (kg/ms) 
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The Reynold’s number of this flow system (2mm diameter tube, with the liquid assumed to have a 
property similar to water at 25°C) is 13.4 at slowest movement (6.7mm/s, F300 in Gcode) and 53.6 at 
fastest movement (26.7mm/s, F1200 in Gcode), which would predict very little turbulent mixing 
between fluid boundaries.  
However the above analysis assumes a smooth cross section across the entire flow channel. Any 
disruption in the tubing, particularly changes in tube cross sectional area or other spatial 
rearrangements would result in a change in hydraulic diameter, and therefore increased mixing as a 
result of turbulence. The cumulative effect of these changes could be significant. In order to reduce 
dimensional change at tube-manifold and tube-block interfaces, pneumatic tube fittings are used. The 
stainless steel pneumatic fittings were purchased from SMC USA, series KQG2, product code KQG2S04-
M5. The datasheet for this item can be found here [172]. This pneumatic connector design has the 
benefit of positive sealing under pressure and simple one push connection and disconnections which 
allow for faster maintenance and assembly. Internal diameter is 2 mm which is ideal for our application. 
This series of connectors is chemically resistant to most disinfectants, and resistant to autoclave 
temperatures. 
Other potential area of turbulence include the motor pump (assuming it is of peristaltic pump design) 
and solenoid valve. The solenoid valve is of particular concern, as the liquid will need to pass through a 
flow chamber of 12mm diameter, which will significantly deform solution boundaries. However the 
majority of the solenoid valves on the manifold do not cause turbulence mixing of solution, since they 
are utilized to regulate flow from reagent source containers, and hence handle only one type of 
solution.  
The implementation of air gaps at plug to buffer boundaries was also considered as a means of 
preventing mixing. This could have been implemented by the replacement of the liquid solenoid valve 
nearest the output of the manifold with a gas solenoid valve. As the boundary of a newly added plug is 
pumped pass the location of the output vent of the gas solenoid valve, gas injection could take place 
enabling the isolation of the plug from the buffer liquid. This was not implemented as the boundary 
distortion was already considered acceptable (see results below) without separation by gas segments. 
Gas solenoid valves are structurally different from liquid solenoid valves, and therefore the 
implementation of a gas solenoid valve would have required significant modification of the PTFE 
manifold. Gas solenoid valve design that utilize electromagnetically controlled tilting plungers and 
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sliding rods would also have been significantly more difficult to fabricate, and would have required the 
use of a 4 axis CNC milling device. Another potential concern is that the gas plug may compress and 
expand as a response to pump pressure, reducing the accuracy of liquid handling.  
 
6.04d Liquid Handling Model 4 (LHM4): 
In the earliest phases of liquid handling design it was assumed that any pump used in this device would 
likely be mono-directional. Therefore due to the cyclical nature of the SELEX process it is essential, under 
such an assumption, that a flowback system is implemented to enable the return of PCR product back to 
the affinity selection chamber. In the absence of reverse flow capable pump, a flowback loop is 
implemented. After the process of PCR, the second solenoid valve manifold switches from drain to loop, 
allowing the solution in the PCR chamber to return to the affinity selection chamber. 
  
 
 
 
 
Fig 6.11 An early Liquid Handling Model (LHM1) operation showing effect of switching output of 2nd 
manifold on flow, which shifts from an source to drain flow system to a cyclic flow system.  
From a liquid handling perspective, the most beneficial property of the WPM-e pump (this peristaltic 
pump will be discussed in the next section) is its ability to operate in both directions. By reversing flow, 
it is possible to transport amplified product from the PCR chamber back into the affinity selection 
chamber. This eliminates the necessity of a loop tube, and more relevantly the solution boundary 
deforming solenoid valve that controls it. Since the loop tube is no longer necessary, it is also no longer 
necessary for the peristaltic pump to be located between the manifold and the loop tube/drain junction. 
It is therefore possible for the peristaltic pump to be located between the last component of the flow 
system and the drain. This prevents deformation of solution interfaces of either the DNA library or PCR 
mix plugs, since neither of these solutions in this new setup has to pass through the peristaltic pump. 
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This enables the entire length of the flow channel after the (single solution) solenoid valve feed to have 
a bore diameter of 2mm, which should minimize mixing through turbulence and allow flow boundaries 
to be maintained. 
Thus the loop solenoid valve in the old model is removed in LHM4, and a new solenoid valve is placed at 
the end of the block, and acts as a second drain while the peristaltic pump is operating to reverse the 
flow. In practice the loop manifold is replaced by a second manifold to take advantage of the reverse 
flow system in enabling a more direct feed to the affinity selection chamber. A reservoir tube is also 
added after the forward drain solenoid valve, to supply fluid to the system while the pump is acting in 
reverse. In practice the only type of solution in the reservoir tube which reenters the system is buffer as 
every step requiring reverse flow is preceded immediately by a buffer wash step. 
For more details on the operational aspects of LHM4, please see the previously discussed protocol 
section (see page 194) and the device operation section (see page 241) of this chapter. 
 
6.04e Liquid Handling Results 
A simulated SELEX round was performed on the ASD, with the reagents being replaced by coloured dyes.  
Correct liquid handling was determined by observation of liquid volume in the source reservoirs. A 
decrease in the correct source reservoir during the simulated steps, and absence of volume change in 
other reservoirs, indicates correct liquid handling has been successfully achieved. This, combined with 
weight measurement of the expelled liquid, which will be discussed in the next section of this chapter, 
enables us to determine that the correct volume of the correct liquid is being handled.  
Boundary distortion were never successfully eliminated, and indeed this might not be realistically 
possible for mesofluidic systems flow tubes with an ID as large as 2mm. The final model of the SELEX 
device reduced distortions at boundaries to at most 4cm, which should be acceptable so long as this 
distortion is taken into consideration in the operational protocols. Assuming each distortion boundary 
extends equally on both sides of a liquid-liquid interface, this means 2cm of a reagent plug would be 
deformed, resulting in a loss of 62.8ul of reagent (3.142mm2 cross sectional area, 20mm section length). 
This equals to 125.7 ul of reagent loss per plug (two liquid-liquid buffer boundaries). Since plugs for DNA 
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library and PCR master mix are planned to be 15.2 cm long, this would equate to a loss of approximately 
26.3%. 
Visual observation of dye section movements through the flow channel also indicates that reagent plugs 
have been successfully formed. Dye molecular weight is significantly lower than those of either template 
or primers (by at least 1 order of magnitude in both cases) so effect of diffusion should be more 
pronounced in this simulation than with actual components of PCR. Free nucleotides utilized in PCR is of 
similar weight to the dyes, but is used in excess concentration during PCR, and therefore their loss can 
be considered less significant than the loss of primers and library sequences. 
 
6.05 Flow Rate Control System 
6.05a Peristaltic Pumps 
A number of liquid handling pumps were considered, both made in house and commercially available. 
Peristaltic pumps were considered the most suitable class of pump for liquid transportation in this 
device. Peristaltic pumps are a form of positive displacement pump. In the vast majority of peristaltic 
pumps, fluid is driven by running a roller along a flexible tube against a circular outer casing. The tubes 
are thus occluded where the rollers have contact, and liquid is thus driven up the tube as the roller 
moves onward. After the roller passes a section of the tube, the tuber expands back, resulting in 
negative pressure which draws liquid into the tube. This peristaltic mechanism is similar to those found 
in biological cases such as the gastrointestinal system.  
One of the inherent advantages of the peristaltic pump is the complete isolation of the tube interior 
surface from the mechanical components of the pump. This is a significant advantage since mechanical 
parts of any pump are difficult to sterilize, mainly because good sterilization techniques are 
incompatible with sound mechanical operation. In peristaltic pumps, the cleanliness of the exterior 
mechanical parts of is irrelevant since only the interior surface of the flexible tube comes in contact with 
reagent. The reverse is also true; in that isolation of the liquid from the mechanical components also 
protects the mechanical components from damage should the pumped liquid be particularly reactive. 
This is not likely to occur with the reagents used in the SELEX process, but broadens the option of 
cleaning methods that can be implemented. 
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Other advantages of peristaltic pumps include mechanical simplicity, and the fact the peristaltic pump 
blocks all liquid movement while not in operation, allowing it to act as a valve. This removes the need 
for a valve to regulate against liquid backflow and overflows in the main channel where the pump is 
present. Although there are limitations in the performance of peristaltic pumps such as maximum flow 
rates and pulsatility, these are not significant ones in the system described here. 
 
6.05b Peristaltic Pump 3 (Welco WPM-E) 
Attempts was made to build an in-house peristaltic pump based on parts fabricated by 3D printing, 
though none were able to achieve the level of precision or mechanical reliability needed for practical 
SELEX operation. The datasheet for the WPM-e pump can be found here [173]. 
In the final design, a commercially available peristaltic pump was selected for the LHS system. The Welco 
peristaltic pump proved to be accurate, chemically resistant and mechanically highly reliable. The device 
was also compact and relatively easy to assemble and disassemble.  
WPM series peristaltic pumps are modular, and thus a number of options regarding structural materials 
and drive motor were available. WPM2-P2EA-CP variant was selected. This variant uses a Pharmed BPT 
for peristaltic tube material and a stepper motor as drive motor. The former was selected for its 
generally good chemical resistance and excellent heat resistance, which should facilitate cleaning 
process. Tube inner diameter was 2mm. Stepper motor was selected for accuracy, controllability and 
simple integration with existing software. The pump is capable of operating under 80°C, which should 
exceed operational requirements.  
The entire device could be autoclaved in disassembled state, though this should not be necessary, as 
only the internal surface of the tube comes into contact with the reaction and thus needs to be 
sterilized. Life span of tube is >1000 hours, which is better than silicone, and the tube could be 
autoclaved repeatedly at 135C. 
The device was tested using SELEX buffer as fluid. The mass of liquid transferred is calculated by weight 
change of a weighing boat. 
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Fig 6.12 Output of Model 3 in weight of liquid transferred standardized to 2.7mm effective movement. 
This translates Gcode based movement commands into syringe movement, which should determine 
volume pumped. Volume is measured in weight due to mode of measurement (a Sartorius scale) 
The results would indicate that the WPM-e pump is able to transfer liquid with a resolution sufficient for 
this application. 
 
6.06 Electromagnetic Separation System (ESS) 
In the final design of the ASD, Magnetic Nanoparticle (MNP) based partitioning of target bound DNA 
from unbound library, as well as single strand separation of affinity selected sequences from PCR 
product was used.  
 
6.06a Preparation of Target MNP 
Target is bound to Streptavidin Coated MNP by a commonly used, NHS-Biotin mediated, bioconjugation 
protocol which can be found in the methodology section (see page 77) 
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6.06b Streptavidin Coated MNP (SCMNP) separation non-selected amplification product 
The ssDNA output library selected by affinity selection should (in theory) all bind to the target molecule. 
However as these sequences are only a small fraction of the input library they need to be re-amplified 
prior to the next selection round. The PCR amplification process generates a double stranded product 
with complementary sequences to the original template.  
This results in the loss of effective DNA concentration, since some sequences will no longer be able to 
bind to target as a result of binding with complementary sequences, as well as possible introduction of 
non-target specific sequences with high affinity to platform.  
A common method of removing these complementary sequences is through the use of biotinylated 
reverse primers during PCR. This results in the final amplified library containing biotinylated reverse 
sequences and unbiotinylated forward sequences. By incubating the amplified pool with excess 
streptavidin-MNP, most of the reverse sequences become bound to the MNPs and can be selectively 
removed from the solution. A comparison of conventional MNP separation protocol and the automated 
MNP separation protocol developed for this study can be found in the protocol section of this chapter 
(see page 194)  
 
6.06c Design of Electromagnet 
Most conventional electromagnets are composed of wire wound around an iron core. In the final design, 
the core is composed of multiple laminar layers of thin insulated iron sheets, derived from the “E” 
component of an E-I lamination. This core design acts as the equivalent of multiple individual magnet 
circuits, each one receiving a small portion of magnetic flux. Since eddy current flows around lines of 
flux, the lamination reduces eddy currents, restricting its flow to smaller, high resistance regions. 
Reduction of eddy currents is important in order to reduce losses by induction heating. An E shaped core 
was selected to increase the surface area of contract between the magnetic pad and the affinity 
selection chamber.  
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The wound wire is composed of copper, 0.5mm in diameter. Application of current through this wire 
results in the formation of a magnetic field, with the polarity of the central prong of the “E” being 
opposite to those of the flanking prongs.  
  
Fig 6.13 Model 3 Electromagnet. (Right) in loose state (Left) In position during operation, note affinity 
selection chamber location between the two magnet prongs.  
The final design of MSS is composed of two of the above described magnetic cores arranged in mirror 
image of each other and held in place with an assembly fabricated from CNC milled PVC. The space 
between the cores is equal to the width of the heating tube surrounding the affinity selection chamber. 
This allows the magnets to be as close to affinity selection chamber as practicable, which is important 
since magnetic field strength drops exponentially as a function of distance.  
Current flow direction is applied in the opposite direction in the two magnets, which result in 
complementary charges between all 3 prongs of both electromagnets. Thus main magnetic field 
between the two magnets run between the prongs and their complements on the other magnet, rather 
than between the differently changed center and flanking prongs. 
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Fig 6.14 Comparison between the EM field of a system with one magnet only and a system with two 
complementing magnets 
 
6.06d Results for ESS 
A pilot simulation of the SELEX operation was conducted in order to determine the performance of the 
ESS. The MNP retention protocol is identical to those of the final SELEX operational protocol, but with 
the wash length extended by 100%. Flow rate during wash is 42 ul/s (13.4mm/s liquid movement along 
flow tube, or F600 in Gcode terms). 
Perhaps the easiest method of quantifying MNP mass in solution is through observation of turbidity, the 
more particles in solution the greater the obstruction of light. A UV/Vis spectrophotometer in scan 
mode could be used as turbidity meter. A literature review did not reveal any previous study describing 
the quantification of MNP using UV/Vis spectrophotometry which could be applied to this application, 
and reference regarding quantification of MNP by UV/Vis spectrophotometry does not exist in the MNP 
manufacturer’s handbook.  
Since no reference sample is available, 3 known concentrations of MNP were used as baseline for 
comparison, these being 100%, 30.3% and 15.2% of the concentration of the MNP in the reservoir (and 
33%, 10% and 5% of the stock MNP solution). Results from MNP retainment from a previous model of 
ESS and from a hand placed strong magnet (80mm long) is also included for comparison. The UV/Vis 
spectrophotometry results of a full concentration of the above samples were not able to distinguish 
between the higher concentrations results, and so all samples were diluted down by a factor of 1/3. 
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Fig 6.15 UV/Vis Spectrograph comparing concentration of MNP isolated using different protocols and 
known concentrations, all samples were diluted down by a factor of 1/3. 
The UV/Vis results would indicate that the final model of ESS is capable of retaining at least 30% of the 
MNP concentration of the input reservoir. The reservoir concentration of MNP is 0.33mg/ml, and 
therefore retained concentration of MNP is 0.1mg/ml. Since target load is 400 pmole per mg of MNP 
(based on manufacturer specifications [174]), this equates to target mass of 1.26 pmole per 10mm 
section of 2mm ID affinity selection chamber. The estimated effective length of the affinity selection 
chamber is 120 mm, therefore total target mass is expected to be at least 15.1 pmole.  
Expected oligonucleotide load is at least 500 pmole per mg of MNP based on manufacturer’s 
specifications [174]), which equates to 18.9 pmole per 120 mm of flow tube length. This is considerably 
below the capacity needed to bind the same volume of 0.4 uM reverse biotinylated sequences present 
in the PCR product solution (both unreacted primers and amplified sequences), which would require a 
binding capacity of 151 pmole. However it should be noted that these figures are based on worst case 
assumptions, with total MNP retainment of 30% (which the results above would indicate that the final 
ESS exceeds). It should also be noted that the total binding capacity per mg of MNP is 2.5 nmole and 
that, due to the shortness of sequence used in this study more oligonucleotide could be bound per mg 
of MNP than 500 pmole. 
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6.06e Results of MNP mediated ss Separation 
The product of MNP separation can pose a challenge to the quality control, as they are similar in 
appearance to the non-specific large amplicons discussed in the Temperature Control System section of 
this chapter (see page 205), typically appearing as multiple distinct bands of different sizes on the 
agarose gel.  
 
Fig 6.16 A comparison of gel electrophoresis results of series 1 from archive samples, with ladder in right 
most well, followed by rounds in ascending order (R1 left most, R12 right most) (left) immediately after 
PCR and (right) after MNP separation. Note that the presence of large non-specific amplicons that have 
started to accumulate by round 11. 
It is hypothesized that the cause of this appearance is the formation of secondary structures by the 
ssDNA product of single strand separation. While the primers of the Trilink library have been designed 
specifically to have no complementarity to each other, the presence of the 30bp random means that 
sequence to sequence affinity is possible. These secondary structure travel down the agarose gel at a 
slower rate, since these aggregates have combined molecular weight greater than the single stranded 
single sequences, resulting in appearance of multiple bands. A comparison between the post PCR and 
post SCMNP based ss separation products (both generated manually for archival and feedstock 
generation purposes), could be found below (see Fig 6.18).  
This analysis is supported by the results of Lambda nuclease digested product, which shows very similar 
results when analyzed using agarose gel. While MNP and Lambda based single strand separation are 
very different, the product of both processes are similar (single stranded sequences, though biotinylated 
sequences are retained in lambda cut, while MNP separation retains non-biotinylated sequences). Since 
Lambda digest is a heatless process in the absence of PCR solution (unlike the automated series 8 SELEX 
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MNP separation process, which is done in the presence of both), the formation of non-specific large 
amplicons during the lambda digest process is impossible and thus the appearance of multiple bands 
can only be the result of ssDNA aggregation as a result of secondary structure formation. 
 
Fig 6.17 PCR product after cleaving by Lambda nuclease. Note similarity between the band patterns to 
those of ss MNP separation, a process with analogous end results.  
Because the automated SELEX protocol includes automated SCMNP based single strand separation (and 
therefore delivers the SELEX product in an ss separated state), this imposes a significant challenge to 
quality control since it prevents the presence of large non-specific amplicons from being observed 
directly by gel electrophoresis of the automated SELEX product (which appears as multiple bands 
regardless of the presence of large non-specific amplicons). It is impossible to extract the product of 
automated PCR (where the presence of large non-specific amplicons could be easily observed on 
agarose gel) and return it for single stand separation due to the volume of the solenoid valve chamber 
(see section 6.10 of this chapter, page 241).  
The solution for this is to observe the product of PCR performed using the single strand separation 
product as template. Secondary structures formed from short sequences are denatured in the melting 
step of PCR, resulting in the breakdown of these aggregates. The component short sequences receive 
complementary sequences with greater thermal stability than the secondary structures, and thus 
secondary structure do not reform after the PCR process. This results in a single distinct band. Non-
specific large amplicons contain primers binding regions, and the whole sequence is amplfied by the PCR 
process, resulting PCR product which display multiple bands of varying sizes on the agarose gel. 
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Fig 6.18 A comparison between gel electrophoresis of (ss separated) extracted product and PCR product. 
Left to Right 1) 100bp ladder 2) ASD product extracted immediately after PCR 3) ASD product, extracted 
after manual MNP ss separation 4) Sample (3) used as template for 12 cycles of manual PCR  
 
6.07 Electronics 
6.07a Arduino 
Arduino is a low cost open-source single-board microcontroller. The Arduino hardware is effectively 
composed of an eight bit Atmel microcontroller (the exact chip varies depending on board) along with 
its necessary infrastructure needed in order to allow it to function (such as a 16MHz clock and 5V 
regulator), and facilitate communication with other devices (such as blank pins used to communicate 
with actuators and sensors and a USB port for communication with a PC).  
The Arduino board variant selected was the Arduino Mega, which contains an Atmel Atmega1280 8 bit 
microcontroller. The datasheet for this device can be found here [175], and for the microcontroller here 
[176]. ArduinoMega board has a total of 39 standard digital pins, 15 PWM digital pins, and 16 analogue 
pins, this exceeds the requirement of the SELEX device, which require 14, 2 and 2 of each respectively. 
The 5V control circuit Arduino board is powered directly by the USB cable. The system has a maximum 
current output of 40mA per I/O pin, and a voltage of 5V. This necessitates the use of an amplifier, which 
mimics the communication signal from the I/O pin of the Arduino board, but with much greater 
amplitude.  
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6.07b Design of Amplifier Circuit 
Both electromechanical relays and solid state transistors were considered for use as amplifiers for the 
remaining actuators. MOSFETs were selected due to lower cost, smaller size and compatibility with 
PWM based temperature control system.  
IRLU 024 MOSFETs (datasheet can be found here [177]) are used for all amplifier circuits connected to 
solenoid valves and electromagnets. The gate pin of the IRLU 024 is connected to the blank digital pin 
assigned to this actuator on the Arduino. A 2kOhm resistor is placed between the MOSFET gate and the 
blank pin as a current limiter. MOSFET ground pin and signal is wired to ground through a 10 kOhm 
resistor. Tyco Electronics RXEF025 Polyswitch [178] is added as a precaution to prevent over current 
from damaging the system. This is particularly important during prototyping stage while the circuit was 
constructed on breadboard, and loose wiring was common. A Vishay 1N4148 [179] flyback diode is 
present to protect system from voltage spikes as a result of inductive load (all actuators in this system 
has a coil magnetic component with the exception of the temperature control system).  
The LED and its current limiter does not play a role in the SELEX machine operation, but are primarily 
present to allow inspection and testing of circuits without the actuator being connected. Additionally 
the solenoid valve housing and the manifold completely enclosed the valve mechanism, thus the only 
method of determining solenoid valve on/off state is by observing the LED for the pin associated with 
this solenoid valve. 
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Fig 6.19 Design for amplifier component of circuit, designed on Eagle CAD.  
 
All MOSFET amplifiers on the circuits are wired in this fashion using the same components, allowing 
them to be interchangeable. This has the added benefit of increasing flexibility in case of future 
modifications. The only exception are the two MOSFETs controlling the heating tube for the 
temperature control system, which utilizes the more powerful International Rectifier IRF640n [180] 
MOSFET with an increased power rating to fulfill the requirements of the nichrome wire heater. This 
MOSFET was observed to heat up quickly during temperature ramps, and so a heatsink-fan cooler 
assembly was attached to the temperature control MOSFET to enhance heat dissipation. 
Stepper driver used to control the LHS is an A4988 Pololu [181] type device, another holdover commonly 
used in basic 3D printer setups. As mentioned in the LHS section, Stepper motor is a brushless DC motor 
that divides a full rotation into a number of equal steps. Each step is generally performed sequentially at 
high speed, giving the appearance of smooth motion, in the same way a PWM digital signal has the 
232 
 
appearance of an analogue signal. The quantitative mode of movement allows the position of the motor 
to be determined without the use of a feedback sensor, based on number of steps moved. 
In practice stepper motors are controlled by 2 signals, one either in a long 0/1 state signal determining 
direction of movement, the other pulsed as a short signal with each 1 resulting in a movement step. This 
signal is generated by the microcontroller as a 5V signal. This signal is not powerful enough to drive the 
mechanical motor, and thus a stepper motor driver (such as Pololu) is used to amplify this control signal, 
as well as provide fractional steps, which smooths out the motion of the stepper motor, reducing 
vibration and jerkiness.  
 
6.07c Migration to Printed Circuit Board (PCB) 
It was decided relatively early into the development of the ASD to migrate the electronics of the 
automated SELEX device onto PCB once electronics design becomes finalised. This was primarily done to 
decrease the total area of the circuit board and the number of failures due to loose connections as the 
complexity of the device increased with development. The PCB was wholly designed by the author using 
Cadsoft Eagle CAD software[182]. Microcontroller board and the PCB circuitry is connected to each 
other in a shield format.  
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Fig 6.20 PCB design for SELEX device control circuit. Red) Top Layer, Blue) Bottom Layer, Cyan) Milled 
Layer, White) Ink Annotation, Green) Copper Pads 
Unlike the breadboard, the PCB cannot be easily upgraded. Thus special care was taken to increase the 
numbers of redundant outputs in anticipation for future use. Two extra redundant solenoid valve 
control circuits were added beyond the number needed for all valves in the original circuit design. Two 
Pololu steppers were also integrated (one needed by original design). 6 digital, 2 analogue and 2 PWM 
connectors were extended on the Arduino shield for easy access in case of future needs. 12V auxiliary 
system power is kept separate from the remaining circuitry hardwired in an always on state, these are 
used by peripheral systems such as cooling fans.  
The PCB was fabricated by KAT Intertech Co.,Ltd. Migration to a PCB could be considered a considerable 
improvement. While no statistics were taken, failure rate decreased significantly after migration to PCB 
(no known failures related to electronics hardware took place). The only noticed flaw in the PCB design 
is that the circuit for the two cooled MOSFETs of the temperature control system are duplicated in 
mirror image to each other. This would result in the two MOSFET facing opposite directions when 
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assembled, preventing use of the same heatsink. This problem was easily resolved by abrading the PCB 
connection to one of the MOSFET, and reconnecting by wire soldering.  
 
6.08 Software 
The software of the SELEX device can be categorized into 3 main elements, the SELEX device-side 
sprinter firmware, PC-side Printrun software, and the Gcode instruction which supplies commands to 
the device. The relationship between this triad can be summarized as the Gcode providing specific 
instructions on how the specific task is to be carried out, the PC-based software providing a means for 
which this instruction could be communicated to the SELEX device in a way that is comprehensible to 
the firmware, and the firmware being the means by which the instruction is coordinated and 
communicated to the correct effector, enabling a correct response to be formed. 
 
6.08a Sprinter Firmware 
Sprinter is an open source 3rd party firmware commonly used in Reprap 3D printers. The firmware 
represents the non-volatile instruction sets of the device, installed within the flash memory of the 
Arduino device, and cannot be changed without complete re-programming. In a sense the firmware 
provides a basic set of functions to the device, providing an environment in which the more volatile 
software could function. The unmodified sprinter firmware can be downloaded here [183]. 
Sprinter firmware was chosen because it is a well proven software which is known for highly stability. It 
has existing infrastructure for PC interaction via USB, pre-existing control coding for motor and 
temperature control, and pre-existing coding for direct Gcode control of blank pins. The presence of SD 
card reading infrastructure in sprinter software raises the possibility in future times of building a 
platform capable of operating without a PC (by allowing the device to directly read Gcode from SD 
device), as well as communication pins needed for integration of direct input and display device to 
enable this. Sprinter is also relatively simple compared to similar 3D printer firmwares, allowing it to be 
easily modified.  
The sprinter firmware was used in a largely unmodified state. The only major modifications made to the 
Sprinter firmware were the integration of the improved PID described in the temperature control 
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section of this chapter (see page 205) by the author using detailed instruction available on both the PID 
designer’s website and the Arduino website’s reference page, as well as considerable assistance form 
the Arduino community in general.  
Some minor modifications to improve the accuracy of the temperature readout by calibration of 
thermistor table values. Some pins were also reassigned in order to allow for easier assembly on 
breadboard and IC board.  
 
6.08b Printrun 
Printrun was utilized without any modification from its original published form [184]. 
 
6.08c Gcode 
Gcode, the colloquial abbreviation of G programming language, is a commonly used numerical control 
programming language primarily used in computer controlled machining and other computer aided 
manufacturing. Gcodes are basically a list of sequential instructions for commanding a computerised 
machine to perform a series of sequential actions. For example, a AutoCAD generated .dxf file 
containing 3D model for one of the Solenoid Array parts is converted by ArtCAM to Gcode, which guides 
a cutting head through a tool path removing unwanted parts in a CNC milling machine, or a solidwork 
generated .stl file containing a 3D model for components of the Syringe pump is sliced by Slic3r to a 
Gcode, which results in the layered fabrication of the machine part by a 3D printer.  
As such most of the Gcodes deal with aspects of computer controlled milling and are not relevant to the 
SELEX operation. Less than a dozen Gcodes are utilized for the control of the SELEX devices: 
G4: Dwell, this causes the device to idle for a specified period of time. Example G4 S5 causes the device 
to idle for 5s. 
G1: Linear movement between two points. The program moves between two points specified via 
interpolated points between the two points, resulting in a linear movement via fastest route (ie a 
straight line). The device automatically calculates the number of steps needed by the stepper motor to 
achieve this. Rounds per second of motor rotation determines speed of movement, though for obvious 
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reasons number of rotation remains the same for all speeds. Direction of movement depends on the 
wiring of the stepper motor. Example G1 Y800 F1200, assuming we start at Y = 0, will induce a 80 cm 
movement at the rate of 20mm/sec. 
G92: Set coordinates to. In computer assisted manufacturing this sets the current position of the 
machine head to the coordinates specified. For this SELEX device it is invariably used as a means of 
resetting Y axis value to 0, resetting the movement. This prevents accumulation of Y value and makes 
the Gcode presentationally easier to understand and more amenable to later modification. 
M42: Switch blank pin on and off. This is used to switch the value of a I/O pin controlling a solenoid 
valve or the electromagnet on or off.  
M104/M140: Set temperature. Sets temperature for either the Affinity Chamber or the PCR Chamber of 
the device. Adjustment of temperature to fit this figure is otherwise automatic. Example M140 S90 sets 
the temperature of chamber controlled by Pin D08 to 90°C. 
  
6.08d Key Software Tasks for SELEX operation 
There are a number of tasks the SELEX device needs to be able to execute in order to perform a SELEX 
round. 
Liquid Handling 
As mentioned in the FRCS section of this chapter (see page 212), the liquid flow rate control from this 
system is controlled by a peristaltic pump, which is driven by a stepper motor. A stepper motor is the 
standard axis regulation component of a CNC milling/3D printer device also, as distances moved by the 
stepper motor can be very exactly controlled. While peristaltic pump’s operational unit for SELEX 
operation is flow rate, the stepping motors unit of action in Gcode is distance moved. Direction of 
movement is regulated by controlled opening and closing of solenoid valves. Control is achieved by the 
following script: 
 
M42 P[Input Port] S255 
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G4 S2 
G92 Y0 
G1 Y[Volume of Flow in theoretical distance] F1200 
G4 S[Time needed for Flow] 
M42 P[Input Port] S0 
 
The first line instructs switches on the O/I pin controlling the input port solenoid valve to high, opening 
the port. S255 simply means signal to high. 
The second line is a 2s wait to allow port to open (theoretical open time is 100ms). 
The third line resets the Y axis to 0 
Fourth line instructs the stepper to move theoretical machine tool to theoretical Y coordinate, result is 
peristaltic pump induced flow proportional to new Y axis value. 
Fifth line holds signaling in wait till step four is completely carried out. Wait time = (theoretical 
distance/movement speed) + margin for error. 
Sixth line closes input port. S0 switches I/O pin to low. 
 
Output port is always the 1st Drain (output from peristaltic pump) with the exception of the step 
reversing flow, at which point the opened solenoid valve is always the reverse Drain (this is the solenoid 
valve at the opposite end of the flow path to the peristaltic pump), source reservoir in such case is from 
the reserve coil attached to the peristaltic pump. Y movement in this case is completely analogous to 
positive movement, but with a negative value. 
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Temperature Control  
Temperature is controlled by heating block. As mentioned in the temperature control section of this 
chapter, temperature is regulated through feedback mechanism by the PID component of the firmware, 
Gcode simply sets the desired temperature of the heating chamber. The following script is used: 
 
M[M104 or M140] S[Desired temp] 
G4 S[Time of heating] 
 
Line 1 sets heating temperature 
Line 2 sets heating time by holds signaling in idle. A good rule of thumb is the desired heating period 
plus (ΔT/3) seconds for heating.  
Two important practical issues need to be emphasized here. 1) The power supply is not designed to 
operate both heaters at once at full power (this never happens in SELEX operation, it was noticed that 
the signal for heating is stuttered even at the initial ramp) 2) This system does not automatically reset 
temperature to 25°C once heating is complete. Thus all heating steps must necessarily be followed by 
M[M104 or M140] S25.  
The most important heating step for the SELEX process is the temperature cycling needed for the 
process of PCR. For the process of PCR the following script is used. 
 
M104 S90 
G4 S140 
 
X [M104 S90 
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G4 S60 
M104 S57 
G4 S65 
M104 S72 
G4 S55 
 
M104 S25 
 
The first 2 lines of the script is a 120s pre heating step, followed by Thermal cycles of 30s melting at 
90°C, 30s annealing at 57°C, and 30s extension at 72°C represented by the area in parenthesis. A delay 
of 30, 35 and 25s are added to the melting, annealing and extending steps respectively to allow heating 
unit to reach the set temperatures (these numbers are reached based on empirical observation). The 
last line returns the heater to room t3emperature. 
 
Magnetic Separator control 
The electromagnetic precipitator is used to separate MNP from solution. The EM precipitator are 
controlled in exactly the same way as the solenoid valves, both being on/off electromagnets. The 
following script is used: 
 
M42 P[Magnet Pin] S255 
M42 P[Magnet Pin] S0 
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The first line switches magnet on 
The second line switches magnet off 
 
In practice this would only result in the MNP in the immediate region nearest to the electromagnet to 
be attracted to the magnet. In order to ensure a significant part of the MNP in the flow tube is attracted 
to the magnet, the system is pulsed forward and backwards gently several times. 
X[ 
M42 P[BUFFER] S255 
G4 S1 
G92 Y0 
G1 Y15 F1200 
G4 S1 
M42 P[BUFFER] S0 
 
M42 P[REVERSE] S255 
G4 S2 
G92 Y0 
G1 Y-30 F1200 
G4 S2 
M42 P[REVERSE] S0 
] 
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It should be noted that during MNP precipitation, it is recommended that a decreased speed of 
movement is used in order to optimize MNP deposition by decreasing hydrodynamic force. 
 
6.09 Minimizing contamination and decontamination 
The importance of avoiding contamination in SELEX cannot be overemphasized. While good technique is 
essential in obtaining consistent results in any molecular biology application, it is particularly important 
in cascading processes such as SELEX, where products of earlier selection rounds are used in subsequent 
rounds of selection.  
The interior flow path of the final design of automated SELEX device is composed of EPDM rubber, PTFE, 
Borosilicate glass and stainless steel. These material are compatible with a wide range of chemical 
cleaning methods (applied by pumping through flow channels in the same manner as reagents), as well 
as high temperature high pressure steam cleaning up to 120°C (either by flooding the interior flow 
channels with high pressure steam or by autoclaving the entire flow path, including solenoid valve 
manifolds).  
The final full cleaning protocol is composed of firstly of disconnecting the reverse flow reservoir. The 
flow tube is then purged with MilliQ water (>100ml per input reservoir), followed by purging with steam 
(>15 sec per input reservoir), followed by purging with Virkon (>20ml per input reservoir), followed by 
purging with sterile buffer (>100ml per input reservoir). Subsequent to each step, the cleaning was 
applied in reverse direction with a reservoir connected to the output of the peristaltic pump, with the 
flow being ejected via the reverse drain. Steam cleaning requires the disconnection of the peristaltic 
pump. The reverse flow tube is cleaned by autoclaving, and reconnected after the final sterile buffer 
purge.  
 
6.10 Device Operation 
Although the product of selection could be sent through another round of SELEX automatically; for the 
purposes of evaluating the performance of the instrument it was decided to extract the sample after 
each round. This served to provide both an evaluation and reserve sample (should the instrument 
malfunction subsequently). Once extract the sample cannot be returned directly to the automated 
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system. This is because the internal volume of the affinity selection chamber (and therefore the volume 
of the extracted plug) is 395 ul (assuming a plug length of 126mm). The solenoid valve chamber on the 
other hand has an internal dead volume of >700ul when open which means a minimum feed volume to 
produce a 400ul plug is 1.1ml.  
 
Fig 6.21 Overview of the protocol used in the final device operation 
The library must therefore be amplified and the single strand separation performed manually and 
returned to the system via a solenoid valve (a 3ml volume in the reservoir is recommended). 
Concentration of the returned DNA is kept as close as feasible to the concentration of the extracted 
SELEX product. Thus while the returned library will be of different volume to the extracted sample, it 
should be of similar composition. 
As mentioned at the start of this section extraction of the product is necessary in order that quality 
control steps can be performed subsequent to every round of selection, so that data obtained could be 
used to further optimize the device and failed SELEX rounds could be identified. The incremental nature 
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of the development of this device also necessitates the synthesis of an archive sample, for use in pilot 
tests or in case an applied upgrade proves to be counterproductive.  
With future development, it is hoped that the device will be capable of performing multiple SELEX 
rounds in a consecutive manner, with reference sample generation and affinity assay being performed 
manually only occasionally between multiple automated rounds.  
A pre-selection round is carried out prior to the first round of selection in order to remove sequences 
with affinity for the MNP. No investigation of the product of this round was carried out, and the product 
was moved to PCR chamber for storage while affinity selection chamber was purged and replaced with 
target enriched MNP. The pre-selected library was then subsequently used in the first round of 
Selection. This round “0” and the first round of selection are performed back to back in a manner similar 
to consecutive SELEX operations. All subsequent rounds of selection follow the protocol described in the 
protocol section of this chapter (see page 194). 
 
6.10a Quantification of Extracted DNA concentration and Quality Control 
The concentration of DNA product of SELEX operation in the extracted samples cannot be directly 
quantified, since the mass of DNA in such sample is too dilute to be measured by the nanodrop device or 
display visible bands on agarose gel. However the concentration of the extracted sample could be 
determined after phenol/chloroform extraction and ethanol precipitation.  
Quality control was performed as described in the MSS section of this chapter (see page 222). 
 
6.10b ELONA determination of selected sequences affinity to target 
Material preparation for the ELONA process was performed manually. PCR was used to generate a pool 
of biotinylated forward (selected) sequence, using purified reference sample as template. The double 
stranded sequences were then cut with Lambda nuclease, which digests 5’-phosphorylated double 
stranded DNA in the 5’ to 3’ direction. Activity against single-stranded and non-phosphorylated 
sequences is negligible by comparison. Thus the biotinylated forward sequence and already single strand 
separated sequences are unaffected by lambda nuclease activity.  
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Fig 6.22 Mechanism of Direct ELONA 
The ELONA protocol used in this study can be found in the methodology section (see section 2.02e of 
chapter 2, page 74) 
 
6.10c ELONA Results for first series of SELEX rounds conducted 
Twelve rounds of SELEX were carried out in the first series, of which the first eight was used in ELONA 
assay. The extracted concentration and quality control data for these can be found in the Appendix J 
(page 319). 
 
Fig 6.23 Direct ELONA results for first series of SELEX rounds, performed against Lysozyme target 
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The results show no significant correlation between round of selection and average sequence affinity to 
target molecule. This could only lead to the conclusion that automated SELEX protocol was not 
successful in generating a final library with a high affinity to target analyte. 
As a response to the failure of the series 1, an attempt was made to determine the most likely cause of 
failure of the SELEX device, so that an attempt could be made to enhance the chance of success of 
future cycles. It was determined that, due to time constraints, major hardware improvements to the 
SELEX device was no longer a feasible option at this point. Thus improvements must be limited to 
protocol, minor hardware, and pre-operation preparation changes. Improvements undertaken are 
described below.  
Software/Protocol based improvement are as follows: 
Implement decreased feed rate during periods in which MNP is to be retained in affinity selection 
chamber by magnetization. This is to prevent loss of MNP material to hydrodynamic pressure.  
Implement agitation during incubation period as forward/backward pulses. This prevents settling of 
MNP during incubation. This improvement may result in a minor increase in liquid border distortion, but 
this trade off was considered acceptable.  
During the separation process the temperature of the affinity selection chamber was kept in an on state 
throughout separation including backflow to PCR chamber, rather than being switched off before back 
flow is implemented. The purpose is to prevent possible reformation of target-aptamer hybrids during 
cooling. Since the reverse flow leads to the heat resistant manifold, and PCR chamber, there is no 
chance of thermal damage to hardware. 
Increased buffer wash period on most buffer washes.  
Preparative improvements are as follows: 
Preparation of DNA library and SELEX product to use glass vessels exclusively whenever possible. This is 
to decrease loss of material as a result of adsorption to container surfaces. PTFE based container was 
also considered but rejected as not likely to provide improvement over borosilicate glass vessels used. 
Buffer preparation no longer to be autoclaved due to possible contamination from shared autoclave 
device. Vacuum filtration to replace autoclave as means of disinfection.  
246 
 
New lysozyme stock was ordered and stored at -20°C instead of 0°C 
Hardware based improvements are as follows: 
Redirection of heating tube cooling fan downwards away from storage vessels for reagents. This should 
decrease possibility of airborne contaminant entry into reagent vessel. 
Improved U shaped reagent bottle plug inlet tube to decrease entry of airborne contaminant to reagent 
storage. This replaces original tin foil cap.  
 
6.10d ELONA Results for second series of SELEX rounds conducted 
Eight rounds of SELEX were carried out in the second series, incorporating improvements suggested as 
feedback from series 1 ELONA results (see above), all of which were used in ELONA assay. The extracted 
concentration and quality control data for these can be found in the Appendix J (page 319). 
 
Fig 6.24 Direct ELONA results for second series of SELEX rounds, performed against Lysozyme target 
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Again, the results show no significant correlation between round of selection and average sequence 
affinity to target molecule. This could only lead to the conclusion that the improved operation protocol 
was not successful in generating a final library with a high affinity to target analyte, and that the 
improvements implemented the series of SELEX rounds has largely failed. 
 
6.10e Conclusion of ELONA results 
The ELONA results above would indicate that the ASM was not able to successfully enrich lysozyme 
binding sequence from the starting library. 
 
6.11 Potential Causes of Failure of SELEX Protocol 
Based on the results that have been obtained so far, it is possible to rule out a number of factors as 
potential causes in the failure of the SELEX device. 
It is unlikely that the PCR amplification protocol of the device is the cause of failed SELEX operation. This 
is because Gel Electrophoresis of SELEX product extracted after PCR amplification (but before MNP 
separation) show a single distinct band of correct MW when observed by agarose gel electrophoresis. 
Post-Selection but pre-amplification mass analysed by gel electrophoresis show no visible bands at that 
MW. Deterioration of PCR Master Mix is not suspected to be the cause of failure of the SELEX operation 
for the same reason. 
Nuclease contamination is unlikely to be the cause of failure since sufficiently high DNA mass of correct 
length was observed post-amplification. 
Liquid handling failure is unlikely to be the cause of failed SELEX operation since the presence of 
amplified mass of DNA suggest that PCR mastermix related plug (the longest step in the liquid handling 
process) has been successfully handled). 
Failure to retain MNP is unlikely to be the cause of failure of the SELEX operation, since the UV/Vis 
spectrograph of MNP mass retained after wash indicates at least 30% of MNP mass is retained (see 
section 6.06 of this chapter, page 222), which is above minimal threshold needed for successful SELEX. 
Sedimentation of MNP in reservoir and tubes is also unlikely to be cause of failure since visual inspection 
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reveals no sedimentation within the flow system. MNP reservoirs are agitated manually prior to MNP 
feeds (automated agitation has not yet been implemented by the latest mode).  
Thus having determined the components which are operating correctly, it is possible to narrow down 
the likely causes of failure of the SELEX device. At present there is a number of reasons for the failure of 
the automated SELEX process, the most likely of which are listed below, along with potential solutions: 
Perhaps the most likely cause of failure of the SELEX operation is the retention of non-specific sequences 
retained in system as a result of target-platform interaction. In other word the sequence amplified 
during the amplification stage of the SELEX operation is not the result of target-aptamer interaction but 
a sequence retained as a result of its affinity to a component of the SELEX platform. PTFE, stainless steel, 
and borosilicate glass are relatively unadsorptive materials. Since these material make up >95% of the 
path length in all models tested, the risk of adsorption of most of the platform is relatively low. The 
greatest weakness by far of the device is at the glass/PTFE tube joints, which are made of vulcanised 
rubber sleeves. In theory this sleeve should not be exposed to the operational solution flow at all. In 
practice gap between glass and PTFE tube result in a gap between the tubes, resulting in both minor 
liquid retainment and exposure of potentially adsorptive material. 
Based on this analysis, the solution to non-specific selection would be the replacement of all glass-PTFE 
EPDM joints with compression joints made out of PTFE. Negative side effect of this is that the joint will 
be impossible to disassemble, as pressure needed would break glass tube and distort the cross section 
of PTFE tube. It is also likely that the compression joint would increase gap at junction, increasing liquid 
retainment and distortion of flow boundary. Another potential solution is to increase the number of 
rounds and stringency of the pre-selection operation, which is designed to remove non-specific platform 
binders. 
Based on the UV/Vis spectrophotometry results, it is possible that the electromagnet does not retain 
sufficient MNP for total removal of PCR generated non-selected complementary sequences. This is 
discussed in the MSS section of this chapter (see page 222). As of the present time no solution to this 
problem has yet been determined.  
Insufficient heat during the separation stage could result in the failure of the separation process, 
resulting in the nucleotide remaining attached to the target-MNP. This would result in loss of the 
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selected library along with the target-MNP when the latter is purged via the drain. A solution to this 
would be to increase separation temperature, perhaps from 80°C to 90°C.  
Another potential cause of failure is loss of initial DNA library mass in reservoir as a result of non-specific 
adsorption to reservoir vessel (disposable syringes are made of polypropylene). This could be solved by 
simply fabricate future reservoir vessels out of milled PTFE. 
 
6.12 Concluding Remarks 
The automated SELEX device was unsuccessful in its intended objective in its present form. None of the 
operational series of SELEX rounds have succeeded in selecting a library with measurably increased 
affinity to the target molecule. 
It is impossible at present to determine conclusively whether mesofluidic device could potentially be 
successful in isolating nucleotides with high affinity to target with further development. The device 
design was developed (including all design, fabrication and testing) within a 15 month period. Thus very 
little optimization has been conducted using feedback from real tests. Time constraints also mean that 
no major modifications to the design philosophy has been considered at all, with all improvements 
based on feedback being limited to software, minor hardware, and pre-operation preparation changes. 
There are a number of future improvements which can be suggested for the device. The most obvious 
short term improvements are noted in section 6.11 of this chapter (see page 247). Many of the 
suggestions made there can be performed with minimal effort, if given the time to do so.  
It needs to be remembered that the final objective of the ASM is to perform multiple consecutive 
rounds of SELEX without human intervention. This may necessitate the addition of components not 
present in the final developed ASM, such as reagent coolers, input air decontaminators, and MNP 
solution mixers. These could be easily implemented (the first two have already been developed, but 
never integrated) respectively by the use of a Peltier’s element connected to a heat sink and aluminium 
block, combining the air intake tube of the reservoirs to a heating block, and either implementation of a 
motor spun magnet or simply by integrating a commercial magnetic stirrer.  
Despite the failure of the integrated device, the subsystems are able to adequately perform their 
specified functions, based on their component results. A number of parties have already expressed 
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interest in the PTFE solenoid valve manifold. The total cost of production of a single ASD is less than 
USD500 (GBP340, Bloomberg 180315), and the total developmental cost of this device did not exceed 
USD1300 (GBP886, Bloomberg 180315), which can be considered relatively low for an automated SELEX 
device.   
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Chapter 7: Concluding Remarks and Future Works 
The scope of the study undertaken for this thesis is divided into three sections.  
The first section of this thesis describes the design and development of an amperometric conformation 
change aptasensors for Kanamycin and Tetracycline, the former having a “signal off” and the latter a 
“signal on” output signal. Both sensors have reproducible signal trends, though variation in signal 
amplitude for both sensors were significant. Testing of the sensor in environmental sample matrix 
buffers showed no change in signal trend compared to those performed under clean buffer conditions. 
Further enhancement of the sensor by gel encapsulation has shown that it is possible to prevent signal 
loss from extended exposure to high nuclease concentrations. 
The Kanamycin and Tetracycline aptasensor were combined and migrated to an automated, 
multichannel format, which was able to detect the presence of both target molecules with minimal 
human intervention. 
This mode of sensing could be improved by the integration of additional conformation change 
aptasensor into the multichannel array. These sensors should target analytes whose detection would be 
beneficial in the environment investigated, such as valuable secondary metabolites for microbial 
product discovery, or toxic contaminants for agricultural regulation. 
Another potential area for future works is to test this sensor format in other environments where 
antibiotic detection could be useful, such as bioreactor monitoring for example. Alternatively, the sensor 
could be tested against a more diverse range of soil and agricultural effluence samples. 
While the gold disc electrode is useful for prototype sensor testing due to its simplicity, it is not 
amenable to scaling up for commercial scale production. Techniques such as gold sputtering and 
automated bioreceptor molecule deposition may not only improve rate of production and individual 
sensor cost, but also improve uniformity and consistency in the electrode fabrication process, resulting 
in a more uniform electrode batch signal amplitude. 
Using multiple large GDEs in a multichannel array also necessitates a large electrochemical cell, which 
results in wastage of reagents. It may be beneficial in future works to integrate multiple biosensors into 
microelectrode arrays.  
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Fig 7.01 Summary of studies conducted on CC Aptasensor. Studies performed in chapter 3 in white 
boxes, studies conducted in chapter 4 in orange boxes. 
The second area of this thesis describes the development of an amperometric biosensor based on 
Enzyme-Linked Oligonucleotide Assay (ELONA) technology. Sensing formats based on both direct and 
indirect ELONA were developed, though only the indirect ELONA based design displayed reproducible 
signal within the concentration ranged used in this study. This sensor has a reproducible signal trend, 
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with a significantly greater signal amplitude than the CCA desgn. However this sensor is also more 
complex than the CCA design, and relies on known spatial interaction between the TBA and HD22 
aptamers and the thrombin target.  
Future works should take one of two directions. The first would be to test the sensor in its most likely 
target environment (simulated by animal serum perhaps). The second would be to automate the IAELAB 
format, which should reduce the effect some of this sensor’s greatest weaknesses (complexity and 
potential for human error).  
 
Fig 7.02 Summary of studies conducted on Configuration Change Aptasensor.  
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The third area of this thesis was not yet complete by the time of conclusion of this study, and describes 
an attempt to develop an automated SELEX device based on mesofluidic flow channels. It was hoped 
that mesofluidic flow channels would retain both the advantages of the conventional SELEX protocols 
(large library and sequence variation), while also gaining the advantages of microfluidic SELEX (reduced 
contamination risk and less reagent wastage). The components deemed necessary for the SELEX 
operation (such as thermal cycler, liquid handling, and electromagnetic separation), as well as 
electronics and software infrastructure necessary for device operation, were designed and fabricated. 
These components individually performed to designed specifications in wet tests, though no nucleic acid 
with high affinity to target has yet to be successfully isolated.  
The most obvious areas of improvements which can be implemented for this device could be found in 
section 6.11 of chapter 6(see page 247). 
At present the ASD is performed in single round operations. The final objective of the ASD is to perform 
multiple consecutive rounds of SELEX without human intervention. The addition of components not 
present in the final developed ASD such as reagent coolers, input air decontaminators, and MNP 
solution mixers will be necessary to achieve this. These components could be easily implemented (the 
first two have already been developed, but never integrated) respectively by the use of a Peltier 
element connected to a heat sink and aluminium block, combining the air intake tube of the reservoirs 
to a heating block, and either implementation of a motor spun magnet or simply by integrating a 
commercial magnetic stirrer.  
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Fig 7.03 Summary of studies conducted on the automated SELEX device 
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Appendix A: Replicate Results of SWV of kanamycin fcn-aptamer biosensor’s 
response to kanamycin titration vs Ag/AgCl, performed in clean buffer. 
 
Replicate 5 of this series of titration can be found in the main body of the text. 
 
 
Table A.1 Summary of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer. 
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0 0.0226 0.0720 0.0727 0.0838 0.0689 0.0464 0.0379 0.0372 0.0453 
75 0.0224 0.0718 0.0752 0.0792 0.0759 0.0386 0.0332 0.0311 0.0346 
150 0.0153 0.0635 0.0621 0.0619 0.0520 0.0278 0.0243 0.0238 0.0291 
300 0.0108 0.0540 0.0508 0.0527 0.0419 0.0181 0.0166 0.0169 0.0139 
600 0.0050 0.0373 0.0390 0.0409 0.0358 0.0086 0.0081 0.0082 0.0064 
1200 0.0010 0.0301 0.0246 0.0309 0.0269 0.0062 0.0058 0.0036 0.0027 
2400 0.0000 0.0210 0.0134 0.0241 0.0202 0.0040 0.0000 0.0000 0.0026 
4800 0.0002 0.0156 0.0117 0.0113 0.0133 0.0088 0.0000 0.0000 0.0000 
Best-fit values 
Bmax -0.0349 -0.0775 -0.1028 -0.0650 -0.0620 -0.0585 -0.0463 -0.0474 -0.0550 
Kd 
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366.800
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248.900
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NS 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
Backgroun
d 0.0241 0.0752 0.0762 0.0860 0.0739 0.0476 0.0391 0.0378 0.0463 
Goodness of Fit 
Degrees of 
Freedom 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
R square 0.9796 0.9876 0.9879 0.9888 0.9391 0.9916 0.9898 0.9977 0.9846 
Absolute 
Sum of 
Squares 0.0000 0.0000 0.0001 0.0001 0.0002 0.0000 0.0000 0.0000 0.0000 
Sy.x 0.0018 0.0033 0.0037 0.0036 0.0073 0.0019 0.0020 0.0009 0.0028 
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Fig A.1 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 1 130714 
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Fig A.2 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 1 130714 
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Fig A.3 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 2 280714 
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Fig A.4 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 2 280714  
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Fig A.5 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 3 120814 
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Fig A.6 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 3 120814 
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Fig A.7 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 4 140814 
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Fig A.8 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 4 140814 
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Fig A.9 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 6 260914 
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Fig A.10 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 6 260914 
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Fig A.11 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 7 221214El1 
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Fig A.12 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 7 221214El1 
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Fig A.13 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 8 221214El2 
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Fig A.14 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 8 221214El2 
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Fig A.15 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 9 231214 
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Fig A.16 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in clean buffer, replicate 9 231214 
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Appendix B: Replicate Results of SWV of kanamycin fcn-aptamer biosensor’s 
response to kanamycin titration vs Ag/AgCl, performed in environmental matrix 
 
Replicate 1 the soil environment, replicate 1 of the soil sample with 2h incubation and replicate 2 of the 
faecal sample titration can be found in the main body of the text. 
 
 
 
Table B.1 Summary of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in environmental matrix 
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0 0.0257 0.0236 0.0161 0.0298 0.0400 0.0088 0.0123 0.0590 
75 0.0237 0.0142 0.0119 0.0283 0.0377 0.0134 0.0101 0.0595 
150 0.0183 0.0086 0.0114 0.0227 0.0290 0.0123 0.0110 0.0551 
300 0.0100 0.0021 0.0087 0.0192 0.0227 0.0082 0.0074 0.0503 
600 0.0051 0.0035 0.0064 0.0121 0.0183 0.0081 0.0055 0.0447 
1200 0.0003 0.0000 0.0000 0.0107 0.0148 0.0049 0.0017 0.0381 
2400 0.0000 0.0000 0.0017 0.0066 0.0054 0.0009 0.0000 0.0339 
4800 0.0000 0.0000 0.0000 0.0049 0.0071 0.0000 0.0000 0.0284 
Best-fit values 
Bmax -0.03877 -0.02633 -0.02051 -0.02913 -0.03973 ~ -7.751 -0.02421 -0.03616 
Kd 421.9 108 538.7 429.3 423.7 ~ 92543 1238 818 
NS 1.85E-06 4.39E-07 6.64E-07 1.99E-07 4.3E-07 
~ 7.722e-
005 1.48E-06 -2.1E-07 
Background 0.02719 0.02382 0.01554 0.03078 0.04082 0.01152 0.01221 0.06049 
Goodness of Fit 
Degrees of 
Freedom 4 4 4 4 4 4 4 4 
R square 0.984 0.9788 0.9603 0.9858 0.9747 0.8924 0.9837 0.9916 
Absolute 
Sum of 
Squares 1.31E-05 1.08E-05 1.01E-05 9.19E-06 0.00003 1.78E-05 2.84E-06 8.14E-06 
Sy.x 0.001811 0.001644 0.001591 0.001516 0.002739 0.002109 0.000843 0.001426 
277 
 
 
Fig B.1 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in soil sample matrix, replicate 2 010914El2 
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Fig B.2 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in soil sample matrix, replicate 2 010914El2 
 
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0 0.2 0.4 0.6 0.8
C
u
rr
e
n
t 
(u
A
)
Potential (V) vs Ag/AgCl
SWV of a Kanamycin Aptasensor in Soil Sample 
Matrix 
Buffer
Kan 75nM
Kan 150nM
Kan 300nM
Kan 600nM
Kan 1200nM
Kan 2400nM
Kan 4800nM
278 
 
 
Fig B.3 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in soil sample matrix, replicate 3 040914El2 
SWV derived peak current of a Kanamycin
Aptasensor in Soil Sample Matrix
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Fig B.4 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in soil sample matrix, replicate 3 040914El2 
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Fig B.5 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in soil sample matrix following a 2h incubation, replicate 2 241014El2 
SWV derived peak current of a Kanamycin
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Fig B.6 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in soil sample matrix following a 2h incubation, replicate 2 241014El2 
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Fig B.7 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performedin faecal sample matrix, replicate 1 040914El3 
SWV derived peak current of a Kanamycin
Aptasensor in Faecal Sample Matrix
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Fig B.8 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in faecal sample matrix, replicate 1 040914El3 
 
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0.55
0 0.2 0.4 0.6 0.8
C
u
rr
e
n
t 
(u
A
)
Potential (V) vs Ag/AgCl
SWV of a Kanamycin Aptasensor in Faecal 
Sample Matrix 
Buffer
Kan 75nM
Kan 150nM
Kan 300nM
Kan 600nM
Kan 1200nM
Kan 2400nM
Kan 4800nM
281 
 
 
Fig B.9 SWV of kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performedin faecal sample matrix, replicate 2 040914El4 
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Fig B.10 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to kanamycin titration 
vs Ag/AgCl, performed in faecal sample matrix, replicate 2 040914El4 
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Appendix C: Replicate Results of SWV of gel encapsulated and unprotected 
kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs Ag/AgCl, 
performed in clean buffer following 2h incubation in nuclease solution. 
 
  Gel Encoated Unprotected 
Ta
rg
et
 
C
o
n
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n
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n
 
(n
M
) 
1
7
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1
4
 E
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e
l 
1
9
1
2
1
4
 E
l1
 n
o
 G
e
l 
1
9
1
2
1
4
 E
l2
 n
o
 G
e
l 
0 0.0705 0.0512 0.0838 0.0689 0.0192 0.0235 0.0292 0.0230 
75 0.0594 0.0463 0.0792 0.0759 0.0234 0.0248 0.0253 0.0193 
150 0.0513 0.0395 0.0619 0.0520 0.0211 0.0243 0.0208 0.0156 
300 0.0352 0.0311 0.0527 0.0419 0.0188 0.0185 0.0146 0.0118 
600 0.0257 0.0233 0.0409 0.0358 0.0131 0.0150 0.0087 0.0087 
1200 0.0168 0.0145 0.0309 0.0269 0.0116 0.0110 0.0052 0.0070 
2400 0.0098 0.0099 0.0241 0.0202 0.0084 0.0086 0.0030 0.0028 
4800 0.0052 0.0083 0.0113 0.0133 0.0094 0.0078 0.0027 0.0015 
Best-fit values 
Bmax 
-
0.07028 -0.05545 -0.06496 -0.06203 0.000585 -0.0331 -0.03472 -0.02012 
Kd 328.5 519.8 314.6 379.6 -68.35 1241 388.2 258.4 
NS 
-4.1E-
08 1.38E-06 -2.7E-06 -5.4E-07 -2.3E-06 1.86E-06 1.08E-06 -6E-07 
Background 0.07139 0.05183 0.08603 0.07392 0.01701 0.02537 0.02987 0.02323 
Goodness of Fit 
Degrees of 
Freedom 4 4 4 4 4 4 4 4 
R square 0.9967 0.9983 0.9888 0.9391 0.7279 0.9664 0.9966 0.9939 
Absolute 
Sum of 
Squares 
1.35E-
05 3.19E-06 5.28E-05 0.000216 6.21E-05 1.18E-05 2.61E-06 2.53E-06 
Sy.x 0.00184 0.000893 0.003633 0.00734 0.003939 0.001721 0.000808 0.000795 
 
Table C.1 Summary of gel encapsulated and unprotected kanamycin fcn-aptamer biosensor’s response 
to kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease 
solution. 
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Fig C.1 SWV of gel encoated kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 1 171214El1 
SWV derived peak current of a Gel
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Fig C.2 SWV derived peak current response of gel-encoated kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 1 171214El1 
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Fig C.3 SWV of gel encoated kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 2 171214El2 
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Fig C.4 SWV derived peak current response of gel-encoated kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 2 171214El2 
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Fig C.5 SWV of gel encoated kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 3 191214El1 
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Fig C.6 SWV derived peak current response of gel-encoated kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 3 191214El1 
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Fig C.7 SWV of gel encoated kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 4 191214El2 
SWV derived peak current of a Gel
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Fig C.8 SWV derived peak current response of gel-encoated kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 4 191214El2 
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Fig C.9 SWV of unprotected kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 1 171214El3 
SWV derived peak current of an
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Fig C.10 SWV derived peak current response of unprotected kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 1 171214El3 
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Fig C.11 SWV of unprotected kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 2 171214El4 
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Fig C.12 SWV derived peak current response of unprotected kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 2 171214El4 
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Fig C.13 SWV of unprotected kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 3 191214El3 
SWV derived peak current of an
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Fig C.14 SWV derived peak current response of unprotected kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 3 191214El3 
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Fig C.15 SWV of unprotected kanamycin fcn-aptamer biosensor’s response to kanamycin titration vs 
Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution, replicate 4 191214El4 
SWV derived peak current of an
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nuclease solution
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Fig C.16 SWV derived peak current response of unprotected kanamycin Fcn-aptamer biosensor to 
kanamycin titration vs Ag/AgCl, performed in clean buffer following 2h incubation in nuclease solution 
replicate 4 191214El4 
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Appendix D: Replicate Results of SWV of kanamycin fcn-aptamer biosensor’s 
response to negative control titration vs Ag/AgCl 
 
Replicate 1 the Streptomycin and replicate 1 of the Gentamicin titration can be found in the main body 
of the text. 
 
 
Target 
Concentration 
(nM) 0608 E1 0608 E2 1208 El1   
Target 
Concentration 
(nM) 2409El1 2409El2 
0 0.058609 0.048495 0.062134   0 0.011525 0.034892 
75 0.055837 0.075639 0.066327   75 0.014261 0.031072 
300 0.057481 0.07534 0.067331   150 0.016936 0.034686 
1200 0.054075 0.069305 0.064964   300 0.015058 0.034791 
4800 0.053971 0.065464 0.059709   1000 0.014408 0.034256 
9600 0.057078 0.054443 0.061515      
 
Table D.1 Summary of kanamycin fcn-aptamer biosensor’s response to negative control titration vs 
Ag/AgCl 
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Fig D.1 SWV of kanamycin fcn-aptamer biosensor’s response to Streptomycin titration vs Ag/AgCl, 
replicate 2 060814El2 
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Fig D.2 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to Streptomycin 
titration vs Ag/AgCl, replicate 2 060814El2 
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Fig D.3 SWV of kanamycin fcn-aptamer biosensor’s response to Streptomycin titration vs Ag/AgCl, 
replicate 2 120814El1 
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Fig D.4 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to Streptomycin 
titration vs Ag/AgCl, replicate 2 120814El1 
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Fig D.5 SWV of kanamycin fcn-aptamer biosensor’s response to Gentamicin titration vs Ag/AgCl, 
replicate 2 120814El1 
SWV of a Kanamycin Aptasensor in
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Fig D.6 SWV derived peak current response of kanamycin Fcn-aptamer biosensor to Gentamicin titration 
vs Ag/AgCl, replicate 2 120814El1 
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Appendix E: Replicate Results of SWV of tetracycline fcn-aptamer biosensor’s 
response to tetracycline titration vs Ag/AgCl, performed in clean buffer. 
 
Replicate 2 of this series of titration can be found in the main body of the text. 
 
 
Ta
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n
 
(n
M
) 
1
8
0
7
1
4
 E
2
 
3
0
0
7
1
4
 
0
4
0
8
1
4
 E
1
 
0
4
0
8
1
4
 E
2
 
0
5
0
8
1
4
 
0 0.007178 0.021718 0.041409 0.063193 0.053365 
4 0.013424 0.044194 0.063381 0.104269 0.081326 
8 0.011966 0.05468 0.080107 0.116517 0.091782 
16 0.019599 0.059445 0.086778 0.125778 0.096692 
32 0.023717 0.065976 0.092279 0.129973 0.10313 
64 0.024779 0.06368 0.095375 0.127436 0.107315 
128 0.028908 0.060644 0.097772 0.137467 0.113035 
Best-fit values 
Bmax 0.02284 0.05335 0.06212 0.06946 0.05237 
Kd 16.89 5.053 5.721 2.553 3.404 
NS 8.53E-06 -9.9E-05 -2.4E-05 3.58E-05 6.78E-05 
Background 0.007345 0.02164 0.04093 0.06306 0.05333 
Goodness of Fit 
Degrees of 
Freedom 3 3 3 3 3 
R square 0.9613 0.9956 0.9916 0.991 0.9989 
Absolute 
Sum of 
Squares 1.44E-05 6.33E-06 2.11E-05 3.43E-05 2.61E-06 
Sy.x 0.002192 0.001452 0.002651 0.003382 0.000933 
 
Table E.1 Summary of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer. 
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Fig E.1 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer, replicate 1 180714El2 
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Fig E.2 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in clean buffer, replicate 1 180714El2 
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Fig E.3 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer, replicate 3 040814El1 
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Fig E.4 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in clean buffer, replicate 3 040814El1 
 
Fig E.5 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer, replicate 4 040814El2 
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Fig E.6 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in clean buffer, replicate 4 040814El2 
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Fig E.7 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in clean buffer, replicate 5 050814 
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Fig E.8 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in clean buffer, replicate 5 050814  
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Appendix F: Replicate Results of SWV of tetracycline fcn-aptamer biosensor’s 
response to tetracycline titration vs Ag/AgCl, performed in soil sample matrix. 
 
Replicate 4 of this series of titration can be found in the main body of the text. 
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0 0.073005 0.08922 0.091762 0.079315 
4 0.087003 0.11574 0.112105 0.103628 
8 0.087117 0.149825 0.123423 0.112893 
16 0.090669 0.160661 0.127574 0.12365 
32 0.094324 0.166797 0.132966 0.130682 
64 0.089485 0.165029 0.137831 0.138354 
128 0.086557 0.158061 0.13978 0.135245 
Best-fit values 
Bmax 0.02354 0.1098 0.04758 0.0675 
Kd 3.389 7.407 4.852 7.788 
NS -7.6E-05 -0.00027 1.93E-05 -5.8E-05 
Background 0.07313 0.08736 0.09165 0.07967 
Goodness of Fit 
Degrees of 
Freedom 3 3 3 3 
R square 0.9513 0.9687 0.9959 0.9963 
Absolute 
Sum of 
Squares 1.31E-05 0.000165 7.01E-06 9.62E-06 
Sy.x 0.00209 0.007418 0.001528 0.001791 
 
Table F.1 Summary of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in soil sample matrix. 
  
302 
 
 
Fig F.1 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in soil sample matrix, replicate 1 310714El1 
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Fig F.2 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in soil sample matrix, replicate 1 310714El1 
 
 
Fig F.3 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in soil sample matrix, replicate 2 310714El2 
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Fig F.4 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in soil sample matrix, replicate 2 310714El2 
 
 
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.2 0.4 0.6 0.8
C
u
rr
e
n
t 
(u
A
)
Potential (V) vs Ag/AgCl
SWV of a Tetracycline Aptasensor in Soil Sample 
Matrix 
0
4
8
16
32
64
128
305 
 
Fig F.5 SWV of tetracycline fcn-aptamer biosensor’s response to tetracycline titration vs Ag/AgCl, 
performed in soil sample matrix, replicate 3 110914El1 
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Fig F.6 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to tetracycline 
titration vs Ag/AgCl, performed in soil sample matrix, replicate 3 110914El1  
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Appendix G: Replicate Results of SWV of tetracycline fcn-aptamer biosensor’s 
response to erythromycin negative control titration vs Ag/AgCl 
 
Replicate 2 of the erythromycin titration can be found in the main body of the text. 
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0 0.073005 0.08922 0.091762 
8 0.087003 0.11574 0.112105 
32 0.087117 0.149825 0.123423 
128 0.090669 0.160661 0.127574 
512 0.094324 0.166797 0.132966 
1024 0.089485 0.165029 0.137831 
 
Table G.1 Summary of tetracycline fcn-aptamer biosensor’s response to erythromycin negative control 
titration vs Ag/AgCl 
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Fig G.1 SWV of tetracycline fcn-aptamer biosensor’s response to erythromycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 1 061014El3 
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Fig G.2 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to erythromycin 
titration vs Ag/AgCl, performed in clean buffer, replicate 1 061014El3 
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Fig G.3 SWV of tetracycline fcn-aptamer biosensor’s response to erythromycin titration vs Ag/AgCl, 
performed in clean buffer, replicate 3 161014El3 
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Fig G.4 SWV derived peak current response of tetracycline Fcn-aptamer biosensor to erythromycin 
titration vs Ag/AgCl, performed in clean buffer, replicate 3 161014El3 
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Appendix H: Replicate Results of SWV of automated kanamycin and tetracycline 
fcn-aptamer biosensor’s response to multi-target titration vs Ag/AgCl, 
performed in clean buffer in multi target assay 
 
Test 5 and 8 can be found in the main body of the text. 
 
 
Fig H.1 SWV of an automated Tetracycline Aptasensor, in multi target assay, replicate 1 (Test 3) 
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Fig H.2 SWV of an automated Kanamycin Aptasensor, in multi target assay, replicate 1 (Test 3) 
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Fig H.3 SWV derived peak current of an automated Kanamycin and tetracycline Aptasensor, in multi 
target assay, replicate 1 (Test 3)  
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Fig H.4 SWV of an automated Tetracycline Aptasensor, in multi target assay, replicate 3 (Test 8) 
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Fig H.5 SWV of an automated Kanamycin Aptasensor, in multi target assay, replicate 3 (Test 8) 
061114ElK1 
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
C
u
rr
e
n
t 
(A
)
Potential (V) vs Ag/AgCl
SWV of an automated Tetracycline Aptasensor, in multi 
target assay
Buffer
4.8uM
Kannamycin,
0.4
0.45
0.5
0.55
0.6
0.65
0.7
0.75
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
C
u
rr
e
n
t 
(A
)
Potential (V) vs Ag/AgCl
SWV of an automated Kanamycin Aptasensor, in multi 
target assay
Buffer
4.8uM
Kannamycin,
128nM
Tetracycline,
4.8uM
Kannamycin
312 
 
 
Fig H.6 SWV derived peak current of an automated Kanamycin and tetracycline Aptasensor, in multi 
target assay, replicate 3 (Test 8) 
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Appendix I: SWV of Thrombin fcn-aptamer biosensor with sandwich 
configuration (IAELAB)’s response to Thrombin titration vs Ag/AgCl 
 
Replicate 3 of this series of titration can be found in the main body of the text. 
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0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
75 0.1222 0.0950 0.1481     0.2595 
150 0.2062 0.2564 0.2905 0.2968 0.3867 0.3608 
300 0.3901 0.5330 0.4153 0.5191 0.8125 0.5402 
600 0.6801 0.4015 0.3132 0.7371 0.9319 0.8231 
1200 0.8286 0.6236 0.5751 0.8117 1.1294 0.8335 
2400 1.6442 0.7496 0.6719     0.8901 
4800 1.1883 1.0082 0.9147 0.9013 1.0606 0.8914 
Best-fit values 
Bmax 1.3400 0.5943 0.5485 1.1560 1.6160 1.1030 
Kd 660.9000 168.6000 144.2000 354.5000 341.0000 266.9000 
NS 0.0000 0.0001 0.0001 0.0000 -0.0001 0.0000 
Background -0.0145 -0.0235 -0.0100 -0.0092 -0.0144 -0.0006 
Goodness of Fit 
Degrees of 
Freedom 3.0000 4.0000 3.0000 2.0000 2.0000 4.0000 
R square 0.9956 0.9540 0.9946 0.9937 0.9825 0.9873 
Absolute 
Sum of 
Squares 0.0049 0.0371 0.0032 0.0037 0.0169 0.0102 
Sy.x 0.0403 0.0963 0.0327 0.0433 0.0920 0.0505 
 
Table I.1 Summary of fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl 
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Fig I.1 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 1 250414 
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Fig I.2 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 1 250414 
 
 
Fig I.3 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 2 300514 
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Fig I.4 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to Thrombin titration vs 
Ag/AgCl, replicate 2 300514 
 
Fig I.5 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 4 140514 
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Fig I.6 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to Thrombin titration vs 
Ag/AgCl, replicate 4 140514 
 
 
 
Fig I.7 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 5 150514 
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Fig I.8 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to Thrombin titration vs 
Ag/AgCl, replicate 5 150514 
 
 
 
Fig I.9 SWV of Thrombin fcn-aptamer biosensor with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 6 
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Fig I.10 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to Thrombin titration vs 
Ag/AgCl, replicate 6 
Appendix J: SWV of Thrombin fcn-aptamer biosensor with direct adsorption 
configuration (IAELAB)’s response to Thrombin titration vs Ag/AgCl 
 
Replicate 2 and 4 of this series of titration can be found in the main body of the text. 
 
 
Fig J.1 SWV of Thrombin fcn-aptamer biosensor with direct adsorption configuration (DAELAB)’s 
response to Thrombin titration vs Ag/AgCl, replicate 1 
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Fig J.1 SWV of Thrombin fcn-aptamer biosensor with direct adsorption configuration (DAELAB)’s 
response to Thrombin titration vs Ag/AgCl, replicate 3 
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Appendix K: SWV of unferrocenated Thrombin aptamer’s response to thrombin 
titration and Thrombin fcn-aptamer biosensor with sandwich configuration 
(DAELAB)’s response to Negative Controls vs Ag/AgCl 
 
Replicate 2 of unferrocenated aptamer titration, 2 of Lysozyme titration and 1 of BSA titration can be 
found in the main body of the text. 
 
 
Fig K.1 SWV of unferrocenated Thrombin aptamer with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 1 
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Fig K.2 SWV of unferrocenated Thrombin aptamer with sandwich configuration (IAELAB)’s response to 
Thrombin titration vs Ag/AgCl, replicate 3 
 
Fig K.3 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to BSA titration vs 
Ag/AgCl, replicate 1 
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Fig K.4 SWV derived peak current response of Thrombin Fcn-aptamer biosensor to Lysozyme titration vs 
Ag/AgCl, replicate 2 
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Appendix L: Quantification of Extracted DNA concentration and observation of 
gel electrophoresis of PCR product formed using extracted DNA as template for 
quality control purposes. 
 
Concentrations of DNA product of SELEX operation, determined after phenol/chloroform extraction and 
ethanol precipitation. It should be noted that the purification process typically results in the loss of 20-
35% of the DNA mass. 
 
Fig L 1 Concentration of DNA extracted after Series 1 of ASD operation 
 
 
Fig L 2 Concentration of DNA extracted after Series 2 of ASD operation 
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Gel electrophoresis results of archival/QC PCR performed on extracted DNA product of series 1 and 2 
operations.  
 
Fig L 3 Gel Electrophoresis of PCR product of DNA extracted from Series 1 operation. 
 
 
Fig L 4 Gel Electrophoresis of PCR product of DNA extracted from Series 2 operation. 
 
 
